Surfaces biomimétiques pour caractériser les interactions induites par les glycosaminoglycanes aux niveaux moléculaire, supramoléculaire et cellulaire by Thakar, Dhruv
Well-defined biomimetic surfaces to characterize
glycosaminoglycan-mediated interactions on the
molecular, supramolecular and cellular levels
Dhruv Thakar
To cite this version:
Dhruv Thakar. Well-defined biomimetic surfaces to characterize glycosaminoglycan-mediated
interactions on the molecular, supramolecular and cellular levels. Biochemistry, Molecular Bi-
ology. Universite´ Grenoble Alpes, 2015. English. <NNT : 2015GREAV005>. <tel-01367359>
HAL Id: tel-01367359
https://tel.archives-ouvertes.fr/tel-01367359
Submitted on 16 Sep 2016
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
 THÈSE 
Pour obtenir le grade de 
DOCTEUR DE L’UNIVERSITÉ GRENOBLE ALPES 
Spécialité : Chimie et Biologie 




« Dhruv THAKAR » 
 
 
Thèse dirigée par « Liliane COCHE-GUERENTE » et  
codirigée par « Ralf P. RICHTER » et « Didier BOTURYN » 
 
préparée au sein du Département Chimie Moléculaire  
UJF-CNRS UMR5250   
dans l'École Doctorale Chimie et Science du Vivant 
 
Surfaces biomimétiques pour 
caractériser les interactions 
induites par les 
glycosaminoglycanes aux 
niveaux moléculaire, 
supramoléculaire et cellulaire 
 
Thèse soutenue publiquement le « 07 septembre 2015 », 
devant le jury composé de :  
Mme Dorothe SPILLMANN 
Assistant professeur, Uppsala, Rapporteur 
Mme Sofia SVEDHEM 
Assistant professeur, Göteborg, Rapporteur 
M David FERNIG 
Professeur, Liverpool, Membre 
Mme Corinne ALBIGES-RIZO 
Professeur, Grenoble, Membre 
Mme Liliane COCHE-GUERENTE 
Maître de Conférences, Grenoble, Membre 
M Ralf P. RICHTER 
Professeur, San Sebastián, Membre 
 
 THÈSE 
Pour obtenir le grade de 
DOCTEUR DE L’UNIVERSITÉ GRENOBLE ALPES 
Spécialité : Chimie et Biologie 




« Dhruv THAKAR » 
 
 
Thèse dirigée par « Liliane COCHE-GUERENTE » et  
codirigée par « Ralf P. RICHTER » et « Didier BOTURYN » 
 
préparée au sein du Département Chimie Moléculaire  
UJF-CNRS UMR5250   
dans l'École Doctorale Chimie et Science du Vivant 
 
Well-defined biomimetic 
surfaces to characterize 
glycosaminoglycan-mediated 
interactions on the molecular, 
supramolecular and cellular 
levels 
 
Thèse soutenue publiquement le « 07 septembre 2015 », 
devant le jury composé de :  
Mme Dorothe SPILLMANN 
Assistant professeur, Uppsala, Rapporteur 
Mme Sofia SVEDHEM 
Assistant professeur, Göteborg, Rapporteur 
M David FERNIG 
Professeur, Liverpool, Membre 
Mme Corinne ALBIGES-RIZO 
Professeur, Grenoble, Membre 
Mme Liliane COCHE-GUERENTE 
Maître de Conférences, Grenoble, Membre 
M Ralf P. RICHTER 







































This  thesis work would  not  have  been  possible without  the  help  and  support  of  the 
people around me, who  in one way or another have assisted  in the completion of this 
project, to only some of whom it is possible to give particular mention here.  
Foremost,  I  would  like  to  express  my  sincere  gratitude  to  my  supervisors  Liliane 
Guerente, Ralf Richter and Didier Boturyn. First of all,  I am grateful  to Ralf Richter  for 
giving me the opportunity to carry out an exciting PhD project in his Chair of Excellence 
“GAG2D” project. From the beginning of my PhD you all have constantly challenged me 
and  there by  inspired me  to  further develop my  scientic knowledge. You have always 
given  me  the  freedom  to  venture  upon  newer  ideas  and  techniques,  and  always 
bestowed  me  with  confidence.  You  have  been  a  huge  source  of  knowledge  and 
inspiration. Your high scientific requirements, deep understanding of matter and perfect 
organization will be a benchmark for my future work. Thanks to all of you!! 
I am grateful  to Dorothe Spillmann and Sofia Svedhem  for  reviewing my  thesis and  to 
Corrine  Albiges­Rizo,  David  Fernig,  Liliane  Coche­Guerente  and  Ralf  Richter  for  being 
members of my examination board. 
Special thanks goes to Pierre Labbé for first of all introducing me to this PhD project and 
for providing me with  the opportunity  to work  in his  laboratory, and  finally  for all  the 
motivation during my entire stay in his lab. Merci beaucoup! 
Another  thanks  goes  to Didier  Boturyn,  Catherine  Picart  and Hugues  Lortat­Jacob  for 
joining my thesis committee, supporting my thesis, and fruitful discussions.  







supply  of  essential  material.  Special  thanks  to  Jerome  Dejeu  and  Angeline  van  der 
Heyden  for their support with SPR measurements. Another  thanks goes  to Rabia Sadir 
for many fruitful discussions, for supplying me with HS and proteins for my project and 
for  helping me with  the  synthesis  and Dot­blot measurements.  I  am  also  grateful  to 
Fabien  Dalonneau  for  introducing me  to  cell  culture,  and  helping me  in  all  the  cell 
assays.  Another  thanks  goes  to  Nico  Eisele,  Galina  Dubacheva  and  Severin  Ehret  for 






Another  thanks  goes  to Olivier  Renaudet  for  allowing me  to work  in  his  lab  and  for 
helping me in the oxime ligation.  



















This  thesis  would  not  have  been  possible  without  the  financial  support  from  the 
Nanoscience Foundation. 
I would also like to thank my second family in France, my friends Adrien, Hélène, Fabien, 
Hugues, Meenakshi, Priyanka, Safeer, Sidhartha, Marc, Noémie, Fatima, Carlo…. for their
support  and all  the nice  time  that we  spent during my entire  stay  in  France, and my 
French friends for teaching me French, specially Adrien. Merci!! 
Last  but  certainly  not  the  least;  I  thank my  family  for  their  unconditional  love  and 
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CS  Chondroitin sulfate    DAPI  4',6­Diamidino­2­phenylindole 
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The  adhesion  and  migration  of  cells  are  important  for  many  physiological  and 
pathological  processes,  including  development,  immune  response,  tissue  remodeling 
and repair, arthritis, tumor metastasis and angiogenesis [1, 2]. In particular, they are key 
in  muscle  development  and  repair  where  myoblasts  (muscle  precursor  cells)  are 
activated  and migrate  to  the  desired  site  to  promote muscle  formation  [3,  4].  The 
adhesion and migration of myoblasts  is guided by  signaling proteins  (chemokines and 
growth  factors)  that  reside  in  the  extracellular  space.  Polysaccharides  of  the 
glycosaminoglycan family (heparan sulfate (HS) in particular) bind signaling proteins. By 




models  mimicking  the  extracellular  environment  due  to  their  limited  availability  in 
sufficiently  pure  and  suitably  functionalized  form,  and  a  lack  of  methodologies  to 
integrate  them  into  assemblies.  The  objective  of  this  PhD  thesis  was  to  develop 
biomimetic surfaces that are highly defined and tunable, for mechanistic studies of GAG­
protein  interactions on the molecular and supramolecular  levels, and  to probe cellular 
responses  to  defined  biochemical  and  biophysical  cues  to  better  understand  GAG­
mediated cell­cell and cell­matrix communications. 
The outline of thesis is as follows: 
Chapter  I provides a general  introduction  into  the biological  context.  It covers muscle 
development and  repair, extracellular matrix  (ECM), and constituents of  the ECM  that 
are of particular importance for this thesis work, i.e. GAGs (HS in particular), chemokines 
(SDF­1α/CXCL12α  in particular) and  their  receptors, and  cell adhesion  ligands  (RGD  in 
particular) and their receptors. Chapter I also covers the methodology adopted to attain 





Chapters  III  and  IV  cover  the  supramolecular  level.  Chapter  III  presents  a  versatile 
strategy to create biomimetic surfaces that present GAGs together with chemokines and 
other cell surface or extracellular matrix molecules in a highly defined and tunable way. 






Chapter  IV  covers  the  application  of  well­defined  model  surfaces  to  study  the 
supramolecular  interaction  between  HS  and  soluble  signaling  molecules  (including 
chemokines). It is shown that such proteins can cross­link and rigidify HS films, and the 
functional implications are discussed. 
Chapter  V  is  dedicated  to  the  application  of  well­defined  surfaces  for  mechanistic 
studies with myoblasts  in the context of muscle development and repair. We  find that 

















L'adhésion et  la migration des  cellules  sont  importantes pour de nombreux processus 
physiologiques  et  pathologiques,  comprenant  le  développement,  la  réponse 
immunitaire,  le  remodelage  et  la  réparation  tissulaire,  l'arthrite,  les  métastases  et 
l'angiogenèse  tumorales  [1,  2].  Ces  processus  sont  essentiels  en  particulier  dans  le 
développement et  la  réparation musculaire où  les myoblastes  (cellules précurseurs du 
muscle)  sont  activés  et migrent  vers  le  site  concerné  pour  favoriser  la  formation  du 
muscle [3, 4].  L'adhésion et la migration des myoblastes sont guidées par des protéines 
de  signalisation  (les  chimiokines  et  les  facteurs  de  croissance)  qui  se  trouvent  dans 
l'espace  extracellulaire.  Les  polysaccharides  de  la  famille  des  glycosaminoglycanes 
(GAGs), ­l’héparane sulfate (HS) en particulier­ se lient aux protéines de signalisation. Ce 
faisant, ils aident à l’organisation et à la présentation des protéines de signalisation dans 





méthodologies  à  les  intégrer  dans  des  assemblages.  L'objectif  de  cette  thèse  est  de 
développer  des  surfaces  biomimétiques  bien  définies  et  modulables,  pour  l’étude 
mécanistique  des  interactions  protéine­GAG  aux  niveaux  moléculaire  et 





développement  et  la  réparation musculaires,  la matrice  extracellulaire  (ECM),  et  les 
constituants  de  l'ECM.  Ces  constitutants  sont  d'une  importance  particulière  pour  ce 
travail  de  thèse:  les  GAGs  (HS  en  particulier),  les  chimiokines  (SDF­1α  /  CXCL12α  en 











Les chapitres  III et  IV couvrent  le niveau supramoléculaire. Le chapitre  III présente une 
stratégie  versatile pour  créer des  surfaces biomimétiques  permettant d‘assembler  les 




Le chapitre  IV couvre en particulier  l'application de  ces  surfaces modèles à  l’étude de 
l'interaction  supramoléculaire  entre  le  HS  et  des molécules  de  signalisation  solubles 
(dont  les chimiokines). Il est montré que ces protéines peuvent réticuler  les chaines de 





CXCL12α  liée aux HS. La présentation des chimiokines par  les chaînes de HS affecte  le 
comportement des cellules, ce qui se  traduit par une motilité cellulaire plus marquée. 
De plus, un effet synergique entre  les récepteurs cellulaires, CXCR4  (le récepteur de  la 
CXCL12α) et  les  intégrines (les récepteurs des  ligands RGD) a été observé  lors de la co­
présentation des ligands respectifs. 
Les observations finales sont formulées et les perspectives discutées dans le chapitre VI. 
Le  travail de  recherche  accompli est présenté dans  les  chapitres  II  à V  sous  la  forme 
d'articles  et  de  manuscrits  en  préparation  pour  des  journaux  à  comité  de  lecture. 
Chacun de ces chapitres contient également des introductions plus détaillées, ainsi que 
des  descriptions  détaillées  des  matériaux  et  des  méthodes  utilisées.  Les  travaux 











Skeletal muscle  constitutes  one  of  the major  parts  of  the  human  body:  around  640 
skeletal muscles account for ~38% and 30% of total body mass for men and for women, 

















injury,  skeletal  muscle  undergoes  a  highly  orchestrated  regenerative  process  that 
involves the activation of satellite cells [9]. Satellite cells are stem cells and are located in 
a  niche  on  the  surface  of  the myofibre  (Figure  I.1.1).  In  response  to  injury,  they  get 
activated,  proliferate,  and  differentiate  into  myoblasts.  These  then  form  myotubes 




Figure  I.1.2: Muscle  regeneration.  The  repair  of muscle  in  response  to  an  injury  involves  the 
activation,  proliferation,  differentiation  and  fusion  of  myoblasts  that  are  derived  from  the 
satellite cells to form myotubes. 
The  regenerative activity greatly  relies on  the dynamic  interplay of  satellite  cells with 
their environment (i.e. the stem cell niche). An important part of the environment is the 












interaction  of  numerous  cellular  processes,  in  which  the  cell  is  guided  by  signals 
originating from the extracellular environment. Signals in the cellular microenvironment 
originate either  from the ECM  (cell­matrix  interactions) or  from neighboring cells  (cell­























essential  physical  scaffolding  for  the  cellular  constituents  and  signals  in  the  form  of 
biochemical and biomechanical cues (Figure I.1.4) [19]. The ECM directly  influences cell 
behavior  through  ECM­specific  receptors  on  the  cell  surface.  By  binding  to  the  ECM 
through  these  receptors,  cells  sense  their  surroundings  and  actively modulate  their 
behavior depending on ECM composition [20, 21]. 
The ECM  is composed of various biochemically distinct components  including proteins, 
(e.g.  collagens,  laminins,  fibronectin,  vitronectin,  elastin,  growth  factors  and  small 
matricellular proteins), proteoglycans, and polysaccharides. The precise composition of 
ECM  in contrast varies  from tissue  to tissue. Both the protein­rich and polysaccharide­
rich (glycosaminoglycans (GAGs) and proteoglycans) molecules of the ECM are secreted 




signaling molecules and presenting  them  to receptors on the cell surface  (Figure  I.1.4) 









Figure  I.1.4: Mechanisms  of  ECM  function.  The  versatile  functions  of  the  ECM  depend  on  its 
diverse  physical,  biochemical,  and  biomechanical  properties.  (1)  Anchorage  to  the  basement 
membrane; depending on contexts, the ECM may serve to block (2) or facilitate cell migration (3); 
In addition, by binding to chemokines and preventing their otherwise free diffusion, the ECM acts 
as  a  sink  for  these  signals  and  helps  shape  a  concentration  gradient  (4);  certain  ECM 
components,  including  heparan  sulfate  proteoglycans  and  the  hyaluronic  acid  receptor  CD44 
selectively bind  to different chemokines and  function as a signal co­receptor  (5) or a presenter 
(6). The ECM also directs signals to the cell by using  its endogenous growth factor domains (7); 
finally, cells directly sense  the biomechanical properties of  the ECM,  including  its stiffness, and 
change a wide variety of behaviors accordingly (8). Image taken from ref [27].  
The ECM is however not a static entity. It is modified, degraded and reassembled during 
















different  molecular  composition  than  the  surrounding  interstitial  matrix. 
Basement  membranes, for  example,  which  are  prototypes  of  pericellular 
matrices are primarily composed of  laminins, collagen  type  IV, and perlecan  (a 
heparan sulphate proteoglycan) [31]. 
For  the work  presented  in  this  PhD  thesis,  glycosaminoglycans,  chemokines  and  cell 




surface  (glycocalyx) and  in  the ECM. They are crucial  for matrix assembly, cell­cell and 





end  to  core  proteins,  forming  the  proteoglycan  [34,  35]  family  (Figure  I.1.5). 
Proteoglycans  occur  as  an  integral  component  of  cell  and  basement  membrane  in 
probably all  the mammalian  tissues.  Interaction of GAGs with other ECM components 
contribute  to  the  general  architecture  and  permeability  properties  of  basement 
membranes, and thus these GAGs play a structural role. Typically, GAG function relies on 
the integration of its multiple interactions with proteins. For example, GAGs control the 
remodeling  of  extracellular  matrices  by  binding  to  structural  proteins  [36,  37], 
crosslinking  proteins  [38,  39]  or  bulky GAG­binding  proteoglycans  [40­42]. Moreover, 
GAGs sequester [43, 44] and regulate the mobility [45] of chemokines or growth factors 
in matrix. Finally, the presentation of chemokines at controlled densities or in the form 







Figure  I.1.5:  An  electron  micrograph  depicting  a  lymphocyte  cell  stained  in  ruthenium  red 







a  glucosamine  [GlcN] or  a  galactosamine  [GalN]),  either or both  of which  (except  for 
hyaluronan)  could  be  sulfated  on  different  positions. With  such  a  basic  disaccharide 
constituent unit, an enormous molecular diversity is generated on three different levels 
for GAGs; firstly, the  length of these chains can vary (chain lengths can range from few 
to  few  thousand  of  disaccharide  units);  secondly,  individual monosaccharides  can  be 
structurally modified  (N­ and O­sulfations and epimerizations);  finally  the number and 
combinations of sulfated regions along an oligosaccharide chain can vary (Figure  I.1.6). 

















Hyaluronan (HA)  is the only GAG which  is not covalently  linked to a protein core  in the 
form of a proteoglycan, but instead interacts non­covalently with selected proteoglycans 
such  as  aggrecan.  It  also  interacts  with  other  proteins  via  their  hyaluronan­binding 
motifs. In addition, it has the simplest structure out of all GAGs as it is not sulfated; it is 
composed of  β­D­glucuronic  acid  (GlcA)  (1­3)­linked  to N­acetyl  glucosamine  (GlcNAc) 
(linkages between disaccharide units are 1­4). Keratan sulfate (KS) disaccharides consists 
of  β­D­galactose  (1­4)­linked  to N­acetyl  glucosamine.  In  chondroitin  sulfate  (CS),  the 
disaccharide unit is a galactose (1­3)­linked to N­acetyl galactosamine (linkages between 









they  interact with  a  plethora  of  ligands.  In  particular, HSPGs  bind  circulating  growth 









vary  in  size  from  ~32  to  500  kDa  [58].  Individual  HS molecules  can  be  imagined  as 
relatively flexible chains. For a mean Mw of 30 kDa, the corresponding contour length is 






and  polymer  modification.  The  biosynthesis  is  initiated  by  the  formation  of  the 






The  polymer  is  subsequently  modified  by  a  series  of  localized,  enzyme­mediated 
reactions that begins by N­deacetylation/N­sulfation of the GlcNAc and is followed by C­
5 epimerization of GlcA to iduronic acid (IdoA) and O­sulfation at different positions (C3 
















Figure  I.1.7:  HS  chain  is  polymerized  as  a  linear  succession  of  disaccharide  units  comprising 
alternating  D­glucuronic  (GlcA)  and  D­glucosamine  (GlcN)  residues.  Consecutive  stretches  of 
these units are modified by  the  concerted activities of multiple biosynthesis enzymes  (red and 




strong hydrophilic nature based on  their extensive  sulfation patterns, which  is  further 
enhanced when they are covalently linked to core proteins. Through their S­domains, HS 
bind  to  a  plethora  of  proteins  including  chemokines.  It  is  via  these  interactions with 
chemokines, that HS (and GAGs in general) control the adhesion and migration of cells.  
I.1.4.	Chemokines	
Chemokines  are  small  proteins  (8­12  kDa  in  their  monomeric  form)  which  possess 
chemoattractant properties.  These  proteins  bind  to  and  trigger  the  activation of  cell­
surface  receptors,  and  thus  regulate many  cellular  functions.  Chemokines  and  their 
receptors are important in various biological processes such as dendritic cell maturation 
[67],  and  T  and  B  cell  development  [68,  69].  Thus  they  are  essential  to  many 
developmental  and  physiological  possesses.  In  particular  chemokines  being 
chemoattractant proteins in nature, control and direct the orientated migration of cells 
during  development,  routine immune  surveillance,  development,  angiogenesis, 
neuronal patterning, hematopoiesis, wound healing,  inflammation, viral  infection, and 
metastasis [70, 71].  
The  chemokine  family  comprises  more  than  50  members.  In  contrast,  there  exist 























receptors which  bind more  than  one  chemokine.  HS  plays  a  vital  role  in  binding  of 
chemokines  to  its  receptors,  it  binds  and  presents  chemokines  to  the  receptor  at 
adequate  orientation  and  thereby  regulates  chemokine  binding  to  the  cell  receptor. 
Chemokine  receptors  are  G  protein­coupled,  seven­helix  transmembrane  receptors 
(GPCRs)  [71].  Chemokines  are  the  only members  of  the  cytokine  family  that  act  on 
GPCRs, where cytokines are small proteins which are important for cell signalling.  
According to the  latest nomenclature, chemokines are classified as CC, CXC, CX3C, or C 
chemokines  depending  on  the  presence  and  structure  of  the  first  two  conserved 
cysteine  motifs  in  the  amino­terminal  region  of  the  molecule  [72].  The  first  two 
cysteines are adjacent in CC chemokines (as in CCL5, commonly known as RANTES), are 
separated by  residues  in CXC  (as  in CXCL8  (interleukin­8,  IL­8) and CXCL12  (commonly 
known as stromal cell­derived  factor­1, SDF­1)). While C chemokines  (XCL1, commonly 
known  as  lymphotactin)  possess  only  a  single  cysteine motif  [73,  74].  This motif  is 
followed by an L  (for  ligand) and an  identifying number  (CCLn or CXCLn  for example). 
Similarly  chemokine  receptors  are named by  the  chemokine  class  they  recognize  and 
numbered  by  their  order  of  discovery  (CCR1  and  CXCR1,  for  example,  are  the  first 
discovered receptors specific for CC and CXC chemokines, respectively). 
	 I.1.4.b.	Migration	in	response	to	chemokines	
Chemokines,  once  secreted  in  response  to  different  stimuli,  are  presented  to  cells  in 
form of gradients which initiates cell migration [75]. This directional migration of cells in 
response  to  soluble,  freely  diffusing  chemoattractants  (chemokines)  is  termed 
chemotaxis  (Figure  I.1.8). GAGs  interact with chemokines and  thus  fulfill several  roles. 
They protect  secreted  chemokines  from proteolysis  [76]; prevent  them  from diffusing 
away  from  their  sites  of  production  and  dispersing  under  the  influence  of  flow,  and 
instead retain them; and finally present them to chemokine receptors [77]. The directed 














as  the  mitogen­activated  protein  kinase  pathway  (MAPK  pathway)  [79­81].  The 
activation  and  successful  signaling  of  GPCRs  is  detected  by  the  phosphorylation  of 
extracellular signal­regulated kinases (ERK), one type of MAPK. These complex signaling 
cascades regulate the adhesion and migration of cells [81]. In order for a cell to initiate 
migration,  it must  undergo  a  polarization  in  its morphology  which  will  enable  it  to 
convert  cytoskeletal  forces  into  a  net  cell­body  displacement.  These  morphological 
changes  involve the rearrangement of the cytoskeleton, changes  in filamentous F­actin 
and  the  formation  of  integrin­mediated  focal  adhesions.  The  cell  binds  and  detaches 
from  the  substrate  in  a  coordinated  manner  with  extension  and  retraction  of 
pseudopods executing the directional migration [82, 83]. 
GAGs  play  an  important  role  in  the migration  of  cells.  They help  in  organizing  and 









Stromal  cell­derived  factor­1  (SDF­1)  is  a member  of  the  CXC  chemokine  family,  and 
hence  called  CXCL12  [73,  84].  CXCL12  has  been  shown  to  be  important  in  cellular 
adhesion  and  migration  in  the  context  of  muscle  development  and  repair,  and  in 













cells  during  inflammation  [87,  88],  and  muscle  precursor  cells  during  embryonic 
myogenesis  [4,  89,  90].  The main  functions  of  CXCL12α  thus  include  leukocyte  and 
muscle  precursor  cell  migration  which  it  controls  by  interacting  with  its  receptors, 
predominantly CXCR4 and CXCR7. The CXCL12α/CXCR4 pair is important, as mice lacking 
either the CXCL12α or the CXCR4 gene die  in utero, with a number of defects  including 
severe  developmental  abnormalities  [91].  Unlike  most  other  chemokines,  the 
production  of  which  is  induced  by  cytokines  or  mitogenic  stimuli,  CXCL12α  is 
constitutively expressed in a large variety of tissues [92­94].  
Structure of CXCL12α: 
The  ternary  structure  of  CXCL12α  as  reported  by  Crump  et  al.  [95]  consist  of  a 





the  sequences are amino acids  that have been  shown  to be  implicated  in GAG­binding. ** KP 





residues  (B), 9 of which being  clustered  into  three putative BBXB HS­binding domains 
with  multiple  HS  binding  domains  (BBXB)  which  are  unique  to  this  isoform  (Figure 
I.1.11).  The  presence  of  the  elongated  C­terminal  reduces  the  interaction  of  the  γ­












an  elongated  30  amino  acid  C­terminal where GAG­binding  domains  (BBXB)  are  indicated  by 
black brackets. Image adapted from ref [43]. 
I.1.5.	HS­chemokine	interactions	
HS  hold  a  significant  biological  importance  as  they  are  key  role  players  in  various 
important biological functions via their interactions with chemokines. The study of these 
interactions  (structural  studies,  dynamics  and  functional  studies)  is  paramount  to 
understanding  the  biological  phenomena  associated with GAGs  as well  as  harnessing 
their properties for therapeutic applications.  
At the site of secretion, chemokines (usually highly basic proteins) bind to HS (or other 
GAGs)  (high  density  of  negative  charge)  through  ionic  interactions.  These  ionic 
interactions between GAGs and chemokines have been demonstrated  in vitro  [97, 98] 
and  in vivo [99].  In the absence of such  interactions, diffusion would occur, dissipating 
directional  gradients  and  ceasing  cell migration  [44].  In  addition,  surface­confined  i.e. 
GAG­bound  chemokines  elicit  different  responses  than  soluble  chemokines.  For 
example,  inside­out  signaling  of  integrins  requires  surface­confined  chemokines  [100­
103].  Paradoxically,  chemokines  are  simple  and  small  proteins  yet  they  orchestrate 





 Chemokine  processing.  Interaction  of  chemokines  with  membrane  serine 









dimerization  and  even  larger  oligomerization  states  of most  chemokines  [66], 
modulate  the  monomer–dimer  equilibrium,  or  even  promote  chemokine 
heterodimerization  [106],  thus  promoting  local  high  concentrations  of 
chemokines in the vicinity of the GPCRs [97]. HS favors dimerization by increasing 
the  local  concentration  of  the  chemokines.  The  oligomeric  state  of  the 













soluble  heparin  has  been  shown  to  inhibit  the  biological  effects  of  chemokines  as 
demonstrated  in  vitro  [98]  and  in  vivo  [114].  Recently,  soluble  heparin  and  HS were 
shown to negatively affect chemotaxis  in vitro mediated by CXCL12α [115]. In addition, 






of CXCl12α  is  close  to 9, hence  it possesses a net positive  charge under physiological 
conditions.  Since  the  interactions  between  chemokines  (and  other  heparin  binding 
proteins)  and  negatively  charged  HS  are  electrostatic,  this  may  lead  to  the  false 
perception  that  chemokines  bind HS  in  a  non­specific manner. However,  it  has  been 
shown that certain residues  in the chemokine sequence have specific  interactions with 






A  technique  to  determine  the  GAG  binding  sites  on  chemokines  is  to mutate  basic 
residues within linear sequences which contain the GAG­binding motif. Despite existing 
as  monomers  under  biological  conditions  in  solutions,  CXCL12α  tends  to 
dimerise/oligomerise  upon  interaction  with  GAGs  [118].  This  oligomerisation  may 
increase the affinity for GAG binding as a larger binding surface is created [119]. 
A few years ago, Lys24 and Lys27 were  identified as essential binding sites of CXCL12α 
on  heparin  by  Amara  et  al.  and  Sadir  et  al.  [76,  85,  86].  Arg41  and  Lys43 were  also 
involved  in  the  interaction, however are not essential. The authors also confirmed the 
involvement of Lys1 along with Lys24, Lys27 in the binding for the polysaccharide (Figure 
I.1.12).  In  addition,  an  octasaccharide  of  HS  was  demonstrated  as  the  smallest  HS 
fragment able to bind CXCL12α efficiently [85]. 
  
Figure  I.1.12:  Orthogonal  representations  of  the  model  for  the  interaction  of  heparin  with 
















observed  in  the  previous  model  from  Sadir  et  al.,  in  addition  to  another  20  other 
residues  on  CXCL12α  that  occur  outside  the  HS  binding  site.  This  observation  was 
attributed  to  a  heparin­induced  dimerization  event  as  has  been  observed  previously 
[118].  An  advantage  of  the NMR method was  the  use  of  13C  labelled  octasaccharide 
which  permitted  defining  also  the  residues  on  the  sugars  that  participated  in  the 
interaction. 
 
Figure  I.1.13:  Structure  of  CXCL12α  dimer  (ribbon  structure)  induced  by  13C  labelled 
octasaccharide. Image taken from ref [120]. 
The  above  studies  have  shown  that  the  heparin was  present  at  the  CXCL12α  dimer 
interface (Figure I.1.14A). Based on NMR, combined with SPR analysis of point­mutated 
CXCL12, Ziarek et al. have identified additional amino acids involved in the binding, and 
proposed  that  heparin  binds  nearly  orthogonal  to  the  dimerization  interface  (Figure 
I.1.14)  [121]. The differences  in  the structural aspects of heparin­CXCL12α  interactions 










Figure  I.1.14:  Schematic  representation  of  the  heparin­CXCL12α  binding  model  proposed  by 
Ziarek  et  al. where  heparin  promotes  CXCL12α  dimerization  by  contacting  residues  along  the 
entire  six­stranded  sheet.  The  highlighted  CXCL12α  residues  associate  with  heparin  as 
determined  by  two­dimensional  NMR,  mutagenesis,  SPR  (blue),  and  three­dimensional  NMR 
(purple). Image taken from ref [121]. 
However, unlike the α­isoform no work has appeared on the ability of γ­isoform to form 
dimers, which  suggests  that  the extended C­terminal of  the  γ­isoform may hinder  the 
formation of dimers. 
I.1.6.	CXCL12α	interactions	with	its	receptor	CXCR4	
Chemokines  which  are  first  bound  to  cell­surface  or  ECM­bound  GAGs,  are  then 
presented to their receptors. Binding to the receptor induces conformational changes in 
the  receptor,  and  thus  trigger  intracellular  signaling  pathways  implicated  in  cell 
movement and activation, explained in more detail below. 
A  common  factor  identified  from  different  studies  on  the  chemokine­receptor 
interactions is that the N­terminus is a key receptor binding domain involved in receptor 
signaling  [122­124].  A  few  years  ago,  a  two­site  model  for  binding  and  receptor 
activation was proposed by Crump et al. [95]. They proposed that at first the chemokine 
core  (RFFESH)  (Figure  I.1.10) binds to the exposed N­terminus of CXCR4; this serves as 
the  initial docking  step  (chemokine  recognition  site 1  (CRS1); “site one”). Then  the N­
terminal  residues  of  the  CXCL12α  bind  to  the  more  hidden  pocket  between  the 
extracellular  loops 2 or 3 within the co­receptor  (signal trigger, chemokine recognition 
site 2 (CRS2); “site two”) (Figure I.1.15). They found that the receptor activation requires 
Lys1  and  Pro2  residues  within  the  N­terminal  region  of  the  chemokine.  These  two 










CXCR4  separately  prior  to  interaction.  CXCR4  is  shown with  the  seven  helices  represented  as 
cylinders, which  are  connected  by  the  surface  and  cytoplasmic  loops.  The  N­terminal  and  C­
terminal segments of the receptor, and the N­ and C­terminus of CXCL12α, are annotated as N 







study  of  CXCL12α  in  the  presence  of  solubilized  CXCR4  demonstrated  that  a  small 
molecule compound, AMD3100 specifically dislodged the CXCL12α N­terminus from  its 
binding  site  on  CXCR4  without  displacing  the  bound  chemokine  core  domain  [128]; 
hence  providing  structural  evidence  supporting  the  two­independent  site  theory.  In 
addition to dislodging CXCL12α N­terminus, AMD3100 has also been shown to prevent 




In  2006,  Veldkamp  et  al.,  showed  that  a  single  sulfotyrosine­containing  N­terminal 
CXCR4 peptide has an increased affinity for CXCL12α [130], and that the monomer­dimer 
equilibrium  of  CXCL12α  is  shifted  towards  a  dimer  in  the  presence  of  the  sulfated 
















which  are  not  observed with  the monomer  CXCL12α  [75].  They  showed  that  the  N­
terminal sulfopeptide derived from CXCR4 bound to a ‘disulfide­locked’ dimer of CXCL12 




previously  observed  2:1  [132].  Thus  these  models  are  not  in  full  agreement.  The 
conformationally  flexible  and  unstructured  nature  of  the  N­terminal  of  CXCR4  has 




M1–K38,  ribbon). Chemokine N  terminus  (green) and N­loop  (blue) correspond  to the expected 









Recently,  Drury  et  al.  showed  that  CXCL12α  monomers  and  dimers  exert  opposing 
effects on migration. Low concentrations of wild type (wt) CXCL12α  induced migration, 
however,  low concentrations of constitutively dimeric CXCL12α or high concentrations 
of wt­CXCL12α,  failed  to  initiate migration  [133].  Importantly, both  the monomer and 
the  dimer  of  CXCL12α  activated  the  CXCR4  receptor  to  a  similar  extent.  The  authors 






dimers were  formed  by  forced  disulfide  bonds  between  two monomers  in  a  locked 
conformation, which are different from the dimers induced by HS attachment where the 
dimers  may  dissociate  upon  binding  to  the  receptor.  In  addition,  the  physiological 
relevance  of  the  chemokine  monomer­dimer  equilibrium  and  the  simultaneous 








adhesion  ligands and  receptors have been  identified, and  those  relevant  for  this work 
will be presented in the following.  
	 I.1.7.a.	RGD	(Arg­Gly­Asp)	
In  an  attempt  to  reduce  complex  macromolecular  ligands  to  small  and  simple 
recognition  sequences,  the  triad  sequence  RGD  (Arg­Gly­Asp)  was  discovered  by 
Pierschbacher and Ruoshlati [134­136] as a basic motif for cell adhesion  in fibronectin. 
Subsequently  it  was  also  isolated  in  other  adhesion  proteins  such  as  vitronectin, 
osteopontin,  collagens,  thrombospondin,  fibrinogen,  and  von Willebrand  factor  [137, 
138].  The  RGD  sequence  is  the  most  frequently  employed  peptide  sequence  for 
stimulated cell adhesion on synthetic surfaces. A likely reason for this is the simplicity of 
producing  it compared to the full  length protein, facilitating  its widespread distribution 
permitting exploitation of  its biological  impact on cell anchoring, behavior and survival. 






RGD  peptides  hold  importance  in muscle  development  and  repair. Mooney  and  co­
workers  showed  that  RGD  coupling  improved  the  initial  adhesion  and  enabled  the 
differentiation of myoblasts cultured on the surface of (2D) or  inside (3D) alginate gels 
[140]. In another study, RGD peptides were found to significantly improve myoblast cell 
adhesion onto grooved polystyrene  substrates  [141]. Kessler et al. demonstrated  that 
the  cyclic  analogue  c[­RGDfV­])  showed  20­  to  100­fold more  affinity  and  specificity 
towards  the  αvβ3  integrin  (receptors of RGD) over  its  linear analogue  [142, 143]. This 
integrin has been shown to be expressed by myoblasts and their interaction with RGD is 
important  in  controlling  adhesion  of  cells  during myogenic  differentiation  [144,  145]. 
Hence,  it  is  of  particular  interest  for  this  thesis  towards  the  study  of  muscle 
development and repair, and described in details later. 
	 I.1.7.b.	Intercellular	adhesion	molecule	1	(ICAM­1)	
Another cell­adhesion  ligand  is  intercellular adhesion molecule 1 (ICAM­1).  ICAM­1  is a 
member  of  the  immunoglobulin  family  of  proteins.  ICAM­1  is  an  endothelial­  and 
leukocyte­associated  transmembrane  protein  known  for  its  importance  in  stabilizing 




Integrins  are  proteins  that  traverse  the  cytoplasmic  membranes  of  the  cells.  Their 
extracellular domain binds cell adhesion ligands and their intracellular domain forms the 
link  to  the cytoskeleton  inside  the cells. The name “integrin” was given  to denote  the 





particular  α  and  β  subunits  determines  the  ligand  specificity  of  the  integrin.  Some 
integrins such as αvβ3 integrin bind to ECM proteins such as vitronectin and fibronectin. 








Figure  I.1.17: The  integrin receptor family.  Integrins are heterodimers; each subunit crosses the 
membrane. Different integrins specific to RGD, cRGD and ICAM­1 are highlighted that have been 
used in this thesis. Image taken from ref [152]. 
Although  not  all  integrins  have  the  same  extremes  in  activation  potential,  most 
integrins,  including  integrins expressed on endothelial cells, have “on” and “off” states. 
The  extracellular  domain  of  αvβ3  integrin  is  bent  or  folded,  thereby  hiding  the  RGD­
binding site and preventing ligand binding. Conversely, RGD­bound αvβ3  integrin has an 
unbent or straighter extracellular domain (Figure  I.1.18). Although  integrin cytoplasmic 

















transmigration  of  leukocytes  across  vascular  endothelia  in  processes  such  as 
extravasation and the inflammatory response [146]. 
In  the  context  of  this  PhD  thesis,  cRGD  was  used  as  cell­adhesion  ligand  to  design 
biomimetic  surfaces  in  the  context of myoblast adhesion and migration under muscle 
regeneration and repair  (Chapter V). As an  initial demonstration of concept, data with 
ICAM­1  in  the  context  of  leukocyte  adhesion  and migration  is  also  briefly  presented 
(Chapter III). 
I.1.8.	Biological	questions	and	methodological	approach	
The  objective  of  the  PhD  thesis was  to  develop  biomimetic  surfaces  that  are  highly 
defined  and  tunable,  for  mechanistic  studies  of  GAG­protein  interactions  on  the 
molecular  and  supramolecular  levels,  and  to  probe  cellular  responses  to  defined 
biochemical and biophysical cues to better understand GAG­mediated cell­cell and cell­
matrix communications. 
Our  approach  consisted  in  reconstituting  GAGs  and  other  cell  membrane  and 
extracellular matrix  components  (cell  adhesion  ligands  and  proteins)  into  tailor­made 














 How  do  immobilized  GAGs  modulate  chemokine­mediated  cell  adhesion  and 
migration?  Of  particular  interest  is  myoblast  adhesion  and  migration  in  the 
context of muscle development and regeneration. 
I.1.9.	GAGs	are	neglected	in	in	vitro	models	
On  the  molecular  level,  it  is  clear  that  the  interaction  kinetics  between  a  given 
chemokine  and  individual  binding  sites  on  the  GAG  chains,  and  the  structure  of  the 
complex,  will  be  functionally  important.  The  local  density  and  arrangement  of 
chemokine binding sites,  for example, will affect  re­binding and  thereby modulate  the 
residence  time  and  diffusion  of  chemokines. Also,  chemokine  oligomers will  not only 
bind with  enhanced  avidity  to  GAGs,  due  to multivalent  binding,  but  they may  also 
induce  cross­linking  and  clustering  of  several  GAG  chains.  With  other  words,  we 
hypothesized  that  the  supramolecular  presentation  of  the  GAG  chains  ­  their  local 
density, orientation and mobility – is an important parameter in the function of GAGs in 
cell migration. This thesis started with the realization that GAGs do not play the role that 
they  deserve  in model  systems,  and  that  the  ability  to  control  and  characterize  the 
supramolecular presentation of GAG chains, in vivo or in vitro, is very limited. 




within a  tissue)  [78]. For quantitative  investigations and mechanistic understanding,  in 
vitro  studies  have  proven  essential  in  which  the  chemokines  are  presented  in well­
defined spatial gradients to the cell, without the presence of GAGs [155]. Despite strong 
indications for their functional  importance, GAGs have so far been  largely neglected  in 




















extracellular matrix  components,  into  tailor­made  and multifunctional model  surfaces 
that recapitulate selected aspects of the in vivo situation. Such model surfaces enable a 
large  range  of  novel  and  quantitative  biomolecular  and  cell  biological  studies,  to 
understand  the  role  of  GAGs  in  cell  migration  and  in  cell­cell  and  cell­ECM 




other  relevant  biomolecules,  in  such  a way  that  the  orientation,  density  and  lateral 
mobility  of  the  exposed  biomolecules  can  be  controlled  and  tuned.  To  this  end,  the 
biofunctionalization of solid surfaces  i.e. designing biomimetic surfaces  is an attractive 
route. The development of such  surfaces was a main objective of  this  thesis work. To 
form biomimetic surfaces, we adopted a bottom­up approach with design steps covering 
different levels of complexity. 
Molecular  level: To  functionalize surfaces with biomolecules, an  important requisite  is 
the availability of specific molecular building blocks. Many building blocks were already 
available but a few needed to be prepared. 







is  original  in  that  we  combined  synthesis  strategies,  state­of­the­art  surface 







We aimed  for a generic platform  to  immobilize  functional molecules  (i.e. a  ‘molecular 
breadboard’,  described  in  detail  later).  The  platform  of  choice  was  a  streptavidin 
monolayer,  to which molecules with  a  biotin  tag  can  be  stably  attached.  It was  thus 
necessary to conjugate biofunctional molecules of interest with biotin. 
Reducing­end biotinylation of GAGs 





via  so­called  hydrazone  ligation.  This  method  was  already  established  in  the 
collaborating  laboratory of Hugues  Lortat­Jacob  and  applications had  frequently been 
reported  [86,  158,  159].  However,  we  found  these  conjugates  to  be  unstable.  This 









end,  amide­coupling  and  a  PEG  chain  with  a  biotin  at  one  end  and  an  N­
Hydroxysuccinimide  (NHS)  group  at  the  other was  used.  The method  is  described  in 
detail  in Annex  (A.1). The PEG  linker between biotin and cRGD enabled control of  the 
thickness of cRGD film adsorbed on the molecular breadboard. 
I.2.3.	Supramolecular	level	
We  combine  state­of­the­art  surface  functionalization  strategies  with  a  toolbox  of 
sophisticated  surface­sensitive  characterization  techniques.  To  reconstitute  the 
biological structure, the molecular building blocks should be brought on the surface  in 
proper  order  and  at  the  right  concentrations.  The  preparation  of  well­defined  and 








a  diversity  of  chemical  and  topographical  patterns,  including  gradients,  on 
surfaces with  inherent  length  scales  that cover a continuous  range  from a  few 
nanometres  to  the  macroscopic  level.  In  combination  with  suitable 
bioconjugation methods, they can be employed as templates  for the controlled 
‘bottom  up’  assembly  of  biomolecular  architectures  on  surfaces.  Such  surface 
biofunctionalization approaches are now commonly applied to proteins, nucleic 
acids and  lipids  [160­162], and they are emerging  for carbohydrates  [163, 164], 
including GAGs [165]. 
 The  native  environment  of  biomolecules  is  water.  To  avoid  perturbation  or 
destruction of  the  sample,  in  situ  characterization  is mandatory. Over  the  last 
decades,  a  large  range of  sophisticated methods  for  the nanoscale  analysis of 
surface­confined  films  in  aqueous  environments  have  been  developed.  This 
‘toolbox’ of surface­sensitive techniques is exquisitely suited for the detailed and 
quantitative  characterization  of  soft  and  hydrated  films  at  the  solid­liquid 
interface, mostly without the need for labels. Parameters that can be quantified 










complexity of  the  real biological  systems. However,  starting  from a  simplified point of 
view on a specific question, the entire puzzle of the biological assembly can potentially 
be  solved.  Taken  together,  surface  science  and bioengineering  can  today provide  the 




One  of  the  paramount  challenges  of  developing  biomimetic  surfaces  is  the  correct 
choice of a solid support and the development of surface chemistry that  is compatible 
with  a  diverse  set  of  biomolecules  while  maintaining  their  integrity,  native 
conformation, and biological function. Various surface functionalization strategies have 
been  used  over  the  last  century  to modify  surfaces with  biomolecules  [166].  All  the 








below.  Self­assembled monolayers  (SAMs)  [167­173]  of  alkanethiolates  on  gold  is  a 
robust  and  one  of  the  most  used  strategies  over  the  last  century  for  surface 
functionalization. SAM formation provides one of the easiest and robust ways to obtain 
ordered monolayers  through  strong  chemisorption  between  the  thiol  group  and  the 
gold surface leading to the preparation of thermodynamically stable monolayers. This is 









for  incorporation  of  different  functionalities  by  forming  “mixed”  SAMs,  which  are 
monolayers comprising a well­defined mixture of molecules. Mixed SAMs can be easily 
formed  by  either  co­adsorption  from  solutions  containing mixtures  of  thiols  (RSH  + 
R′SH), or adsorption of asymmetric disulfides (RSSR′). The most common way of forming 
mixed  SAMs  is  to  use    a  mixture  of  thiols  where  one  thiol  possesses  a  particular 
functionality which can be exploited for futher surface modification.  
In the context of this thesis, we used an OEG monolayer based on gold­thiol adsorption 
as  developed  by  Svedhem  et  al.  [175,  176].  Even  though  these OEG monolayers  are 
unlikely  to have  the  thiol groups arranged orderly,  they work equally well as SAMs of 
alkanethiolates on gold,  i.e.  it  is also robust and  leads to a reproducible monolayer.  In 
the context of this thesis, we formed a mixed OEG monolyer by using a mixture of thiols 




has  been  hypothesized  that  the  ability  of OEG monolayers  to  bind  large  amounts  of 
interfacial water presents  them  the non­fouling or protein  resistant property  [179].  In 
addition  to passivation against proteins,  the OEG monolayers also provide passivation 






this  thesis  for cell mechanistic studies. We  thus exploited OEG monolayers  for cellular 
assays.  
Supported  lipid bilayers  (SLBs) have also become popular  [182, 183] as model systems 
for the cell membrane [184, 185] and as a building block for biofunctional surfaces [186, 
187].  The  creation  of  SLBs  by  adsorption  and  spreading  of  vesicles  on  hydrophilic 
supports  [188, 189]  is attractive by  its simplicity.  Important  insights  into  the nature of 
this self­organization process have been gained a few years ago [190­193] and a detailed 
picture of  the  structural  intermediates  in  the  SLB  formation process  is now available. 




SLBs were  used  to  study  the molecular  dynamics  at  the  biological  interface  as  these 
bilayers provide lateral mobility to anchored molecules whereas anchored molecules are 




Figure  I.2.1: Main  surface  functionalization  strategies  selected  for  this  thesis work.  These  are 
based on oligo ethylene­glycol  (OEG) monolayers on gold and supported  lipid bilayers  (SLB) on 
glass. 
These  platforms  provide  tight  control  on  the  orientation,  density,  two­dimensional 
mobility and distribution of biomolecules, and a background of  low unspecific binding. 

























Our  method  to  form  biomimetic  surfaces  relies  on  an  intermediate  monolayer  of 
streptavidin (SAv) between the surface and the biomolecule to be grafted (Figure I.2.2). 
This  strategy provides  tight  control on  the attachment of biomolecules  to  the  surface 
and  tunability  of  the  grafting  density,  where  multiple  biomolecules  can  be 
simultaneously  grafted  permitting multifunctionality.  In  addition,  the  SAv monolayer 
acts  as  a  passive  background  which  is  inert  to  the  nonspecific  binding  of  proteins. 
Specifically,  OEG  monolayers  or  SLBs  exposing  biotin  served  as  a  platform  for  the 
attachment  of  SAv  monolayer  exploiting  self­assembly  through  strong  and  specific 
biotin­SAv  interactions,  as  previously  developed  [38,  159,  175,  194].  In  this  case, we 
expect SAv to be immobilized such that two of its four biotin­binding sites are facing the 
surface  for  immobilization while  the other  two binding sites are  facing  the solution  to 
accommodate  target molecules embedded  in a background  that  is  largely  inert  to  the 
undesired nonspecific adhesion of biomolecules or cells, the SAv monolayer thus serves 






This  strategy  presents  a  controlled  manner  of  biomolecular  grafting  compared  to 
conventional deposition methods. For example, grafting of biomolecules directly to the 


















attached molecules, as many biomolecules  tend  to  interact non­specifically with gold, 
i.e. immobilization does not occur exclusively through the thiol groups (Figure I.2.3). 
 




is  not  available,  through  biotinylated  adapter  molecules.  In  particular,  GAGs  were 
immobilized with controlled orientation through a biotin tag introduced at the reducing 
end  (Figure  I.2.4).  Similarly,  biotinylated  cell­adhesion  ligands,  chemokines  and  other 
molecules were also grafted on the surface. 
 
Figure  I.2.4:  Schematic  representation  of  biomimetic  surfaces  presenting  a GAG,  a  chemokine 
and a cell adhesion ligand on a molecular breadboard. 
The  development  of model  surfaces  is  covered  in  detail  in  Chapter  III.  These model 




























Instead,  we  employ  a  ‘toolbox’  of  techniques  for  the  detailed  interrogation  of  the 
created biomolecular assemblies. With  this  toolbox of  techniques, parameters such as 
thickness,  hydration,  and  mechanical  properties  of  the  model  films,  as  well  as  the 





The  quartz  crystal microbalance  (QCM)  is  a  nanogram  sensitive  technique  based  on 
inverse piezoelectric effect discovered by Curies in the 19th century [195]. This technique 
utilizes acoustic waves generated by oscillating a piezoelectric, single crystal quartz plate 
to measure mass.  There  are  several ways  to perform QCM measurements  [196­199]. 
One  way  is  to  examine  the  polarization  at  the  crystal  surface  as  a  function  of  the 
frequency of  the  applied  voltage,  the  so­called  impedance  analysis, which  along with 
resonance  frequency  fi  yields  another  parameter  called  bandwidth  Γi  [200,  201].  The 
alternative method  is  the  “ring­down” method which  led  to  the  development  of  the 
QCM­D  technique  by  Rodahl  et  al.  [202].  The QCM­D method was  used  in  the work 
presented in this thesis, and its working principle is described in details below.  
QCM­D [196, 197, 203] is now widely used to study soft and solvated interfaces. QCM­D 
affords monitoring  of  adsorption  processes  in  real  time  in  liquids,  providing  detailed 
information  about  the  binding  kinetics,  and  the morphology  and  stability  of  surface­
confined  films  without  requiring  labels.  In  addition,  fitting  of  QCM­D  data  with 
viscoelastic model  provided  quantitative  information  about  thickness  and  viscoelastic 
properties of the film. 
Working principle 















voltage  results  in  resonance  in  the  shear  motion,  where  top  and  bottom  surfaces  move 
tangentially  in  an  anti­parallel  fashion  (C). QCM­D  uses  a  so­called  ring­down method.  After 
cutting the driving circuit, the freely decaying oscillation of the crystal is monitored (D, E). From 





fitting  an  exponentially  decaying  oscillating  curve  to  the  data  (Figure  I.2.5D),  the 
resonance frequency (f) of the crystal and the energy dissipation (D), are extracted. The 
envelope of the decaying oscillation, ui, is decaying exponentially over time: 𝑢𝑖 ∝ 𝑒−𝜋𝑓𝑖𝐷𝑖𝑡  1. 3 
 
The damping factor, Di, is called dissipation, which is defined as 
𝐷𝑖 = 𝐸𝑑𝑖𝑠𝑠𝑖𝑝𝑎𝑡𝑒𝑑2𝜋𝐸𝑠𝑡𝑜𝑟𝑒𝑑   1. 4  












QCM­D measures  the  changes,  Δf  and  ΔD  in  real  time by  the  reverse  piezo­electrical 
effect,  i.e. the oscillation of the quartz crystal translates into an oscillating voltage. The 
presented way to extract frequency and dissipation from a decaying curve after cutting 
voltage  is called ring­down approach and  is characteristic for QCM­D. The resolution  in 
frequency is currently in the range of 0.2 Hz (in liquid), corresponding to a resolution  in 
areal mass  density  of  a  few  ng⋅cm­2.  The  time  resolution  of  the QCM­D  technique  is 
typically better than 1 s. 
Determination of areal mass density  
The  Sauerbrey  equation  [204]  relates  the  adsorbed mass  per  surface  of  the  sensor 
crystal (areal mass density), mQCM with the changes in frequency, Δf: 𝑚QCM = ∆𝑚 = −𝑣q𝜌q2𝑓𝑜2 ∆𝑓𝑖𝑖 = −𝐶 ∆𝑓𝑖𝑖 1. 5  
where C  is  the mass  sensitivity  constant, and ρq and νq are  the density of quartz and 
speed of sound in quartz, respectively. The mass sensitivity constant C depends solely on 
the  material  properties  of  the  sensor  crystal  and  is  thus  independent  from  the 
adsorbate. For a sensor with a fundamental frequency of f0 ≈ 4.95 MHz, C = 18 ng⋅cm­
2⋅Hz­1.  Although  originally  derived  for  applications  in  air  or  vacuum,  the  Sauerbrey 







is  the  areal  mass  density.  In  contrast  to  optical  mass­sensitive  techniques,  QCM­D 
measures  all  material  that  is  mechanically  excited,  and  hence  it  measures  the 
hydrodynamically  coupled  solvent, msolvent  in  addition  to  the  areal  biomolecular mass 









In  some of  the applications,  the adsorbed  film  is not  rigid and  the Sauerbrey  relation 
becomes  invalid.  A  film  that  is  sufficiently  soft  (ΔD  >  0) will  not  fully  couple  to  the 
oscillation of the crystal; hence the Sauerbrey equation will underestimate the real mass 
of the layer. Under these conditions, QCM­D is also sensitive to viscoelastic properties of 
the  film  [196]. Soft and highly hydrated  films can be  treated as a homogeneous  layer 
with a given thickness, density and effective viscoelastic properties. Viscoelastic models 
can be used  to  fit  the QCM­D data  (at several overtones), which  relates  the shifts  in  f 
and D to the film thickness and viscoelastic properties.  




software  (D.  Johannsmann,  Technical University  of  Clausthal, Germany;  option  “small 











Spectroscopic  ellipsometry  (SE)  is  an  optical  technique  that  is  versatile  for  the 
characterization  of  interfaces  [207,  208].  For  biomolecular  films  it  can  provide 
quantitative  information about  the  surface density of biomolecules, and  the  thickness 




Ellipsometry  is based on the measurement of changes  in the polarization of  light upon 
reflection at an interface. Spectroscopic ellipsometry measures the polarization changes 
over  a  spectrum  of  wavelengths.  Polarization  is  parameterized  in  the  form  of  two 












According  to Maxwell  theory,  light  is  an  electromagnetic  wave  represented  by  two 
vectors: 𝐸 ⃗⃗  ⃗ represents the electric field, and 𝐵 ⃗⃗  ⃗ the magnetic field. 𝐸 ⃗⃗  ⃗ and 𝐵 ⃗⃗  ⃗ are oriented 
perpendicular to each other and to the direction, z, of light propagation. 
 
Figure I.2.6: Polarization of light: The electric field vector, 𝐸 ⃗⃗  ⃗, can be described as a superposition 




To understand the principles of polarization, consider the electric field vector, 𝐸 ⃗⃗  ⃗, which 







respectively.  The  variation  with  time  of  the  orientation  of  𝐸 ⃗⃗  ⃗along  the  propagation 
direction at a fixed  location  is called polarization. The polarization of the  light depends 
on the phase shift between Ex and Ey and their ratio. When 𝐸x⃗⃗⃗⃗  ⃗and 𝐸y⃗⃗ ⃗⃗  ⃗are in phase, the
resulting light will be linearly polarized. The relative amplitudes determine the resulting 
orientation.  If  the  two  components are 90° out of phase and equal  in amplitude,  the 








































tan(𝜓)exp (𝑗∆) = 𝐸rp/𝐸ip𝐸rs/𝐸is   1. 8  
ψ  and  Δ  express  the  amplitude  ratio  and  phase  difference  between  p­  and  s­
polarizations, respectively: 
∆= 𝛿𝑟𝑝 − 𝛿𝑟𝑠     and     |tan(𝜓)| = |𝐸𝑟𝑝/𝐸𝑖𝑝||𝐸𝑟𝑠/𝐸𝑖𝑠|   1. 9 
 
where δrp and δrs are phase shifts in parallel and perpendicular vectors.  
The  relation between Ψ  and Δ  can  thus be expressed  in  the  form of  the  ratio of  the 
Fresnel coefficients (rp and rs), which for a model substrate/film/ambient is obtained as: 












Based on  the measured n and d,  the  surface density  (Γ)  can be  calculated,  to a good 
approximation for biomolecular films [207], according to de Feijter [210]: 
𝛤 = 𝑑film(𝑛film − 𝑛solvent)𝑑𝑛adsorbate/𝑑𝑐   1. 11  
where dfilm  is the effective thickness of the film, nfilm  is the refractive  index of the film, 






good  approximation,  the  refractive  index  increment  is  constant  over  the  relevant 
concentration range. 
Fitting of SE data requires careful consideration of the optical properties of the substrate 




the  areas  of  biochemistry,  biology,  and  medical  sciences  [211­214].  It  provides 





(e.g.  glass)  to  a material with  a  lower  refractive  index  (e.g. water),  the  light  is  either 
reflected  or  refracted  depending  on  the  angle  of  incidence,  θi.  When  the  angle  of 
incidence  θi  is  equal  to  or  greater  than  a  critical  angle  (θC),  total  internal  reflection 
occurs, and thus no light is refracted.  
If the surface of the glass is coated with a thin film of a noble metal (e.g. gold or silver), 
instead  of  being  internally  reflected,  some  of  the  light may  couple with  the  electron 
cloud  (plasma)  in  the metal  and  propagate  along  the metal  surface.  This  absorption 
process  leads  to  a  reduction  in  the  amount  of  reflected  light.  There  exists  a  second 
angle, greater  than the critical angle, at which this  loss  is greatest and the  intensity of 
reflected  light reaches a minimum or  'dip' (Figure I.2.8). This angle  is called the surface 
plasmon resonance angle (θSPR). The electron plasma waves are called surface plasmons, 
and θSPR represents a resonance condition at which the wave vector of the incident light 














The  energy  of  the  light  coupled  to  the  surface  electron  cloud  creates  an  evanescent 
electric  field at  the  interface between  the metallic  film and  the adjacent medium. The 
amplitude  of  the  wave  field  decays  exponentially  with  the  distance  from  the metal 
surface, with a decay length of typically 300 nm. 
The  optical  phenomenon  of  SPR  can  be  used  to  monitor  interactions  between 
biomolecules. This  sensing application  relies on  the  fact  that changes  in  the  refractive 
index  of  the medium  in  the  vicinity  of  the metal  surface  upon  binding  of molecules 




Figure  I.2.9:  Surface  plasmon  resonance  (SPR)  detects  changes  in  the  refractive  index  in  the 
immediate vicinity of  the surface  layer of a sensor chip. SPR  is observed as a sharp  ‘dip’  in  the 
intensity of reflected light at an angle θSPR that is dependent on the refractive index, and thus the 
areal mass density of material, at the surface. The SPR angle shifts (from I to II in the lower left­
hand  diagram) when  biomolecules  bind  to  the  surface  and  thus  increase  the  local  refractive 












and kinetics of  interactions between an  immobilized  ligand and an analyte  in  solution 
(Figure I.2.9). For this application, ligand (the GAG, HS in our case) was immobilized on a 
gold­covered surface so as to form the internal surface of a flow cell. The corresponding 
analyte  (the  chemokine  CXCL12α  in  our  case) was  then  injected  into  the  flow  cell  in 
buffer  solution,  and  binding  monitored.  As  more  analyte  binds  to  the  surface,  the 
change in θSPR increases in magnitude giving rise to the association curve recorded in the 




passes  through  the  flow cell and  the analyte dissociates  from  the surface  leading  to a 
decrease in the signal and the dissociation curve. This association and dissociation cycle 









The  sensorgrams  are  then  subjected  to  fitting  with  a  kinetic  model  using  analysis 
software  in  order  to  extract  association  and  dissociation  rates  and,  if  possible, 





SPR  was  used  to  study  the  binding  kinetics  between  GAGs  and  chemokines.  Main 
advantages of SPR over SE are superior sensitivity, an automated and purpose­designed 
fluid handling system, and low sample consumption, and these features are particularly 
attractive  for  the  study  of  binding  kinetics. However,  quantification  of  absolute  areal 
mass  densities  of  molecules  using  SPR  is  not  trivial,  because  being  based  on  an 
evanescent wave, the SPR response depends sensitively on the distance  from the gold 
surface  at  which  molecules  bind.  The  SE  response,  on the  other  hand,  is  rather 








the hydrodynamically  coupled  solvent, msolvent  (equation  (1.  6)).  In  contrast,  the  areal 
mass density measured by SE, mSE, represents exclusively the adsorbate (mSE = mads). 
By exploiting  this difference  in mass sensitivity,  information about  the solvent content 
(e.g. hydration or porosity) of solvated films as a function of time can be extracted from 
combined  SE/QCM­D measurements,  a  quantity  that  cannot  generically  be  obtained 













setup  permitted  4 measurements  in  parallel,  thus  significantly  enhancing  throughput 
compared to SE or combined SE/QCM­D measurement which are not parallelized. Last 
but  not  least,  the  complexity  of  the  measurement  and  a  relatively  large  sample 
consumption  make  the  combined  QCM­D/SE  impractical  for  routine  analysis.  Taken 














 How  does  the  presentation  of  chemokines  in  the  HS­bound  form  affect  the 
interaction with its cell­surface receptor?  




in  Chapter  V.  To  establish  the  use  of  HS­presenting  biomimetic  surfaces  in  cellular 
assays,  these were  also  employed  for  studies with  a  leukocyte  cell model  (Jurkat)  by 

















are used  to  study  T  cell  signaling,  leukemia  and  the  expression of  various  chemokine 
receptors susceptible to viral entry, particularly HIV [86, 218]. 
To  perform  the  cellular  assays  a  novel  approach  was  adopted.  A  gold­coated  glass 
coverslip was attached to the bottom of a custom­designed teflon holder thus forming 
wells. The bottom surface of the wells was functionalized as desired, and the cells were 




The cellular  response  to  the molecular cues presented by  the biomimetic  surface was 




 Cell  spreading  assays:  For  this  purpose  the  cells were  fixed,  stained  and  then 
visualized by  fluorescence microscopy  to obtain quantitative  information about 
cell area and circularity [15]. 
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functionalization  of  GAGs.  The  method  should  find  broad  use,  as  a  tool  in  the 
glycosciences and in biotechnological applications. The control over and stability of GAG 
conjugates  proved  crucial  for  the  reliable  preparation  of GAG­functionalized  surfaces 
described in Chapter III. 
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des  modifications  chimiques  de  la  chaîne  de  GAG,  ou  par  des  contraintes 
conformationnelles ou spatiales. 
La  ligation  chimiosélective  par  formation de  lien  oxime  s’avère  être  une méthode  de 
couplage simple qui est  largement applicable à  la conjugaison de  l'extrémité réductrice 
des  glycosaminoglycanes  qui  permet  de  remédier  au  manque  de  stabilité  et  au 
rendement  limité du couplage par  formation de  lien hydrazone. Ce procédé peut être 
largement appliqué à  la  fonctionnalisation d’oligosaccharides et de différents  types de 
GAG  dont  les  GAGs  polymériques  de  poids moléculaire  élevé.  La  caractérisation  par 
QCM­D  de  l’adsorption  des  conjugués  préparés  à  partir  de molécules  chimiquement 
complexes tels que les GAG, a fourni des informations pertinentes sur les rendements de 
réaction  de  couplage  et  la  dégradation  des  échantillons  qui  est  difficile  à  évaluer  en 
utilisant  des  techniques  analytiques  classiques,  en  particulier  lorsque  la  quantité 
d'analyte est limitée à quelques microgrammes. 
La  ligation  chimiosélective par  formation de  lien oxime pourra être utilisée  largement 
comme  outil  de  fonctionnalisation  dans  le  domaine  des  glycosciences  et  dans  des 
applications de biotechnologie. Pour des applications en ingénierie tissulaire ou pour des 
études  biologiques  fondamentales,  le  contrôle  et  la  stabilité  de  conjugués  de  GAG 
s’avèrent déterminants pour la préparation fiable des surfaces fonctionnalisées. 
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A quartz crystal microbalance method to study the
terminal functionalization of glycosaminoglycans†
Dhruv Thakar,ab Elisa Migliorini,ab Liliane Coche-Guerente,ab Rabia Sadir,cde
Hugues Lortat-Jacob,cde Didier Boturyn,ab Olivier Renaudet,ab Pierre Labbeab and
Ralf P. Richter*abfg
Wedemonstrate the quartz crystal microbalance as a novel method to
quantify the reaction yields and stability of the terminal conjugation of
chemically complex molecules. Oxime ligation is identified as a
facile, broadly applicable method for the reducing-end conjugation
of glycosaminoglycans that overcomes the limited stability and yield
of popular hydrazone ligation.
Linear polysaccharides known as glycosaminoglycans (GAGs) are
ubiquitous cell surface and extracellular matrix components and
fulfill crucial biological functions. Advanced screening applications
(e.g. glycan microarrays1,2), functional molecular and cellular
assays,3 as well as biosensors and biomaterials4 require the
attachment of GAGs to surfaces or other scaﬀolds (e.g. with a
biotin that can be anchored to biotin-binding proteins). In this
regard, site-specific conjugation through the reducing end is
desirable, as it eﬀectively mimics the cell surface presentation of
GAG motifs and avoids alteration of GAG–protein interactions by
chemical modifications along the GAG chain, or by surface-
imposed conformational or spatial constraints.5
An important but still underestimated challenge with the
conjugation of GAG-derived oligosaccharides, and in particular
polymeric GAGs, is the characterization of the reaction products.
The often low isolated yields from natural sources, the GAG’s
hydrophilic nature and lack of a suitable chromophore, and the
GAG’s acidity, fragility, polydispersity and heterogeneous sulfation
make their characterization not readily amenable by NMR, reverse-
phase HPLC and mass spectrometry,6 respectively.
Here, we demonstrate that quartz crystal microbalance with
dissipation monitoring (QCM-D), a surface-sensitive technique
popular for biosensing applications, enables quantitative analysis
of conjugation yields and stability with a few micrograms of GAGs
of arbitrary complexity. To this end, we compared the biotinylation
of GAGs via two diﬀerent chemoselective ligation chemistries
(Scheme 1A).7 Hydrazone ligation has become the most frequently
used strategy for GAG functionalization.1,8–10,11 Oxime ligation (for
selected references, see ref. 12), on the other hand, has only rarely
been applied to polysaccharides,13 and to our knowledge not to GAGs.
Scheme 1 (A) Strategies adopted for the biotinylation of GAGs at their
reducing end, exemplified with a selected HS. Conditions: (a) 1 (0.33 mM), 4
(10 mM), PBS, pH 7.4, RT, 48 h; (b) 1 (4 mM), 5 (3.4 mM), aniline (100 mM),
acetate buﬀer (100 mM), pH 4.5, 37 1C, 48 h. (B) Library of biotin conjugates
of the GAGs HS and HA of various sizes, prepared using oxime ligation. HS
consists of GlcA b(1- 4) GlcNAc a(1- 4) disaccharides; X can be either H
or SO3H; Y can be either Ac or SO3H. HA is unsulfated and consists of GlcA
b(1- 3) GlcNAc b(1- 4) disaccharides. R = remaining GAG chain.
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We show that conventional hydrazone ligation is inefficient, in
particular for long GAGs, due to a low yield, and confirm that
hydrazone conjugates are unstable in an aqueous environment.14,15
In contrast, oxime ligation emerges as a facile, rapid and efficient
method that provides conjugates with higher stability and can be
broadly applied, i.e. for different GAG types and for oligosaccharides
as well as polymeric GAGs of high molecular weight.
The reducing terminus of GAGs can selectively react with
biotin derivatives presenting aminooxy or hydrazide groups to
provide oxime and hydrazone linkage, respectively. For oxime
ligation, the reaction was successful only by using aniline as a
catalyst as described previously.16 To reproduce a commonly
reported protocol,1,8,10,11 we did not use aniline for hydrazone
ligation, although this compound is also known to enhance this
reaction.17 We created a library of biotin-conjugates through
oxime ligation, containing GAGs of diﬀerent types and defined
chain lengths (Scheme 1B): hyaluronic acid (HA; oligosaccharides
with 2 and 5 disaccharide units (dp4, dp10), and a 360 kDa
polysaccharide) and heparan sulfate (HS; dp6, dp8, dp10, dp12,
and a 12 kDa polysaccharide).
For b-HA_dp4 10, mass analysis (Fig. S1, ESI†) demonstrated
that one biotin molecule is attached per HA while NMR analysis
(Fig. S2, ESI†) confirmed that the biotin is attached at the reducing
end, forming E and Z oxime isomers in a 73/27 ratio. Notably, these
conventional characterization methods did not provide useful
information on any of the other compounds produced.
To characterize the conjugation of more complex GAGs, we
exploited the high aﬃnity of the streptavidin (SAv)–biotin
interaction,8,18 and followed the binding of GAGs to surfaces
displaying a SAv monolayer (Fig. 1B, inset) by QCM-D (Fig. S3,
ESI†). Fig. 1A and B illustrates the differences in the stability of
biotinylated HS (b-HS made from 1,B22 disaccharides) prepared
through hydrazone and oxime ligation, 2 and 3, respectively, as a
function of storage time (up to two months) at 4 1C. The binding of
b-HS samples was evaluated using two different parameters: the
QCM-D frequency shift at saturation (Dfsat; proportional to the areal
mass density of immobilized b-HS (Fig. S4, ESI†)) and the maximal
binding rate (Df/Dt; proportional to the concentration of b-HS in
the sample solution (Fig. S5A, ESI†)). The magnitudes of Dfsat and
Df/Dt decreased appreciably with increasing storage time for b-HS
hydrazone (Fig. 1A), whereas only minor changes were observed for
b-HS oxime (Fig. 1B). Moreover, the magnitudes of Df and Df/Dt
for 2 were lower than for 3, even when de-frozen aliquots were
used immediately. We argue that these effects are the result of
the release of biotin upon degradation of the conjugates, i.e.
the hydrazone but not the oxime is already appreciably degraded
immediately after purification, and further degrades upon storage
at 4 1C.
To understand this, we note that the QCM-D responses in
Fig. 1 are exclusively due to binding of intact b-HS. Biotin-free
HS did not bind (Fig. S3, ESI†) and free biotin (produced as the
result of degradation) did not by itself give rise to a measurable
signal (Fig. S6, ESI†). A decrease in the magnitude of Dfsat,
therefore, is consistent with partial occupancy of the surface
with b-HS and saturation of the remaining binding sites by free
biotin (Fig. S7, ESI†). Further analysis of the QCM-D responses,
including the dissipation shift DD, in terms of so-called DD vs.
Df curves (Fig. 1C and D) revealed invariant curve shapes,
indicating that the film morphology (at a given surface coverage)
was comparable for all compounds tested. A plausible explanation
is that the composition of the film in terms of the HS molecular
conformation or size distribution is not altered by the degradation
or the type of conjugation. This implies that degradation of b-HS
occurs exclusively through cleavage of the bond that links biotin to
HS, which is due to the hydrolysis of hydrazone (and to a much
lesser extent oxime) under physiological conditions.14
We note in passing that the biotin released upon degradation
would occupy a fraction of the available binding site on any
biotin-capturing surface. This influences the surface density of
immobilized GAGs, and thus entails a limited reproducibility of
surface functionalization. This shortcoming needs to be considered,
for example, in solid-phase molecular binding assays such as by
surface plasmon resonance.11,19
For a quantitative analysis of reaction yields and degradation
rates, we determined steady-state binding rates (Fig. 2A and Fig. S5A,
ESI†) through linear fits to appropriate portions of the binding
curves in Fig. 1A and B. At steady state, binding is mass-transfer
limited, and with total HS concentrations and flow conditions
remaining unchanged in our assay, any decrease in the binding
rate reflects a proportional decrease in the concentration of intact
b-HS in the probed solution.20 From the binding rate of freshly
Fig. 1 Binding assay to study the yield and stability of hydrazone and oxime
conjugation. (A, B) QCM-D frequency shifts, Df, obtained for the specific
binding of 2 (A) and 3 (B), stored at 4 1C for variable times (as indicated), on
streptavidin-coated surfaces (schematically shown in the inset). Samples
were incubated for 10min (from 2 to 12min) at a total GAG concentration of
50 mg mL1, which was followed by exposure to buﬀer solution. (C, D)
Parametric plots of QCM-D dissipation shifts, DD (not previously shown) vs.
Df (from A and B, respectively). The plots inform about the evolution of the
HS film mechanical properties and morphology with increasing surface
coverage. All curves had comparable shapes, indicating that all compounds
tested generate comparable film morphologies at a given surface coverage.
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de-frozen 3 and through comparison with a reference molecule
of known concentration we could estimate the reaction yield of
oxime ligation (Fig. S5, ESI†); comparison of the binding rates
in Fig. 1 then yielded the fraction of intact b-HS in all probed
solutions (Fig. 2). The fraction of the biotinylated analyte in the
freshly de-frozen 3 was 54 � 8%. This value was confirmed by
weighing 10 (which in contrast to larger GAGs could be readily
separated from non-biotinylated GAGs; Fig. S1, ESI†). The
activity of freshly defrozen 2 was almost 5-fold smaller than
that of 3, indicating that reaction yields are considerably
improved for oxime ligation (Fig. 2B). The 5-fold improvement
in yield was confirmed by dot-blot analysis (Fig. S8, ESI†).
Moreover, the fraction of intact 2 decreased by another 5-fold over
60 days of storage at 4 1C, indicating substantial degradation,
whereas 3 was only marginally degraded over the same time
interval (Fig. 2B).
Concerning the GAGs of various chain lengths, a clear trend
in the Df values at saturation (Fig. 3A for HS and Fig. 3B and C for
HA) and in the DD vs. Df curves (Fig. 3D–F) as a function of size
confirmed that QCM-D curves are indeed sensitive to variations in
molecular weight. Differences in molecular weight, as small as one
disaccharide for oligomeric GAGs, can be readily distinguished
through DD vs. Df curves (Fig. 3D, inset). Thus, the DD vs. Df curves
represent a useful tool that provides insight into sample composi-
tion. HA_dp10 8 bound to SAv monolayers with a response similar
although not identical to HS_dp10 11 (Fig. 3B and E). We propose
that the slightly stronger Df shift for 8 over 11 reflects an increased
film thickness, resulting from a stronger repulsion between the
sulfated and thus more highly charged HS chains in 8. Notably,
even the long HA polymer 12 with B900 disaccharides could be
readily biotinylated (Fig. 3C), indicating that the polymer length
does not affect conjugation.
In summary, QCM-D together with a suitably functionalized
sensor surface has proven to be instrumental for the characteriza-
tion of conjugates made from chemically complex molecules such
as GAGs, providing information about reaction yields, sample
degradation and sample composition that is diﬃcult to assess
using conventional analytical techniques, in particular when
the amount of sample is limited to a fewmicrograms. Moreover, we
have established oxime ligation as a facile, one-step method for the
selective conjugation of GAGs at the reducing end. The method is
superior in yield and stability to the commonly used hydrazone
ligation, and versatile in that it can be applied to GAGs of various
(most likely any) types and sizes. The methods should find broad
use, as tools in the glycosciences and in biotechnological applica-
tions. In particular, the control over and stability of GAG conjugates
are crucial for the reliable preparation of GAG-functionalized
surfaces and scaﬀolds for tissue engineering and fundamental
biological studies.22
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Supplementary Materials and Methods 
GAGs and proteins 
HS with an average molecular weight of 12 kDa and a polydispersity of 1.59,1 derived from porcine intestinal mucosa, 
was obtained from Celsus Laboratories (Cincinnati, Ohio). HS oligosaccharides (HS_dp6, HS_dp8, HS_dp10, 
HS_dp12) presenting GlcNAc at their reducing end were prepared as previously described.2 HA oligosaccharides 
(HA_dp4, HA_dp10) presenting GlcNAc at their reducing end were purchased from Hyalose (Oklahoma, OK, USA). 
Lyophilized streptavidin (SAv) and bovine serum albumin (BSA) were purchased from Sigma-Aldrich (Saint-Quentin 
Fallavier, France), suspended in autoclaved Hepes buffer (10 mM Hepes (Fisher, Illkirch, France), pH 7.4, 150 mM 
NaCl (Sigma-Aldrich)) and stored at -20°C. 
An oligonucleotide (5’X AAT TCG CTA GCT GGA GCT TGG ATT GAT GTG GTG TGT GAG TGC GGT GCC C3’, 
X represents the 5’ amino linker; Mw = 15 440 Da) and an equivalent oligonucleotide with a biotin (5’AAT TCG CTA 
GCT GGA GCT TGG ATT GAT GTG GTG TGT GAG TGC GGT GCC C X3’, X represents the 3’ biotin 
tetraethyleneglycol linker; Mw = 15595.3 Da) were synthesized at 0.2 µmol scale using standard -cyanoethyl 
phosphoramidite chemistry on a DNA synthesizer (ABI 3400). After elongation, oligonucleotides were cleaved from 
the solid support and released into solution by treatment with 28% ammonia (1.5 mL) for 2 h and finally deprotected 
by keeping in ammonia solution for 16 h at 55 °C. Purifications were carried out by denaturing polyacrylamide gel 
electrophoresis and oligonucleotides were desalted by SEC on NAP-10 columns (GE Healthcare, Velizy-Villacoublay, 
France). Quantifications were performed at 260 nm using a CARY 400 Scan UV-Visible Spectrometer (L-tym: 16 
nmoles, 13 %, ε260nm= 463600 M-1cm-1); ε was estimated according to the nearest neighbour model. 
Biotinylation of GAGs 
For oxime ligation, the GAGs (4 mM) were suspended in 100 mM acetate buffer , made from glacial acetic acid 
(Fisher, Illkirch, France) and sodium acetate (Sigma-Aldrich), at pH 4.5. They were then reacted with b-OEG-ONH2 5 
(3.4 mM; synthesized as described on page S3) in the presence of aniline (100 mM; Sigma-Aldrich) for 48 h at 37°C. 
Hydrazone ligation was performed as previously described.3 Briefly, HS suspended in phosphate-buffered saline (PBS; 
Sigma Aldrich), pH 7.4 at 0.33 mM was reacted for 48 h at room temperature with 10 mM biotin-LC-hydrazine 
(Pierce, Rockford, USA). The final mixtures for both reactions were purified either by extensively dialyzing against 
water through membranes with a molecular weight cutoff (MWCO) of 1000 Da (Spectra/Por, France) or by using a 
desalting column (Pd-10 G-25M with MWCO = 5000 Da; GE Healthcare), depending on the molecular weights used, 
to remove unreacted biotin and aniline. The final products, typically containing a mixture of unreacted and biotin-
conjugated GAGs, were then lyophilized and stored at -20°C, either as is or re-solubilized in Hepes buffer or ultrapure 
water at a concentration of 10 mg/mL. Under these storage conditions, none of the samples was found to degrade 
appreciably. For further use, the conjugates were diluted to desired concentrations in Hepes buffer. 
Quartz crystal microbalance with dissipation monitoring (QCM-D) 
QCM-D measures the changes in resonance frequency, Δf, and dissipation, ΔD, of a sensor crystal upon molecular 
binding events on its surface. The QCM-D response is sensitive to the mass (including hydrodynamically coupled 
water) and the mechanical properties of the surface-bound layer. Measurements were performed with a Q-Sense E4 
system equipped with 4 independent Flow Modules (Biolin Scientific, Västra Frölunda, Sweden). Before use, the walls 
of the liquid handling system were passivated against biomolecular binding with bovine serum albumin (BSA). The 
system was operated in flow mode with a flow rate of typically 10 μL/min using a peristaltic pump (ISM935C, 
Ismatec, Zurich, Switzerland). The working temperature was 24°C. Δf and ΔD were measured at six overtones (n = 3, 
5, ..., 13), corresponding to resonance frequencies of fn ≈ 5, 15, 25, ..., 65 MHz; changes in dissipation and normalized 




Synthesis of b-OEG-ONH2 5 
 
Scheme Syn1. Steps for the synthesis of the bi-functional linker b-OEG-ONH2 5, presenting a biotin and an oxyamine 
moiety (–ONH2). 
The synthesis route is schematically shown in Scheme Syn1. Unless otherwise stated, chemical reagents were 
purchased from Sigma Aldrich (Saint Quentin Fallavier, France) or Acros (Noisy-Le-Grand, France) and were used 
without further purification. Analytical RP-HPLC was performed on a Waters system equipped with a Waters 600 
controller and a Waters 2487 Dual Absorbance Detector. Analysis was carried out at 1.0 mL/min (EC 125/3 nucleosil 
300-5 C18) with UV monitoring at 214 nm and 250 nm using a linear A–B gradient (buffer A: 0.09% CF3CO2H in 
water; buffer B: 0.09% CF3CO2H in 90% acetonitrile). Preparative separation was carried out at 22 mL/min (VP 
250/21 nucleosil 300-7 C18) with UV monitoring at 214 nm and 250 nm using a linear A–B gradient (buffer A: 0.09% 
CF3CO2H in water; buffer B: 0.09% CF3CO2H in 90% acetonitrile). Mass spectrometry was performed using 
electrospray ionization on an Esquire 3000+ Bruker Daltonics in positive mode. 1H NMR spectra were recorded in 
D2O at 400 MHz with a Bruker Avance 400 spectrometer.  
Synthesis of compound 13. TrtNH-PEG2-NH2 (200 mg, 0.43 mmol; Calbiochem-Novabiochem (Merck Biosciences - 
VWR, Limonest, France)) and biotin-OSu (220 mg, 0.65 mmol; Calbiochem-Novabiochem) were dissolved in dry 
DMF (10 mL) containing DIPEA (75 µL, 0.43 mmol) and the solution was stirred at room temperature. After 45 min 
RP-HPLC analysis indicated complete reaction (R t = 12.29 min, 5-100% B in 20 min). The solvent was then 
evaporated under reduced pressure and the crude oily residue was taken up with a solution of 10% TFA in CH 2Cl2 (10 
mL) containing 0.1% of triisopropylsilane. The solution was evaporated after 1 h and diethyl  ether was added to 
precipitate compound 13 which was obtained as a white powder after centrifugation. Yield: 77% (149 mg); R t = 7.97 
min (5-100% B in 20 min); ESI-MS: m/z calcd. for C20H39N4O5S (M + H)
+ 447.3, found 447.5. 
Synthesis of compound 5. Compound 13 (50 mg, 0.11 mmol) was dissolved in dry DMF (5 mL) containing DIPEA 
(19.5 µL, 0.11 mmol). Boc-Aoa-OSu (39 mg, 0.13 mmol) was added to the solution and the mixture was stirred at 
room temperature until complete disappearance of the starting material observed by analytical HPLC (R t = 10.17 min, 
5-100% B in 20 min). The solvent was removed and the residue was precipitated in diethyl ether. The resulting white 
powder was next stirred 30 min at room temperature in 50% TFA in CH2Cl2 (5 mL). After solvent evaporation, the 
crude mixture was purified by preparative RP-HPLC to afford compound 5 (Fig. Syn1). Yield: 74% (43 mg); Rt = 7.96 
min (5-100% B in 20 min); ESI-MS (Fig. Syn2): m/z calcd. for C22H42N5O7S (M + H)
+ 520.3, found 520.5. 
 
Figure Syn1. Crude RP-HPLC profile (5 to 100% B in 100 min, λ = 214 nm) of compound 5. 
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Figure Syn2. ESI-MS (positive mode) of compound 5. 
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Figure S1. Analysis of biotinylated HA_dp4. (A) Mass spectrum (ESI-MS, negative mode) of biotinylated HA_dp4 
(b-HA_dp4 10), m/z calcd for C50H83N7O29S: 1278.3; found m/z: 1277.3, the peak at 1298.3 corresponds to [M+Na-H]-
. This confirms the attachment of one biotin group per HA chain.  (B) HPLC Chromatogram (5 to 100% B in 100 min, 
λ= 214 nm) of 10. The peak at 11.1 min corresponds to the final product. HA_dp4 (1.4 mg, 1.8 μmol) was mixed with 
b-OEG-ONH2 5 (3.4 mM) and aniline (100 mM) in acetate buffer (100 mM), pH 4.5, 37°C for 48 h. The reaction 




Figure S2. NMR analysis of b-HA_dp4 10. The 1NMR analysis shows the formation of E and Z conformations of 10, 
indicating that the attachment of biotin occurs at the reducing end of HA which leads to both the open and closed 
forms. Integrating the signals corresponding to the two conformations, the oxime link was found to be 73% and 27% in 




Figure S3. QCM-D binding assay. (A) Schematic presentation of the streptavidin (SAv)-presenting surface used to 
study the yield and stability of GAG biotinylation. (B) Representative QCM-D binding assay with frequency shifts, Δf, 
and dissipation shifts, ΔD. Prior to each QCM-D measurement, QCM-D sensors with a new gold coating (QSX301, 
Biolin Scientific) were cleaned by rinsing with ultrapure water, blow-drying with N2 and exposure to UV/ozone 
(Jelight, Irvine, CA, USA) for 10 min; within 5 min after UV/ozone treatment, the sensors were immersed in an 
ethanolic solution (Fisher) of oligo ethyleneglycol (OEG) disulfide and biotinylated OEG thiol (Polypure Oslo, 
Norway), at a total concentration of 1 mM and a molar ratio of thiol equivalents of 999:1 ; after overnight incubation, 
the sensor surfaces were rinsed with ethanol and blow-dried with N2, before being installed in the QCM-D modules. 
Start and duration of sample incubation steps are indicated by arrows on top of the plot; during remaining times, the 
surface was exposed to Hepes buffer solution. SAv was initially incubated at a concentration of 1 µg/mL at a small 
flow rate (6 µL/min) for 4 min, and then at 20 µg/mL at standard flow rate (10 µL/min). At equilibrium, SAv 
generated frequency shifts Δf = - 23  1 Hz and dissipation shifts ΔD < 0.4  10-6 which are characteristic for the 
formation of a dense protein monolayer. The injection at low concentration was routinely performed to confirm the 
absence of protein depletion resulting from undesired adsorption to the walls of the tubing or the QCM -D flow module 
due to insufficient passivation: any depletion of SAv from the solution would result in a decreased binding rate. GAGs 
were incubated at 50 µg/mL. End-biotinylated HS (b-HS_12kDa 3 (oxime), black lines with square symbols) readily 
bound to the free biotin-binding sites on the SAv monolayers. The ensuing shift in frequency and the strong increase in 
dissipation indicate the formation of a soft and hydrated layer as would be expected for a film of end-grafted HS 
chains. Biotin-free GAGs (grey lines with circle symbols) showed no response, confirming that the immobilization of 
GAGs on the SAv monolayer occurs exclusively through the biotin moiety at the GAG’s reducing end.  
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Figure S4. Relationship between the QCM-D frequency shift and areal mass density. Data were acquired through 
a combined QCM-D and spectroscopic ellipsometry (SE; M2000V, J. A. Woollam, Lincoln, NE, USA) measurement. 
The graph shows Δf (from QCM-D) vs. areal mass density Γ (from SE) for the adsorption under static conditions of 3 
(A, blue line; at a total HS concentration of 1 μg/mL), and of a biotinylated oligonucleotide (B, green line; at 1.56 
μg/mL) that served as a reference molecule in Fig. S5. The data are well approximated by straight lines through the 
origin (black lines) confirming that the relationship between Δf and Γ is roughly linear for these compounds. The 
slopes of the linear fits       were –0.67 ± 0.01 Hz/(ng/cm2) for 3 and –0.42 ± 0.01 Hz/(ng/cm2) for the biotinylated 
oligonucleotide (mean ± S.E.M. from three independent measurements). The combined QCM-D and SE measurement was 
performed with a custom-built open fluid cell as described earlier.4, 5 Before use, the walls of the fluid cell were 
passivated against biomolecular binding with BSA. SE measures changes in the polarization of light upon reflection at 
a planar surface, from which the areal mass density can be quantified through fitting of the SE data to an optical 
model. Fitting was performed, as described in detail elsewhere;6 the opaque gold film with the OEG monolayer was 
treated as a single isotropic layer and fitted as a B-spline substrate; SAv and b-HS film were considered as separate 
transparent Cauchy layers; b-HS areal mass densities were determined through de Fejter’s equation, 4 using a refractive 
index increment of dn/dc = 0.15 cm3/g. 
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Figure S5. Quantification of active analyte concentrations from QCM-D binding assays. (A-B) QCM-D responses 
(Δf) for the adsorption of 3 (freshly defrozen and incubated at 1 µg/mL total HS concentration; A) and a biotinylated 
oligonucleotide (incubated at cref = 1.56 µg/mL; B) to a SAv monolayer. The oligonucleotide served as reference 
molecule to determine the concentration of intact b-HS, cb-HS, in the HS solution, as described in the following. 
Binding of an analyte (b-HS in our case) to a ligand (SAv) on the QCM-D sensor surface is a two-step event, 
consisting of mass transfer to the sensor surface followed by the actual binding to the ligand. Since the biotin-SAv 
bond forms rapidly, the first step is rate limiting in our assay, except at high coverage were the scarcity of available 
binding sites limits binding. For mass-transfer limited binding, the binding rate depends exclusively on the flow 
conditions (i.e. flow-cell geometry and flow rate, maintained constant in our assay) and the analyte’s active 
concentration (i.e. the concentration of HS being effectively biotin-conjugated, cb-HS) and diffusion coefficient, Db-HS.
7 
Considering the flow conditions in our experimental setup (i.e. laminar flow in a slit) , the binding rate is given by        -     -       -   [Eq. S1] 
in steady state.7 From a comparative measurement with a reference molecule of known concentration cref and diffusion 
coefficient Dref, the analyte’s active concentration can be determined through    -    ref                      -        ref  [Eq. S2A] 
The ratio            is identical to the ratio of the molecules’ hydrodynamic radii               due to the Stokes-Einstein 
equation. Moreover, the relationship between Γ and Δf is linear for the molecules of inerest (Fig. S4), and hence   -    ref                          -        ref                   -     [Eq. S2B] 
The extended linear binding regimes in A and B (black solid lines are fits with slopes         -   = -0.82 ± 0.03 Hz/min 
and            = -1.86 ± 0.03 Hz/min (mean ± S.E.M. from three independent measurements)) confirm mass-transfer 
limited binding in steady state. Equation S2B, with       taken from Fig. S4 and rh determined through dynamic light 
scattering (see C-D below), resulted in cb-HS = 0.54 ± 0.08 µg/mL. Finally, comparison with the total HS concentration 
employed reveals that 54 ± 8% of the HS chains were effectively biotinylated. This value is in excellent agreement with the 
yield obtained through weighing of purified HA_dp4 10 (Fig. S1). 
Equation S1 shows that, during mass-transfer limited binding, the binding rate is directly proportional to the analyte’s 
active concentration, and a reduction in the binding rate (e.g. in Fig. 1) reflects a proportional decrease in the analyte’s 
active concentration (since the analyte’s diffusion coefficient is unchanged). To obtain the fractions of b-HS in Fig. 2, 
relative changes in the slopes in Fig. 1 were compared, and combined with the value of 54% for freshly defrozen 3. 
(C-D) Quantification of hydrodynamic radii by dynamic light scattering (DLS). Mass-weighted distributions (A) of 
hydrodynamic radii (rh) of HS_12kDa 1 (C) and the reference oligonucleotide (D) with peaks at rh,b-HS = 4.7 ± 0.2 nm 
and rh,ref = 3.3 ± 0.1 nm (mean ± S.E.M. from 6 independent measurements; we estimate that addition of the small 
biotin moiety to polymeric HS and oligonucleotide does not affect rh appreciably) corresponding to the size of 
individual molecules. Secondary peaks at 100 nm and more are likely to correspond to aggregates; although these 
peaks dominate the mass-weighted distribution, their contribution in numbers is very small (less than 0.1%). 
Measurements were performed as described in detail elsewhere.8 Autocorrelaton functions were collected at 25.0 ± 0.1 
C for a counting time of 60 s at 90 degrees scattering angle. Radius distributions were obtained using CONTIN 
analysis9 of the autocorrelation functions. 
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Figure S6. Binding of free biotin to streptavidin monolayers does not elicit a measurable QCM-D response. 
QCM-D responses (Δf – blue lines with circle symbols, ΔD – red lines) during the formation of a SAv monolayer 
(conditions as in Fig. S3) followed by sequential exposure to b-OEG-ONH2 5 (50 µg/mL) and 3 (50 μg/mL). Start and 
duration of sample incubation steps are indicated by arrows on top of the plot; during remaining times, the surface was 
exposed to Hepes buffer solution. The absence of b-HS binding confirms that free biotin saturated all biotin-binding 
sites on the SAv monolayer. Yet, the SAv-bound biotin (i.e. 5) did not by itself give rise to a measurable QCM-D 
response, presumably due to the compound’s low molecular weight and the location of the biotin-binding pocket deep 
inside SAv. 
 
Figure S7. Free biotin, released upon degradation, contributes to the occupation of binding sites in streptavidin 
monolayers. QCM-D responses (Δf – blue lines with circle symbols, ΔD – red lines) during the adsorption of a 
partially degraded sample (2, 7 days storage at 4°C; 50 μg/mL) to a SAv monolayer followed by incubation of a non-
degraded sample (3, freshly de-frozen; 50 μg/mL). Start and duration of sample incubation steps are indicated by 
arrows on top of the plot; during remaining times, the surface was exposed to Hepes buffer solution. Incubation with 
the non-degraded sample did not lead to significant additional binding. This confirms that no free biotin binding sites 
were available after incubation with the supposedly degraded sample, i.e. the biotin released due to de gradation 
saturates all available biotin binding pockets. 
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Figure S8. Dot-blot analysis confirms HS biotinylation. 50 µL of b-HS samples at a range of total HS 
concentrations were spotted on a (positively charged) nitrocellulose membrane (Genomic Zeta-Probe; Bio-Rad, 
Marnes-la-Coquette, France) which retains (negatively charged) HS but not free biotin. Membranes were pre-washed 
with PBS at pH 7.4 using a vacuum-assisted dot-blot apparatus, rinsed twice with PBS, blocked for 30 min at 37°C in a 
5% (w/v) dry milk solution in Tris-buffered saline (TBS; Sigma-Aldrich) at pH 7.4, and extensively rinsed with TBS. 
The blots were probed with extravidin-labeled horseradish peroxidase (exAvHRP; Sigma-Aldrich) diluted 1:3000 in 
TBS with 0.05% (w/v) Tween20 for 45 min under shaking. After 6 cycles of washing (5 min each) with TBS and 
0.05% (w/v) Tween20 at RT, the biotinylated samples were revealed by incubation of the membrane with hydrogen 
peroxide and the chemiluminescent detection reagent (Luminata Classico Western HRP Substrate; Millipore, 
Molsheim, France) for 1 min, followed by autoradiography (Amersham Hyperfilm ECL; GE Healthcare). (A) 
Autoradiograph of membranes spotted with 2 and 3 with total HS quantities per spot (in ng) indicated. (B) Dot 
intensities, quantified by densitometry using ImageJ software, for b-HS hydrazone 2 (red squares) and b-HS oxime 
(blue circles) from the membrane displayed in A. Intensities were offset by the intensity of the control samples lacking 
b-HS (0 ng). Both data sets were well approximated by the expression                           , where Imax is 
the intensity at saturation, [HS] the total HS quantity per spot and [HS]1/2 the total HS quantity at which half-maximal 
intensity is attained. Black lines are best fits, giving Imax = 16500 (set to be identical for both curves) and [HS]1/2 = 
40.6 and 8.3 ng for 2 and 3, respectively. The ratio of the two [HS]1/2 values is 4.9, confirming that the concentration 
of biotinylated HS in the oxime conjugate 3 is about 5 times larger than in the equivalent hydrazone conjugate 2, as 
determined from the analysis of the QCM-D data (Figs. 2 and S5). 
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interactions  on  the  molecular,  supramolecular  (in  this  chapter  and  Chapter  IV)  and 
cellular  levels  (in  this  chapter  and  Chapter  V),  and  should  find  great  potential  in 
mimicking the extracellular matrix by grafting different biomolecules. 
 
My  contribution:  I  co­designed  research  (together with Elisa Migliorini,  Liliane Coche­
Guerente  and  Ralf  P.  Richter).  I  performed  and  analyzed  the  QCM­D measurements 
(together with Elisa Migliorini), and the spectroscopic ellipsometry and surface plasmon 





Les  glycosaminoglycanes  (GAGs)  omniprésents  à  la  surface  des  cellules  et  dans  la 
matrice extracellulaire  jouent un rôle essentiel pour  l'assemblage de  la matrice et dans 
les  interactions  cellule­cellule et  cellule­matrice. La présentation  supramoléculaire des 
chaînes de GAGs avec d'autres composants de la matrice extracellulaire, est susceptible 
d'être  fonctionnellement  important, mais reste difficile à contrôler et à caractériser,  in 
vivo et aussi in vitro. 
Nous présentons une méthode pour créer des surfaces biomimétiques bien définies qui 
portent  des GAGs,  seuls  ou  accompagnés  de  ligands  d’adhesion,  sur  un  substrat  qui 
supprime  les  interactions  non­spécifiques.  Grâce  à  la  conception  d’une  plate­forme 
d'immobilisation ­ une monocouche de streptavidine qui sert de plateforme moléculaire 
modulable  à la  fixation de divers  ligands biotinylés  ­ et d’un ensemble de  techniques 
d'analyse  in  situ  de  surface  sensibles  (microbalance  à  quartz  et  ellipsométrie 
spectroscopique), les surfaces biomimétiques sont réalisées sur mesure avec un contrôle 
étroit de l'orientation biomoléculaire, de la densité de surface et de la mobilité latérale.  
En  analysant  les  interactions  entre  un GAG  sélectionné  (l’héparane  sulfate, HS)  et  la 
chimiokine CXCL12α (également appelé SDF­1α) qui se  lie au HS, nous avons démontré 
que ces surfaces sont polyvalentes pour réaliser l’étude des interactions biomoléculaires 
et  cellulaires.  Les  lymphocytes­T  adhérent  spécifiquement  aux  surfaces  présentant  la 
chimiokine  CXCL12α,  liée  réversiblement  au  HS  ou  irréversiblement  lorsqu’elle  est 
immobilisée  sur  le  substrat  inerte,  y  compris  en  l'absence  d'un  ligand  d'adhésion 
cellulaire.  La  présence  simultanée  sur  les  surfaces  fonctionnelles  de  la  chimiokine 
CXCL12α liée au HS et du ligand d'adhésion ICAM­1 (molécule d'adhésion intercellulaire 
1)  exerce  un  effet  synergique  qui  favorise  l'adhésion  cellulaire.  Notre  stratégie  de 
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a b s t r a c t
Glycosaminoglycans (GAGs) are ubiquitously present at the cell surface and in extracellular matrix, and
crucial for matrix assembly, cellecell and cell-matrix interactions. The supramolecular presentation of
GAG chains, along with other matrix components, is likely to be functionally important but remains
challenging to control and to characterize, both in vivo and in vitro. We present a method to create well-
deﬁned biomimetic surfaces that display GAGs, either alone or together with other cell ligands, in a
background that suppresses non-speciﬁc binding. Through the design of the immobilization platform e a
streptavidin monolayer serves as a molecular breadboard for the attachment of various biotinylated li-
gands e and a set of surface-sensitive in situ analysis techniques (including quartz crystal microbalance
and spectroscopic ellipsometry), the biomimetic surfaces are tailor made with tight control on bio-
molecular orientation, surface density and lateral mobility. Analysing the interactions between a selected
GAG (heparan sulphate, HS) and the HS-binding chemokine CXCL12a (also called SDF-1a), we demon-
strate that these surfaces are versatile for biomolecular and cellular interaction studies. T-lymphocytes
are found to adhere speciﬁcally to surfaces presenting CXCL12a, both when reversibly bound through HS
and when irreversibly immobilized on the inert surface, even in the absence of any bona ﬁde cell
adhesion ligand. Moreover, surfaces which present both HS-bound CXCL12a and the intercellular
adhesion molecule 1 (ICAM-1) synergistically promote cell adhesion. Our surface biofunctionalization
strategy should be broadly applicable for functional studies that require a well-deﬁned supramolecular
presentation of GAGs along with other matrix or cell-surface components.
© 2014 Elsevier Ltd. All rights reserved.
1. Introduction
Glycosaminoglycans (GAGs), a group of acidic and linear poly-
saccharides including e.g. heparan sulphates (HS) and hyaluronan
(HA), are ubiquitously present at the cell surface and in extracel-
lular matrix. They interact with many structural (e.g. collagen,
ﬁbronectin) and signalling (e.g. chemokines, growth factors) pro-
teins and thereby regulate matrix assembly and remodelling, as
well as cell-matrix and cellecell interactions [1]. Typically, GAG
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function relies on the integration of multiple interactions rather
than on individual binding events. Examples are (i) the remodelling
of extracellular matrices by GAGs binding to structural proteins
[2,3], by GAG-crosslinking proteins [4,5] or by bulky GAG-binding
proteoglycans [6e8], (ii) the sequestration [9,10] and tightly regu-
lated mobility [11] of chemokines or growth factors in matrix and
(iii) the presentation of chemokines at controlled densities or in the
form of gradients to promote distinct cellular responses such as
adhesion or directed migration [12,13].
In all these cases, the local arrangement and density of GAGs,
along with other cell surface or matrix components, is of key
functional importance. Studies in this direction, however, are
challenging because the supramolecular presentation of GAG
chains is difﬁcult to control and to characterize, not only in vivo but
also in vitro. For example, GAGs have so far been largely neglected in
the design of in vitro cell migration assays [14], despite their
recognized functional importance. A likely reason is the limited
commercial availability of sufﬁciently pure and suitably function-
alized GAGs, and of methodologies to integrate GAGs into assem-
blies that mimic the presentation at the cell surface or in matrix
well. Only few studies demonstrate, so far, the possibility to
immobilize and to control GAG surface densities and/or orienta-
tions on supports [15e18]. Moreover, to the best of our knowledge
the cellular interaction with such surfaces has not been studied. To
study the role of GAG-protein interactions in matrix assembly and
in cell behaviour in vitro, it would be desirable to be able to prepare
materials that present GAGs together with other relevant bio-
molecules in such a way that the orientation, density and lateral
mobility of the exposed biomolecules can be controlled and tuned.
Here, we present a method to fabricate biomimetic surfaces that
display GAGs and other biomolecules of interest at well-deﬁned
orientation, density and lateral mobility (Fig. 1). The method re-
lies on a stratiﬁed monolayer of streptavidin (SAv) and self-
assembly through strong and speciﬁc interactions. Embedded in a
background that is largely inert to the undesired nonspeciﬁc
adhesion of biomolecules or cells, the SAv monolayer serves as a
molecular breadboard for the selective attachment of biotinylated
molecules. The method is generic in the sense that various bio-
molecules can be (co-) immobilized at tuneable surface densities,
either through a site-speciﬁcally attached biotin tag, or if that is not
available, through biotinylated adapter molecules. In particular,
GAGs are immobilized with controlled orientation through a biotin
tag introduced at the reducing end. As a prerequisite of the present
work, a method for the preparation of stable and terminally func-
tionalized GAG conjugates was recently developed (Thakar D,
Migliorini E, Guerente L, Sadir R, Lortat-Jacob H, Boturyn D,
Renaudet O, Labbe P, Richter, RP manuscript submitted).
Two in situ surface sensitive analytical techniques, quartz crystal
microbalance (QCM-D) and spectroscopic ellipsometry (SE), were
combined to monitor in real time the assembly of the biomimetic
surfaces and to ascertain that the desired functionalities are indeed
realized. In particular, QCM-D provides time-resolved information
about the assembly process, including overall ﬁlm morphology and
mechanics [19], while SE enables time-resolved and label-free
quantiﬁcation of biomolecular surface densities and binding stoi-
chiometries [20].
To demonstrate the versatility of our approach for well-
controlled and quantitative biomolecular and cellular studies, we
selected HS as GAG, and stromal-cell derived factor 1 (CXCL12a,
also called SDF-1a) as GAG-binding chemokine [21]. We ﬁrst
quantify the kinetics of CXCL12a binding to HS-displaying surfaces
by surface plasmon resonance and then investigate the adhesion of
Jurkat cells as a CXCL12a sensitive T-lymphocyte cell line [13] to a
range of biomimetic surfaces, including surfaces that present HS-
bound CXCL12a along with the intercellular adhesion molecule 1
(ICAM-1). CXCL12a is known to bind with high afﬁnity to the T cell-
surface receptor CXCR4 [22,23]; the ensuing activation of T cells as
well as the binding of T cells to ICAM-1 at the endothelial cell
A
B
Fig. 1. Design of biomimetic surfaces that reproduce the presentation of cell-surface GAGs. Schematic presentation of well-deﬁned model surfaces presenting heparan sulphate
(HS). HS is biotinylated site-speciﬁcally at the reducing end (b-HS) and immobilized on a streptavidin (SAv) monolayer with controlled orientation. (A) Model surface based on a
gold-supported OEG monolayer exposing biotin at the end of a fraction of the OEG molecules. Stable attachment to the gold is mediated by thiols. (B) Model surface based on a
silica-supported lipid bilayer (SLB) exposing biotin at the head of a fraction of the lipids. All molecules are drawn approximately to scale, with the scale bar indicating the
approximate size. The OEG monolayer and the SLB confer a background of low nonspeciﬁc binding. On ﬂuid SLBs (B) but not on the OEG monolayers (A), HS chains can diffuse
laterally together with the anchoring SAv (thin arrows).
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surface of blood vessels are of particular importance in immune cell
trafﬁcking [12,24,25]. With this study, surfaces thus become avail-
able that mimic selected aspects of the endothelial cell surface,
towards mechanistic cellular studies in an environment that is
well-deﬁned and tuneable.
2. Methods
2.1. Buffer, heparan sulphate and proteins
The working buffer used for all experiments and for protein dilution was made
of 10 mM Hepes (Fisher, Illkirch, France) at pH 7.4 and 150 mM NaCl (Sigma Aldrich,
Saint-Quentin Fallavier, France) in ultrapure water.
Heparan sulphate (HS) derived from porcine intestinal mucosa with an average
molecular weight of 12 kDa and a polydispersity of 1.59 [26] (Celsus Laboratories,
Cincinnati, OH, USA) was conjugated with biotin through an oligoethylene glycol
linker of approximately ~1 nm length, site-speciﬁcally attached to the reducing end
by oxime ligation. In contrast to the conventionally used hydrazone ligation, oxime
ligation produces conjugates that are stable for many weeks in aqueous solution.
CXCL12a (amino acids 1 to 68; 8.1 kDa) was produced by solid-phase peptide
synthesis as previously reported [9]. The same CXCL12a construct with a biotin
conjugated to the C-terminal lysine through a tetraethylene glycol (OEG) linker (b-
CXCL12a; 8.6 kDa), was also produced by solid-phase peptide synthesis. A protein
construct containing two Z-domains of protein A, separated by an extended peptide
spacer from an Avi-tag carrying a single biotin (b-ZZ, 31.8 kDa) was produced
recombinantly in Escherichia coli by co-expression with the biotin ligase BirA.
Lyophilized streptavidin (SAv, 60 kDa), bovine serum albumin (BSA) and ﬁbronectin
(Fn) were purchased from Sigma Aldrich. A chimera of the Fc part of IgG and two
human ICAM-1 extracellular domains (Fc-ICAM-1; 152 kDa) was obtained from R&D
Systems (Minneapolis, MN, USA). All proteins were diluted to concentrations be-
tween 0.2 and 1 mg/mL in autoclaved working buffer and stored at 20 C. Thawed
protein solutions were used within 5 days and further diluted as desired.
2.2. Sensors and surface preparation
QCM-D sensors with gold (QSX301) and silica (QSX303) coatings were pur-
chased from Biolin Scientiﬁc (V€astra Fr€olunda, Sweden). Appropriately sized silicon
wafers with a native oxide layer of less than 2 nm thickness or with an optically
opaque gold coating (100 nm, sputter-coated) were used for SE measurements. SPR
gold-coated sensor chips (SIA Kit Au) were purchased from Biacore (GE Healthcare
Bio-Sciences, Uppsala, Sweden). Glass cover slips (24  24 mm2; Menzel Gl€aser,
Braunschweig, Germany) for cellular studies were cleaned by immersion in freshly
prepared piranha solution (i.e. a 1:3 (v/v) mixture of H2O2 (ACROS Organics, New
Jersey, USA) and concentrated H2SO4 (Sigma Aldrich)) for 1 h, rinsing with ultrapure
water, and blow-drying with N2. They were used as such or sputter-coated with a
titanium adhesion layer (~0.5 nm) and a semi-transparent gold ﬁlm (~5 nm). All
substrates were exposed to UV/ozone (Jelight, Irvine, CA, USA) for 10 min prior to
further use.
2.2.1. Functionalization of surfaces with a biotin-displaying and otherwise inert
background
Gold-coated surfaces were immersed overnight in an ethanolic solution (Fisher,
Illkirch, France) of OEG disulﬁde and biotinylated OEG thiol (Polypure, Oslo, Norway)
at a total concentration of 1 mM and a molar ratio of thiol equivalents of 999:1, and
subsequently for 20 min in a stirred solution of pure ethanol, and blow-dried in N2.
Biotin-functionalized supported lipid bilayers (SLBs) were prepared by the method
of vesicle spreading though exposure of small unilamellar vesicles (SUVs; at 50 mg/
mL in working buffer supplemented with 2 mM CaCl2 (VWR International, Leuven,
Belgium)) to silica-coated surfaces, as described earlier [27]. SUVs were prepared by
sonication, as described earlier [28], from mixtures of dioleoylphosphatidylcholine
(DOPC) and dioleoylphosphatidylethanolamine-CAP-biotin (DOPE-CAP-b) (Avanti
Polar lipids, Alabaster, AL, USA) in a molar ratio of 95:5.
2.2.2. Surface functionalization with BSA and Fn
BSA and Fn were physisorbed on uncoated glass cover slips. To this end, the
cover slips were exposed to solutions of either BSA at 5 mg/mL or Fn at 5 mg/mL in
working buffer for 20 min.
2.3. Assembly of biomimetic surface coatings
The rationale behind the design of the self-organized biomolecular assemblies is
provided in the results section (Fig. 1). Unless indicated otherwise, the following
concentrations and exposure times were used: SAv e 20 mg/mL, 20 min; b-HS e
50 mg/mL, 10 min; CXCL12a e 5 mg/mL, 20 min; Fc-ICAM-1 e 0.1 mM, 30 min. Under
these conditions, binding is expected to saturate or equilibrate, irrespective of
whether the solution is ﬂown (in QCM-D and SPR measurements), stirred (in SE
measurements) or still (for cell assays). In QCM-D measurements, the injection was
sometimes also stopped earlier once the binding curve had reached a plateau. To
obtain surfaces that display HS-bound CXCL12a together with Fc-ICAM-1, b-HS
(1 mg/mL; 30 min) and b-ZZ (0.05 mM; 5 min) were sequentially exposed to the SAv-
coated surfaces. Here, the concentrations and incubation times were chosen to
obtain desired surface densities (see Fig. S4 for details). Fc-ICAM-1 and CXCL12a
were then incubated until saturation and equilibrium, respectively, were reached.
For QCM-Dmeasurements, exposure to 20 mg/mL SAvwas routinely preceded by
a ﬁrst SAv injection at low concentration (1 mg/mL) and decreased ﬂow rate (6 mL/
min) for 5 min, to conﬁrm the absence of protein depletion resulting from undesired
adsorption to the walls of the tubing or the QCM-D ﬂow module due to insufﬁcient
passivation: any depletion of SAv from the solution would result in a decreased
binding rate (compared to the established standard rate of 0.5 ± 0.1 Hz/min, see
Fig. 2AeB).
2.4. Quartz crystal microbalance with dissipation monitoring (QCM-D)
QCM-Dmeasures the changes in resonance frequency, Df, and dissipation, DD, of
a sensor crystal upon molecular adsorption on its surface. The QCM-D response is
sensitive to the mass (including hydrodynamically coupled water) and the me-
chanical properties of the surface-bound layer. Measurements were performed with
a Q-Sense E4 system equipped with 4 independent FlowModules (Biolin Scientiﬁc).
Sensor functionalization with biotinylated OEG monolayers was performed ex situ
before the measurement. All other surface functionalization steps proceeded in situ.
The systemwas operated in ﬂowmodewith a ﬂow rate of typically 10 mL/min using a
peristaltic pump (ISM935C, Ismatec, Zurich, Switzerland). The working temperature
was 24 C. Df and DDwere measured at six overtones (i¼ 3, 5,…, 13), corresponding
to resonance frequencies of fi z 5, 15, 25, …, 65 MHz; changes in dissipation and
normalized frequency, Df ¼ Dfi/i, of the third overtone (i ¼ 3) are presented; any
other overtone would have provided comparable information.
For sufﬁciently rigid biomolecular layers at high surface coverage, the ﬁlm
thickness was estimated from d ¼ C/r  Df, where r is the ﬁlm density and
C ¼ 18.06 ng/cm2/Hz the mass sensitivity constant for a sensor with a
fundamental resonance frequency of 4.95 MHz [19]. For very soft ﬁlms, such as HS
monolayers, this equation is not valid. Here, ﬁlm thickness was determined by
ﬁtting the QCM-D data to a continuum viscoelastic model [29] with the software
QTM (D. Johannsmann, Technical University of Clausthal, Germany) [30,31] as
described in detail elsewhere [32]. These thickness values are provided as
average ± standard deviation from at least three independent experiments.
2.5. Spectroscopic ellipsometry (SE)
SE measures changes in the polarization of light upon reﬂection at a planar
surface. SE was employed in situ with a M2000V system (J. A. Woollam, Lincoln, NE,
USA) to quantify the surface density of adsorbed biomolecules in a time-resolved
manner [28]. The desired substrate was installed in a custom-built open cuvette
featuring a magnetic stirrer for continuous homogenization of the sample solution
(~150 ml; samples were pipetted into the solution) and a ﬂow-through system for
rapid solution exchange during rinsing steps. Before use, the cuvette walls were
passivated against biomolecular binding with BSA [4]. Substrate functionalization
with biotinylated OEG monolayers was performed ex situ, before the measurement.
All other surface functionalization steps proceeded in situ. Measurements were
performed at room temperature.
Surface densities were quantiﬁed through ﬁtting of the data to optical models, as
described in detail elsewhere [28,33]. The opaquemetal ﬁlm and the OEGmonolayer
on gold-coated silicon wafers were treated as a single isotropic layer and ﬁtted as a
B-spline substrate. The bulk silica of native wafers was also modelled as a B-spline
substrate. The native oxide ﬁlm, alone or together with a deposited SLB, were
modelled as a single transparent Cauchy layer. Areal mass densities were deter-
mined through de Fejter's equation [20], using refractive index increments, dn/dc, of
0.15 cm3/g for b-HS, 0.18 cm3/g for all proteins and 0.17 cm3/g for lipids.
2.6. Surface plasmon resonance (SPR)
SPR measurements were performed with a Biacore T200 (GE Healthcare Bio-
Sciences) operated with Biacore T200 evaluation software (version 2.0.1). All mea-
surements were performed at 25 C using a working buffer solution supplemented
with 0.005% (w/w) surfactant P20 (an additive employed to reduce nonspeciﬁc
adsorption to ﬂow system surfaces). The gold-covered Biacore sensor chips were
ﬁrst coated ex situwith a biotinylated OEG monolayer, and further functionalization
with SAv and b-HS to saturation proceeded in situ. Binding experiments were per-
formed by injecting CXCL12a at desired concentrations and at a rate of 75 mL/min for
4.5 min. Between binding assays, the surface was regenerated by two steps of
exposure to 2 M NaCl for 2min each. Upon NaCl treatment, the SPR signal returned to
within 5 RU to the level before incubation with chemokine, indicating full regen-
eration. Reference measurements were performed in parallel on SAv monolayers
lacking HS. To obtain the sensorgram shown in Fig. 4A, the reference data were
subtracted from the binding curves on HS ﬁlms. The responses in the reference
channel were always below 10% of the total response, indicating that non-speciﬁc
binding and solution effects on the SPR response were minor.
2.7. T-lymphocyte culture and adhesion assays
The Jurkat cell line was obtained from the European Collection of Cell Cultures
(ECACC). Cells were maintained in Roswell Park Memorial Institute (RPMI 1640)
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medium, supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 units/ml
penicillin, 100 mg/mL streptomycin (all from LifeTechnologies, Carlsbad, CA, USA).
Cells were grown at 37 C under a 5% CO2 atmosphere, and passed at densities
between 2  105 and 2  106 cells/mL.
For cell adhesion assays, glass coverslips e either uncoated or coated with gold
and a biotinylated OEG monolayer e were attached, using a bi-component glue
(Picodent, Wipperfürth, Germany), to a custom-built teﬂon holder, thus forming the
bottom of 4 identical wells with a volume of ~50 ml each. Biomolecular samples for
surface functionalization were incubated in still solution. To remove excess sample
after each incubation step, the content was diluted by repeated addition of a 2-fold
excess of working buffer and removal of excess liquid until the concentration of the
solubilized sample, estimated from the extent of dilution, was below 10 ng/mL.
Repeated aspiration and release ensured homogenization of the liquid volume at
each dilution step. Care was taken to keep the substrates wet at all times. To avoid
unbinding of CXCL12a from HS ﬁlms, excess CXCL12a in solution was not removed
and all cell suspensions were supplemented with 5 mg/mL CXCL12a prior to cell
plating.
Prior to plating, cells were re-suspended at a concentration of 106 cells/mL in
RPMI medium without serum. For life cell nuclear labelling, Hoechst 33342 (Sigma
Aldrich) at a concentration of 100 ng/mLwas added to the cell suspension. To test for
the speciﬁcity of the cellular recognition of CXCL12a through the receptor CXCR4, T-
lymphocytes were treated with the human monoclonal anti-CXCR4 antibody 12G5
(R&D Systems), which inhibits interaction with CXCL12a [13], at a concentration of
1 mg/mL for 1 h. For assays involving ICAM-1 displaying surfaces, 1 mM MgCl2 and
1 mM EGTA were added to the cell suspension 10 min before plating; this treatment
enhances the afﬁnity of the ICAM-1 cell-surface receptor LFA-1 and thus promotes
adhesion to ICAM-1 displaying surfaces [34].
Cells were plated at a density of 2.5  105 cells per cm2 on the functionalized
glass cover slips. After incubation for 1 h, non-adhesive (and weakly adhesive)
cells were removed by gentle rinsing with a pipette in phosphate-buffered saline
(PBS; Sigma Aldrich) at pH 7.4. Differential interference contrast (DIC) micro-
graphs and epi-ﬂuorescence micrographs of the nuclear labelling were taken
shortly before and after the rinsing step, using an inverted microscope (IX81;
Olympus, Hamburg, Germany) equipped with a 60 oil immersion objective
(PlanAPoN60XO; Olympus). At least 20 locations were imaged on each sample,
covering a surface area of at least 2 mm2, and used for further quantitative
analysis. The same locations were imaged before and after the rinsing step.
Volocity visualization software (PerkinElmer, Wlatham, MA, USA) was used for
analysis of ﬂuorescence micrographs, to detect the cells and quantify cell surface
densities. From a comparison with manual cell counts on selected samples, we
estimate the error in the automated determination of cell surface densities to be
below 5%. All assays were repeated at least 4 times with independent cell cul-
tures. The percentage of adherent cells is presented as mean values ± standard
deviation of four independent experiments. To evaluate the statistical signiﬁ-
cance between the mean values of more than two samples, the ANOVA test with
Bonferroni correction was applied, and a p-value for a ¼ 0.05 was extracted for
each sample combination.
3. Results
3.1. Design of well-deﬁned biomimetic surfaces
The design of our biomimetic glycosaminoglycan-presenting
surfaces is schematically shown in Fig. 1. Two different ap-
proaches were used to immobilize GAGs. Both have in common that
they use biotinylated GAGs (here HS) and a monolayer of strepta-
vidin (SAv) on a passivating background that prevents non-speciﬁc
binding. The passivating background was either a gold-supported
oligo(ethylene glycol) (OEG) monolayer exposing biotin at the
end of a fraction of the OEGmolecules (Fig.1A) or a silica-supported
lipid bilayer (SLB) exposing biotin at the head of a fraction of the
lipids (Fig. 1B).
The design rules were chosen such that ensuing molecular in-
teractions give rise to self-assembled yet stable model surfaces that
are well-deﬁned and tuneable with regard to the density, the
Fig. 2. Step-by-step self-assembly of GAG-presenting model surfaces. Surface functionalization was followed in situ by QCM-D (frequency shifts, Df e blue lines with square symbols,
dissipation shifts, DD e red lines) on an OEG monolayer (A) and on a SLB (B). Start and duration of incubation steps with different samples are indicated by arrows; during all other
times, the surface was exposed to working buffer. HS lacking biotin functionality did not bind to the SAv ﬁlm on OEG monolayers (C) or SLBs (E) and CXCL12a did not bind to either
SAv ﬁlm in the absence of HS (D, F). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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orientation and the lateral mobility of the displayed molecules. In
particular, we expect SAv to be immobilized such that two of its
four biotin-binding sites are facing the surface for immobilization
while the other two binding sites are facing the solution to
accommodate target molecules. In this regard, SAv performed
better than neutravidin (which is perhaps more frequently used in
molecular labelling applications), because neutravidin has an
enhanced tendency to aggregate [35] and hence does not form
well-deﬁned monolayers. Biotin conjugation of the target molecule
at a speciﬁc site affords immobilization at a well-deﬁned and
desired orientation on SAv monolayers. In the case of HS, for
example, site-speciﬁc biotinylation at the reducing end ensures
binding with an orientation that mimics the attachment to HS-
displaying core proteins in the cell membrane [36]. Moreover,
because binding is stoichiometric and very stable, more than one
type of biotinylated molecules can be sequentially immobilized on
SAv monolayers. Because the bond forms rapidly (i.e. binding is
mass-transfer limited at sufﬁciently low surface densities), surface
densities of target molecules can be quantitatively tuned by varying
their solution concentrations and incubation times. The main dif-
ference between the two passivating backgrounds is the lateral
mobility of the SAv molecules. On SLBs, SAv and any target mole-
cule anchored to it can rotate and diffuse laterally (as illustrated by
the black arrows in Fig. 1B), provided that the SAv surface density is
low enough to prevent two-dimensional protein crystallization
[37,38] (the latter was reported to occur at surface densities above
75% relative to that of the crystalline phase, i.e. above 200 ng/cm2,
on lipid monolayers [39]).
To validate our approach, the step-by-step assembly of our
biomimetic surfaces was monitored by QCM-D (Fig. 2). OEG
monolayers were prepared ex situ prior to installing the gold-
coated sensors in the QCM-D chamber. SLBs were formed in situ
by the method of vesicle spreading, through incubation of the
silica-coated QCM-D sensor with 50 mg/mL SUVs (Fig. 2B). The ﬁnal
shifts in frequency (Df ¼ 26 ± 0.5 Hz) and in dissipation
(DD 0.3106) indicates the formation of a conﬂuent SLB of good
quality [40]. The binding kinetics upon successive incubation with
1 mg/mL (to check for sample depletion in the ﬂuidic system, see
Methods for details) and 20 mg/mL (to rapidly saturate the surface)
SAv were comparable on both surfaces. At equilibrium, SAv gener-
ated frequency shifts of 23 ± 1 Hz on OEG monolayers
and 27 ± 1 Hz on SLBs, and on both supports, the shifts in dissi-
pation were below 0.4  106. From the frequency shifts, and
assuming a mean density of 1.2 g/cm3 for the SAv ﬁlmwith trapped
solvent [41], a ﬁlm thickness of approximately 4 nm can be deter-
mined using Sauerbrey's equation, consistent with the molecular
dimensions of SAv. Overall, these responses are as expected for the
formation of rather dense protein monolayers [16,41], in which
each SAv molecule exposes two biotin-binding sites each towards
the surface and the bulk solution, respectively.
b-HS, incubated at 50 mg/mL, readily bound to the free biotin-
binding sites on the SAv monolayers, with frequency shifts at
equilibrium of 31 ± 1 Hz on OEG monolayers and 33 ± 2 Hz on
SLBs, and with corresponding dissipation shifts of 5.0 ± 0.5  106
and 5.5 ± 0.5  106, respectively. These responses indicate the
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Fig. 3. Quantiﬁcation of adsorbed amounts. Surface functionalization was followed in situ by spectroscopic ellipsometry (SE) on a gold-supported OEG monolayer (A) and a silica-
supported lipid bilayer (B). Incubation steps and sample concentrations were as for Fig. 2. Each incubation step started at 0 min; the start of rinsing in working buffer is indicated by
an arrow.
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ﬁlm was completely stable to rinsing in buffer, as expected for
immobilization through the strong biotin-SAv bond. We note that
the HS surface densities obtained in the present measurements
correspond to the maximal attainable coverage. Lower surface
densities can be readily obtained by tuning b-HS incubation time
and concentration. By ﬁtting the QCM-D responses to a viscoelastic
model, the effective thickness of the HS ﬁlms was estimated to be
11.6 ± 1.2 nm. In comparison, the average contour length of the
employed HS chains is approximately 25 nm. The QCM-D data are
hence consistent with the formation of a ﬁlm of end-grafted HS, in
which the individual chains are slightly coiled and/or point in
random directions with respect to the surface normal.
The chemokine CXCL12a, incubated at 5 mg/mL, generated
negative shifts in frequency (9 ± 1 Hz on both surfaces), indicating
binding. The strong concomitant decrease in dissipation
(by5 ± 1106 on OEGmonolayers and4.4 ± 1106 on SLBs)
indicates protein-induced rigidiﬁcation of the HS ﬁlm. This
remarkable effect merits further investigation, which will be the
subject of a forthcoming study. Upon subsequent rinsing in buffer,
frequency and dissipation increased slowly but did not return to the
level of the virgin HS ﬁlm, demonstrating that some CXCL12a was
released over experimentally accessible time scales whereas a
sizeable fraction remained rather stably bound and displayed byHS.
We performed several additional assays to validate the quality of
our surfaces and the speciﬁcity of immobilization. Bovine serum
albumin (BSA) at 100 mg/mL did not bind to the OEG monolayer
(Fig. 2A), conﬁrming that the OEG ﬁlm indeed effectively blocks
against access of proteins to the underlying gold surface. BSA also
did not bind to the SLB or to the SAv monolayers (not shown). HS
lacking biotin functionality did not bind to any of the SAv mono-
layers (Fig. 2C and E), conﬁrming that b-HS is exclusively immo-
bilized through the biotin moiety at the GAG's reducing end.
CXCL12a did not bind any of the SAv monolayers in the absence of
HS (Fig. 2D and F), conﬁrming that chemokine binding to HS is
speciﬁc. Moreover, the CXCL12a fraction that remained in the HS
ﬁlm after rinsing with buffer could be eluted, and the HS ﬁlm thus
fully regenerated, by exposure of the surfaces to 2 M of either
guanidine hydrochloride (GuHCl; Fig. S1) or NaCl (not shown).
3.2. Quantitative analysis of surface densities of functional
biomolecules
The surface densities of biomolecules during the step-by-step
assembly of the biomimetic surfaces were quantiﬁed by spectro-
scopic ellipsometry (SE; Fig. 3). As for the QCM-D measurements,
OEG monolayers were formed ex situ, whereas all other immobili-
zation steps were followed in situ. Time-resolved data for OEG
monolayers and SLBs are displayed in Fig. 3A and B, respectively,
and Table 1 provides quantities extracted at equilibrium. The lipid
surface density at equilibrium (380 ng/cm2) is consistent with ex-
pectations for an SLB. At the maximal attained SAv coverage on
SLBs, the average surface area available per SAv molecule was
~37 nm2. In comparison, the projected surface area of an appro-
priately oriented SAv molecule was estimated to
4.3 nm  5.4 nm z 23 nm2 [41], conﬁrming that SAv formed a
dense monolayer. Consistent with expectations from the QCM-D
frequency responses (Fig. 1AeB), OEG monolayers could accom-
modate a similar yet slightly (18%) lower density of SAv, corre-
sponding to an average surface area per molecule of ~45 nm2. The
increased binding on SLBs could be due to the lateral mobility of
SAv on ﬂuid SLBs, allowing reorganization into a more densely
packed monolayer. Taken together, with two biotin-binding sites
available per SAv molecule, the average surface area per biotin-
binding site (i.e. anchor point for b-HS) on saturated SAv mono-
layers would be 21 ± 2 nm2, corresponding to an average spacing of
4.5 nm (assuming packing in a square lattice).
The binding curves for b-HS in Fig. 3 reveal a constant binding
rate up to approximately 80% of maximal coverage, and a rapid
saturation thereafter. This indicates that HS binding is mass-
transfer limited at low surface densities [42], and that kinetic
limitations due to crowding of HS chains on the surface do only
weakly affect HS binding even at high surface densities. This would
suggest that all solution-facing biotin-binding sites (i.e. two per SAv
molecule) can be occupied with b-HS. According to Table 1, and
considering a SAv molecular mass of 60 kDa [41], the amount of HS
bound on average per biotin-binding site is 5.2 ± 0.6 kDa. This value
is inferior to the average HS molecular mass employed (12 kDa).
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Fig. 4. SPR analysis of CXCL12a binding to HS ﬁlms. (A) SPR response for the binding of CXCL12a at different concentrations (0e800 nM, as indicated, corresponding to 0e6.4 mg/mL)
to a model surface presenting a dense monolayer of b-HS on a SAv-coated OEG monolayer as represented in Fig. 1A. The chemokine was injected from 0 to 270 s, followed by rinsing
in buffer alone. (B) Quantitative analysis of SPR data through ﬁtting. The binding isotherm, obtained from the SPR responses close to equilibrium in A (black symbols) was well
described by a Langmuir isotherm (red line) with KD ¼ 0.13 ± 0.02 mM (or 1.1 ± 0.2 mg/mL) and a maximal binding of 1910 ± 100 RU (mean ± standard deviation of 3 measurements).
Data at 25 nM from a selected measurement (inset, blue line) were ﬁt with a one-to-one Langmuir type kinetic model (black line), from which kon ¼ 2.3  105 M1 s1,
koff ¼ 1.7  102 s1, KD ¼ 73 nM (or 0.59 mg/mL) and a maximal binding of 790 RU were extracted. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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The discrepancy is likely a consequence of the large size distribu-
tion of HS in solution, i.e. capture on SAv has selected the shortest
chains in the initial HS sample. The binding of smaller molecules
tends to be favoured, because of their faster diffusion and hence
mass transfer to the surface [42] and because they may also
penetrate an existing HS ﬁlm more easily. Assuming an average
molecular mass of an HS disaccharide of 500e550 Da [43], we can
estimate that 10 ± 2 disaccharides are bound on average per biotin-
binding site. With a length of 1.0 nm per disaccharide, the average
chain contour length would then be 10 nm. The ﬁnal b-HS surface
density on OEG monolayers was slightly lower than on SLBs. This is
most likely a consequence of the reduced SAv density on OEG
monolayers. Indeed, within the experimental uncertainties, the
mass ratio of b-HS to SAv was constant on both surfaces.
The binding curve for CXCL12a reproduced many features
already observed by QCM-D (Fig. 2AeB), such as rapid binding and
equilibration and partial release of proteins upon rinsing in buffer.
Thanks to the quantiﬁcation of surface densities afforded by SE
(Table 1), and with a CXCL12a molecular mass of 8.1 kDa, it is
possible to estimate that each CXCL12a molecule has approxi-
mately 3.5 kDa HS, corresponding to roughly 7 disaccharides,
available on average at equilibrium.
3.3. Application of the biomimetic GAG-presenting surfaces to
molecular interaction analysis
Surface plasmon resonance (SPR) was used to analyse thermo-
dynamic and kinetic parameters of the interaction of CXCL12awith
HS ﬁlms (Fig. 4). SPR studies of CXCL12a binding to HS have pre-
viously been reported [9] using a ﬁlm of carboxymethylated
dextran (i.e. Biacore CM4 sensor chips) with covalently immobi-
lized SAv as an immobilization platform. The dextran ﬁlm is
approximately 100 nm thick [44] and hence represents a three-
dimensional environment into which b-HS was bound (at un-
known volume densities). The model surfaces in our study are
distinct, in that all HS molecules are presented at the same orien-
tation in the form of a monolayer with controlled surface density.
As for QCM-D (Fig. 2A) and SE (Fig. 3A) measurements, the gold-
coated SPR sensor chip was ﬁrst functionalized ex situ with an
OEG monolayer, and subsequent functionalization was monitored
in situ. At saturation, 2550 ± 25 and 330 ± 20 response units (RU)
were reached for SAv and b-HS, respectively. According to Table 1,
these values correspond to surface densities of approximately 235
and 35 ng/cm2, respectively.
The sensorgram in Fig. 4A shows a response in CXCL12a binding
that is dose dependent in the initial binding rates and the binding
equilibrium, as expected. For low protein concentrations
(100 nM), the binding curves were conventional and the protein
could be close-to-completely removed upon rinsing in buffer. The
unbinding curves at the lowest employed concentration (25 nM)
were well-ﬁtted by a one-to-one Langmuir type binding model
(Fig. 4B, inset), revealing an association rate constant
kon ¼ 2.3  105 M1 s1, a dissociation rate constant
koff ¼ 1.7  102 s1, and hence a dissociation constant KD ¼ koff/
kon¼ 73 nM (or 0.59 mg/mL), and amaximal response of 790 RU. The
results of the ﬁt varied somewhat depending on how much of the
unbinding curve was included in the ﬁt, and from these variations
we estimate the KD to be accurate to within a few 10%. The simple
one-to-one binding model increasingly failed to reproduce the
experimental data with increasing protein concentration. Above
100 nM, a peculiar multi-phase binding response appeared: a ﬁrst
fast binding was followed by a quasi-plateau and a phase of slower
binding before equilibrium was reached. Moreover, a substantial
fraction of the chemokine remained bound upon rinsing in buffer at
these protein concentrations. The multi-phase binding response
and the limited release appear to be correlated, suggesting that
CXCL12a can bind to HS in at least two distinct ways.
The complex binding pattern precluded a further quantitative
analysis of the kinetic SPR data. However, a binding isotherm was
constructed from the SPR responses close to equilibrium (Fig. 4B).
The data could be ﬁtted with a Langmuir isotherm with
KD ¼ 0.13 ± 0.02 mM (or 1.1 ± 0.2 mg/mL) and a maximal response of
1910 ± 100 RU, both signiﬁcantly larger though of the same order of
magnitude as the values obtained above for a solution concentra-
tion of 25 nM. Considering the complex binding pattern observed by
SPR, and the heterogeneous sulphation of HS, it is rather surprising
that the binding isotherm is so well described by the simple
Langmuir binding model. The agreement might well be coinci-
dental, and we therefore suggest that the KD ¼ 0.13 mM obtained
through the binding isotherm should be considered an effective
value rather than representing the true binding afﬁnity of a one-to-
one binding interaction. Notably, our effective KD value is compa-
rable to the value of 0.20 mM, previously obtained by SPR with a ﬁlm
of HS-functionalized carboxymethylated dextran using an HS
preparation of comparable sulphation and molecular weight [9].
The KD ¼ 73 nM obtained through analysis of the kinetic data at
25 nM, on the other hand, may be a true binding constant, repre-
senting the highest-afﬁnity binding sites in the HS ﬁlm. Since
CXCL12a tends to bind to highly sulphated regions [47], one would
expect this number to be comparable to the afﬁnity of CXCL12a for
the highly sulphated GAG heparin. Indeed, a similar value of 93 nM
has been reported for heparin [9].
We note that the SPR responses at equilibrium upon CXCL12a
binding (Fig. 4A) were several fold larger than what was previously
reported on CM4 sensor chips [9]. Most likely, this is due in part to a
higher HS density selected in our assays and in another part to an
enhanced sensitivity of our assay (i.e. because the SPR sensitivity
decays exponentially with the distance from the gold surface, and
the interactions in our assay are conﬁned to within about 20 nm
whereas the CM4 chip samples approximately 100 nm). By
comparing the SE data for CXCL12a binding (at 5 mg/mL or 620 nM
solution concentration; Table 1) with the Langmuir isotherm
Table 1
Adsorbed amounts (Gmax) and surface areas available per molecule (Amin) at equilibrium for SAv, b-HS and CXCL12a. Data was extracted from SE measurements. Mean values
and standard errors from the mean were derived from 3 independent measurements. The adsorbed amount and the average surface area occupied per deposited molecule
were estimated to quantify the number of SAv or HS molecules grafted per unit surface area, and the stoichiometry of chemokine binding.
Immobilization platform SAv b-HS CXCL12a
Gmax Amin Gmax Amin Gmax Amin
(ng/cm2) (nm2) (ng/cm2) (nm2) (ng/cm2) (nm2)
OEG monolayer on gold 235 ± 6 42.4 ± 1.1 35.5 ± 2.2 56.3 ± 3.5a 78 ± 7 17.4 ± 1.6
SLB on silica 273 ± 8 36.5 ± 1.5 46.8 ± 1.5 42.6 ± 1.4a 120 ± 20 11.5 ± 1.9
a Assuming an averagemolecular weight of 12 kDa per surface-bound b-HS. This assumption is based on the averagemolecular weight determined for HS in solution prior to
biotinylation. In reality, the surface-binding might favour low molecular weight HS. When assuming instead that two HS chains are bound per SAv molecule, the average
molecularweight per surface-bound b-HSwould be 5.2±0.3 kDa on SLBs and 4.6± 0.4 kDa onOEGmonolayers and Amin for b-HSwould correspond to 0.5 times theAmin for SAv.
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Fig. 5. T-lymphocytes adhere speciﬁcally to model surfaces presenting HS-bound chemokine. (A) Representative images of T-lymphocytes that were plated on surfaces presenting
different surface functionalizations. Molecules used for functionalization are listed on the left, and “þ” indicates that a compound was used on a given surface. BSA and ﬁbronectin
(Fn) were physisorbed on glass cover slips and used as the negative and positive control, respectively, for cellular adhesion. All other functionalizations were performed on OEG
monolayers on coverslips coated with a 5 nm gold ﬁlm. Whenever CXCL12a was used, the chemokine was maintained in the soluble phase throughout the cell adhesion assay at
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derived from SPR (Fig. 4B), we can estimate that the maximal SPR
response of 1910 RU corresponds to roughly 6 disaccharides
available on average per CXCL12a. CXCL12a is known to dimerize
upon binding to GAGs, with the GAG binding site being located at
the interface between the constituent monomers [45e47], i.e. 12
disaccharides would be effectively available per CXCL12a dimer
binding site. In comparison, structural models and binding data
have suggested that a CXCL12a dimer occupies approximately 6
disaccharides [47,50]. Thus, if all CXCL12a are bound directly to HS
and if CXCL12a binds exclusively to the highly sulphated regions,
then this would mean that about one half of the HS is highly
sulphated. The degree of sulfation in HS is diverse and depends on
the source, but the above calculation is clearly in the range of what
is possible.
3.4. Application of the biomimetic GAG-presenting surfaces to
cellular interaction studies
Increasing complexity, the biomimetic GAG-presenting surfaces
were used to trigger speciﬁc cellular responses. As a model system,
we chose CXCL12a-loaded HS-presenting surfaces and Jurkat cells
as a CXCL12a sensitive T-lymphocytes cell line [13]. In a ﬁrst step,
the adhesion of Jurkat cells to surfaces with different functionali-
zations was assessed by quantifying the fraction of cells that
resisted gentle rinsing with a pipette after 1 h of exposure to the
surface (Fig. 5). Less than 20% of cells adhered stably to glass cover
slips with physisorbed BSA whereas more than 60% of cells
remained attached on glass cover slips with physisorbed ﬁbro-
nectin (Fn). These surfaces served as negative and positive controls,
respectively.
All other functionalizations were performed on OEGmonolayers
on coverslips coated with a 5 nm (i.e. semi-transparent) gold ﬁlm,
following the previously established protocol (Fig. 1A). Surfaces
displaying a virgin SAv monolayer or a SAv monolayer with HS ﬁlm
showed a level of cellular adhesion that was comparable to the
negative control (Fig. 5). This demonstrates that our surfaces are
resistant to non-speciﬁc cellular adhesion, as desired. The presence
of CXCL12a at 100 ng/ml in the bulk solution did not enhance cell
adhesion to a virgin SAv monolayer. At this chemokine concentra-
tion, close to CXCL12a plasma concentration during inﬂammation
[48], T-lymphocytes are known to become activated [49]. Evenwith
CXCL12a at 5 mg/mL in the bulk solution, T-lymphocyte adhesion
remained at baseline level on virgin SAv monolayers. We conclude
that stimulation through CXCL12a in the solution does not promote
signiﬁcant (non-speciﬁc) cell adhesion.
In contrast, when CXCL12a was presented by the surface
through HS (Fig. 5), cellular adhesion increased signiﬁcantly, to
levels that were comparable or even superior to Fn-displaying
surfaces. Considering that CXCL12a is not known as a cell adhe-
sion ligand and that CXCL12a binds reversibly to the HS-coated
surface, this ﬁnding is surprising. When CXCL12a-binding to its
cell-surface receptor CXCR4 was blocked with the anti-CXCR4
antibody 12G5 [13], cell adhesion returned to baseline levels,
demonstrating that CXCL12a-mediated adhesion of Jurkat cells to
HS-presenting surfaces is speciﬁc and mediated by CXCR4.
In a complementary assay, we tested if the presence of HS was
required for CXCL12a-mediated cellular adhesion (Fig. 5). To this
end, CXCL12a was immobilized directly on the SAv monolayer
using a biotinylated protein construct (Fig. S2). Site-speciﬁc
conjugation with a biotin at position 68, the C-terminal residue
that is not expected to interfere with CXCL12a binding to HS (see
Fig. S2A) or to the cell surface receptor CXCR4 [50], ensured
close-to-stoichiometric binding of CXCL12a to SAv (i.e. two
CXCL12a molecules per SAv, Fig. S2B) at appropriate orientation.
There was no signiﬁcant difference in the cellular adhesion be-
tween the two methods of CXCL12a presentation (Fig. 5B; p-
value ¼ 0.9). Therefore, under the employed conditions
(including CXCL12a surface densities of similar magnitude, see
Fig. 3A and Fig. S2B), the presentation of the chemokine through
HS does apparently not alter the cellular response in terms of
adhesion to CXCL12a as compared to chemokine presentation in
the absence of HS.
3.5. Cell adhesion on surfaces presenting GAGs together with cell
adhesion ligands e towards more complex cellular interaction
studies
With its modular design, our surface functionalization platform
can readily accommodate multiple biotinylated compounds,
generating multifunctional surfaces (Fig. 1A). To demonstrate this,
surfaces were created onwhich the intercellular adhesionmolecule
1 (ICAM-1) was immobilized, either alone or in combination with
HS. ICAM-1 is known to be presented by the endothelial cell surface
and to bind to the leucocyte function-associated antigen-1 (LFA-1;
also called integrin aLb2). This interaction is responsible for the
attachment of T-lymphocytes to the vascular endothelium, a pre-
cursor step towards migration through the endothelial barrier [51].
Here, we tested how the co-presentation of HS-bound CXCL12a and
ICAM-1 affects cell adhesion.
The assembly of the new model surface was ﬁrst characterized
by QCM-D. A fusion protein made from two ICAM-1 extracellular
domains and an immunoglobulin Fc domain (Fc-ICAM-1) could
be immobilized stably and with desired orientation through an
adaptor protein (b-ZZ) that contained two Z-fragments of Protein
A (for binding to the Fc domain) and a site-speciﬁcally conjugated
biotin (for binding to SAv) (Fig. S3). Fig. 6A conﬁrms that b-HS
and b-ZZ can be sequentially immobilized on the same SAv
monolayer, and that the resulting surface can be used to co-
display CXCL12a (speciﬁcally through b-HS, see also Fig. S3A)
and Fc-ICAM-1 (speciﬁcally through b-ZZ, see also Fig. S3B). For
the cell adhesion assays, surfaces presenting HS-bound CXCL12a
together with ICAM-1 were compared with surfaces presenting
either HS-bound CXCL12a or ICAM-1 alone. Surfaces displaying
b-ZZ, either alone or with HS, were used as negative controls.
Throughout the assay, surface densities of the incubated com-
ponents were maintained constant. The surface coverage of b-HS
and b-ZZ was controlled by varying the samples' solution con-
centrations and incubation times and exploiting the fact that
binding to SAv is mass transport limited at sufﬁciently low b-HS
and b-ZZ surface densities (Fig. S4). The surface density of b-HS
was ﬁxed to 35 ± 5% of the maximal surface density (Fig. S4A),
corresponding to an average distance of about 13 nm between
neighbouring HS chains. Onto this low-density HS ﬁlm, CXCL12a
bound with an equilibrium surface density of 35 ± 4 ng/cm2
(Fig. S4B). b-ZZ was immobilized at 7 ng/cm2 (Fig. S4C). This
surface density, corresponding to an average distance of 28 nm
indicated concentrations. Jurkat cells were incubated for 1 h and non-adhesive cells were then removed by gentle rinsing. Micrographs (DIC (gray scale) overlayed with ﬂuorescence
of labeled cell nuclei (blue)) are representative and were taken shortly before (left columns) and after (right columns) rinsing. (B) Box plot representing the distribution of the
percentage of adherent cells that remained after rinsing as a function of surface functionalization. The small square and the horizontal line inside the box indicate the mean and the
median, respectively, the lower and upper boundaries of the box are determined by the 25th and 75th percentiles, respectively. The crosses correspond to the maximum and to the
minimum value observed. ANOVA tests were performed to obtain p-values. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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between neighbouring anchor points for Fc-ICAM-1, was chosen
to have an ICAM-1 surface density not too high to be able to
appreciate the effect of the co-presentation of the integrin ligand
with the chemokine presented through HS.
Considering the molecular dimensions of the Fc-ICAM-1
construct e the ﬁve immunoglobulin (Ig)-like domains per each
of the two ICAM-1 domains [52] and the four Ig domains of the Fc
part [53] are expected to form an assembly of two bent rods
aligned at the Fc part, where each rod is about 26 nm long and
2 nm in diameter e it is unlikely that steric constraints will limit
the binding of Fc-ICAM-1 to b-ZZ, and the average distance be-
tween ICAM-1 dimers is therefore estimated to be also 28 nm.
Moreover, with the chosen surface densities, surface crowding
should not limit immobilization of any of the molecular species. In
contrast to the previous assay (Fig. 5), Jurkat cells were treated
with 1 mM MgCl2 and 1 mM EGTA to induce high-afﬁnity binding
of LFA-1 to ICAM-1 and thus to enhance T-lymphocyte adhesion
[54,55].
Results are presented in Fig. 6BeC. Only 10% of the cells adhered
to the negative control surfaces, comparable to the BSA control
previously used (Fig. 5B), conﬁrming low non-speciﬁc binding. A
larger fraction of cells, about 34% and 26%, adhered to surfaces dis-
playing either Fc-ICAM-1 or HS-bound CXCL12a alone, respectively.
Interestingly, the adhesion increased drastically, to about 80%,when
ICAM-1 andHS-boundCXCL12awere presented together. This assay
thus demonstrates that the co-presentation of an integrin ligand
and a GAG-bound chemokine elicits a cellular response that is
distinct from the response to each individual cue alone.
4. Discussion
We have developed a bottom-up biosynthetic approach to
reconstitute GAGs and other cell membrane and extracellular ma-
trix molecules (lipids and proteins) into well-deﬁned model sur-


























+ + + + +
+ + +
































SAv + + + + +
b-ZZ + + + +
Fc-ICAM-1 + +












Fig. 6. T-lymphocytes differentially respond to surfaces presenting HS-bound chemokine with an integrin ligand. (A) The assembly of a biomimetic surface displaying HS-bound
CXCL12a together with the cell adhesion molecule ICAM-1 on a SAv-coated gold-supported OEG monolayer was demonstrated by QCM-D (Df e blue line with square symbols, DD e
red line). Start and duration of each incubation step with different samples are indicated by an arrow; during all other times, the surface was exposed to working buffer. SAv was
incubated as in Fig. 2A, b-HS at 1 mg/mL, b-ZZ at 0.05 mM, Fc-ICAM-1 at 0.1 mM, and CXCL12a at 5 mg/mL. (B) Representative micrographs of Jurkat cells plated on surfaces presenting
different surface functionalizations. Surface densities of all displayed molecules were kept constant throughout the assay as described in the main text. Cells were incubated, and
micrographs are presented as described in Fig. 5A. (C) Box plot representing the distribution of the percentage of adherent cells that remain after rinsing as a function of surface
functionalization (analysis analogous to Fig. 5B). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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biomimetic environments for quantitative molecular and cellular
studies.
The presented surface functionalization strategy is versatile. SAv
monolayers serve as a molecular breadboard for the selective
coupling of various biomolecules. SAv acts as a host for biotinwhich
is site-speciﬁcally conjugated, either directly to the desired
biomolecule (e.g. Fig. 2 and Fig. S2) or to an adaptor molecule that
binds other tags. The latter was demonstrated here with b-ZZ and
an Fc chimera (Fig. S3) and other highly speciﬁc yet stable in-
teractions can also be exploited (e.g. multivalent NTA constructs
and histidine tags [56]). Moreover, the surface density e and hence
also the average molecular spacing e can be controlled (Fig. 3) and
tuned (Fig. S4). Although not explicitly demonstrated in this study,
the design principle also enables comparative studies on surfaces
displaying immobile (Fig. 1A) vs. laterally mobile (Fig. 1B) mole-
cules, e.g. to assess the importance of ligand clustering in cellular
interactions. Taken together, surface functionalization combined
with the design of molecular building blocks through synthetic
conjugation chemistry or biochemistry thus provide a toolbox of
interactions for the assembly of multifunctional surfaces in a
molecular-lego-type fashion.
The employed surface design, validated by QCM-D and SE
characterization, confers control on molecular orientation such
that the appropriate molecular face is exposed to the solution
phase. This ensures that the vast majority of immobilized mole-
cules remains active, in contrast to conventional immobilization
approaches such as physisorption (e.g. in enzyme-linked immu-
nosorbent assays (ELISA)) or covalent coupling through random
sites (e.g. carboxylic acids or primary amines via EDC NHS
chemistry), where surface-induced denaturation and/or spatial
constraints can drastically limit the activity of immobilized
molecules [57,58]. Biospeciﬁc interactions are also more rapid
than practically relevant covalent chemistries (including the so-
called ‘click’ chemistries), thus enabling rapid assembly of the
biomimetic surfaces. The interactions between biotin and SAv, or
between Fc and Z domains, are strong enough for the surfaces to
remain stable over many hours. Where required, such non-
covalent yet rapid and highly speciﬁc interactions could be
exploited for initial coupling to guide the subsequent formation
of covalent bonds at desired sites with enhanced rates [59],
thereby enhancing stability and further broadening the applica-
tion range.
Several proof-of-concept measurements illustrated the use of
the biomimetic surfaces for mechanistic studies. On the molecular
scale, we ﬁnd that CXCL12a may bind to HS in several distinct
ways (Fig. 4). CXCL12a is known to dimerize upon binding to GAGs
[45e47], and higher-order oligomers of this chemokine have also
been reported [60]. Moreover, HS are heterogeneously sulphated
and CXCL12a is known to bind preferentially to the highly
sulphated domains [47]. All these factors might contribute to the
complex binding behaviour, in a way that remains to be eluci-
dated. We also ﬁnd that CXCL12a rigidiﬁes HS ﬁlms (Fig. 2AeB),
indicating that the interaction of this chemokine affects the su-
pramolecular arrangement of HS chains. In future studies, the
model surfaces should be versatile towards elucidating the mo-
lecular mechanism behind GAG matrix remodelling by CXCL12a
and its functional consequences. More generally, it becomes
possible to study directly on the supramolecular scale how
extracellular proteins bind to GAG matrices and remodel them, or
how the presentation of GAGs affects protein retention and dy-
namics (e.g. towards the formation of chemokine gradients
[24,61]).
At the cellular level we demonstrate that the speciﬁc interaction
between HS-bound CXCL12a and the receptor CXCR4 promotes T-
lymphocyte adhesion (Fig. 5). Given that the interaction between
HS and CXCL12a is reversible and considering that no other bona
ﬁde cell adhesion receptor is involved, this ﬁnding is remarkable. It
suggests that CXCL12a can interact simultaneously and in trans
with HS and CXCR4 and that this interaction is strong enough to
confer adhesion. The CXCL12a-mediated bridging of CXCR4 and HS
is consistent with the observation that in CXCL12a, the binding
domains for GAG and CXCR4 are spatially distant and do not
interfere functionally [62].
Although the presentation of CXCL12a through HS and in the
form of b-CXCL12a is distinct e HS displays CXCL12a in dimeric
form [45e47] and reversibly bound whereas b-CXCL12a is
monomeric and irreversibly immobilized e no signiﬁcant dif-
ference in the adhesion of T-lymphocytes was found. This
observation might suggest that the speciﬁc conformation in
which CXCL12a is presented is not crucial for chemokine
recognition by T-lymphocytes. It has been demonstrated that,
when presented in solution, both monomeric and dimeric
CXCL12a are recognized by CXCR4. However, the oligomerization
state has antagonistic effects on cell signalling and function [63]:
low monomer concentrations enhanced chemotaxis while the
dimer inhibited chemotaxis [64,65]. The assays here developed
enable the presentation of CXCL12a in a matrix-bound form,
mimicking in this way the endothelial cell surface, and thus
provide means to test how distinct presentations of CXCL12a in a
matrix-bound form affect cellular response. Future studies
should investigate if the display of CXCL12a through an HS ma-
trix, and the potential internalization of the reversibly HS-bound
chemokine by the cell, leads to distinct downstream effects that
are not detectable in the simple cell adhesion assay used here. It
will also be interesting to analyse how the oligomerization state
of CXCL12a affects the cellular response. Moreover, assays with
distinct GAG conjugates would enable to study how the HS sul-
phation pattern or the GAG type affect chemokine-mediated
cellular responses.
While integrins and L-selectin are recognized as the major
adhesion receptors expressed on the surface of T cells [51], it is
known that signals from homeostatic chemokine receptors are
essential for stable cell adhesion and migration [66,67]. Here, we
demonstrate that when chemokines and integrin ligands are co-
presented, their combined effect increases the adhesion of T-
lymphocytes as compared to either molecule alone (Fig. 6). Future
studies should investigate if ICAM-1 and HS-bound CXCL12a
promote cell adhesion independently, or if the enhanced adhesion
is the consequence of any cooperative action involving cross-talk
between receptors. For example, it has been proposed that the
cellular signalling pathways triggered by CXCL12a and ICAM-1
cooperate, increasing LFA-1 avidity to ICAM-1 [68]. Such a study
will require analysis of cell signalling processes, which is
amenable with our surfaces yet outside the scope of the current
work.
The discussed examples illustrate that the strategy to create
biomimetic surfaces described here represents a versatile experi-
mental platform for mechanistic studies of GAG-protein in-
teractions on the molecular and supramolecular scale, and of GAG-
mediated cellecell and cell-matrix communication. The platform
could also be useful for in vitro diagnostic studies and for drug
development. Indeed the strategy could be used for the formation
of surfaces presenting gradients of GAGs and proteins, to study the
effect of speciﬁc compounds/drugs on T-lymphocyte migration
during the immune response. Moreover, methods for the controlled
presentation of chemokines by HSmay be of key importance for the
design of chemokine-loaded implantable devices for regenerative
medicine or tissue remodelling purposes. For example, it was
recently shown that CXCL12a-HS binding is necessary for post
ischemia revascularization [69].
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5. Conclusions
We have presented a versatile strategy to create biomimetic
surfaces that present GAGs together with other cell surface or
extracellular matrix molecules in a background of low non-speciﬁc
binding. We have demonstrated that the orientation of the
immobilized molecules can be controlled and their surface density
tuned, thanks to the surface design and quantitative characteriza-
tion by surface sensitive techniques, and how this platform can be
used for functional studies on the molecular, supramolecular and
cellular levels. T-lymphocytes adhere speciﬁcally to surfaces pre-
senting CXCL12a and CXCL12a presented through HS enhanced
cellular adhesion when co-immobilized with ICAM-1. The strategy
to create multifunctional biomimetic surfaces should be broadly
applicable for functional studies that require a well-deﬁned su-
pramolecular presentation of GAGs along with other matrix or cell-
surface components.
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Figure S1. Regeneration of HS films by guanidine hydrochloride (GuHCl). QCM-D (∆f  blue lines with 
square symbols, ∆D  red lines) was used to follow the surface functionalization on a gold-supported OEG 
monolayer and the effect of GuHCl on the model surface. Start and duration of each incubation step with different 
samples are indicated by an arrow; during all other times, the surface was exposed to working buffer. The 
assembly of the model surfaces, including loading with CXCL12α, was performed as in Fig. 2A. Upon exposure of 
the CXCL12α-loaded surface to 2 M GuHCl (GuHCl (Sigma Aldrich) was dissolved at 8 M in ultrapure water and 
then diluted in working buffer to the desired concentration), frequency and dissipation shifts recovered the values 
for a virgin HS film, indicating (i) total release of the protein, and (ii) that the HS film itself is not significantly 
affected by GuHCl. A second injection of CXCL12α generated the same shifts in frequency and dissipation as the 
first one, confirming that the surfaces can be effectively regenerated by 2 M GuHCl. Horizontal black dashed lines 
are provided to facilitate comparison of data at different times. The large changes in ∆f and ∆D observed during 
incubation with GuHCl are predominantly due to changes in the viscosity and density of the bulk solution owing to 
the presence of GuHCl and thus unrelated to surface processes. 
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Figure S2. Assembly of surfaces presenting b-CXCL12α. (A) Functionalization of a gold-supported OEG 
monolayer was followed by QCM-D (∆f  blue lines with square symbols, ∆D  red lines). Start and duration of 
incubation steps with different samples are indicated by an arrow; during all other times, the surface was exposed 
to working buffer. SAv was incubated at 20 μg/mL, b-CXCL12α at 5 µg/mL and HS at 50 µg/mL. b-CXCL12α 
bound stably with final shifts of ∆f = -13 ± 0.5 Hz and ∆D = 0.4 ± 0.1  10-6. Assuming a density of 1.2 g/cm3 for 
the b-CXCL12α film with trapped solvent, the frequency shift would correspond to a film thickness of 
approximately 2.0 nm, slightly lower than the dimensions of CXCL12α monomers (2.7 to 4 nm, depending on the 
exact orientation [1]). The QCM-D response is hence consistent with the formation of a monolayer of monomeric 
CXCL12α. HS (without biotin) bound readily to the CXCL12α monolayer, but not to a virgin SAv monolayer (Fig. 
2C), confirming that the accessibility of the HS binding site was not obstructed by the immobilisation of CXCL12α 
through the C-terminal biotin. HS binding is partially reversible, as previously observed for CXCL12α bound to b-
HS films (Fig. 2A-B). (B) Formation of a b-CXCL12α monolayer followed by SE. The surface was prepared as in 
A; incubation of b-CXCL12α started at 0 min, and the start of rinsing in working buffer is indicated by an arrow. 
From the molecular weights and maximal surface densities of SAv (60 kDa; 235 ng/cm2, see Table 1) and b-
CXCL12α (8.6 kDa; 59 ng/cm2), we calculate a binding stoichiometry of 1.8. This confirms that biomolecules can 
be immobilized with a maximal stoichiometry close to two, provided they are small enough to avoid packing 
constraints, consistent with every immobilized SAv molecule exposing two binding sites as expected from the 
design of our immobilization platforms. 
 
Figure S3. Assembly of surfaces presenting ICAM-1. Fc-ICAM-1 was immobilized in an oriented manner 
through a biotinylated linker molecule with a ZZ domain (b-ZZ) which recognizes the Fc-tag on ICAM-1. 
Functionalization of a gold-supported OEG monolayer was followed by QCM-D (∆f  blue lines with square 
symbols, ∆D  red lines). Start and duration of incubation steps with different samples are indicated by an arrow; 
during all other times, the surface was exposed to working buffer. SAv was incubated as in Fig. 2A, b-ZZ at 0.05 
μM, Fc-ICAM-1 at 0.2 μM, CXCL12α at 5 µg/mL and b-HS at 1 μg/mL. (A) The binding curves for b-ZZ and Fc-
ICAM-1 saturated and binding was stable upon rinsing in working buffer, indicating formation of stable 
monolayers. The frequency shift at saturation for b-ZZ (-35.5 Hz) corresponds to a film thickness of approximately 
6 nm (assuming a film density of 1.2 g/cm3), consistent with the hydrodynamic diameter (7.1 nm; measured by 
dynmic light scattering) of b-ZZ. The lack of response for CXCL12α confirmed that ICAM-1 did not compromise 
the inertness of the surface against non-specific binding of chemokines. (B) In the absence of b-ZZ, Fc-ICAM-1 
did not bind to a bare SAv monolayer nor to a SAv monolayer presenting b-HS (at approximately half-maximal 






































































































Figure S4. Tuning of biomolecular surface densities on SAv monolayers. Adsorption was followed by SE; 
each incubation step started at 0 min; the start of rinsing in working buffer is indicated by an arrow. (A) Adsorption 
of b-HS at a concentration of 1 µg/mL from still solution to a SAv-coated OEG monolayer. Only initial binding is 
shown, as adsorption did not reach saturation within reasonable times at such a low solution concentration; b-HS 
surface densities can be tuned by interrupting incubation at desired time points. For example, to create the 
surfaces used for Fig. 6B-C, b-HS was incubated for 30 min (indicated with dotted lines), reaching an areal mass 
density of 12.7 ± 1.3 ng/cm2 (average value over 4 independent measurements, not shown), corresponding to 35 
± 5% of maximal coverage. (B) Representative data for the adsorption of CXCL12α at a concentration of 5 µg/mL 
on such a low density b-HS film. At equilibrium, the areal mass density of CXCL12α was 35 ± 4 ng/cm2. (C) 
Adsorption of b-ZZ at a concentration of 0.05 µM from still solution to a SAv monolayer. Only initial binding is 
shown, as adsorption did not reach saturation within reasonable times at such a low solution concentration; b-ZZ 
coverage at saturation was found to be around 118.6 ± 0.2 ng/cm2 using higher b-ZZ concentrations in solution 
(data not shown). To reach the b-ZZ surface density of 7 ng/cm2, desired for Fig. 6B-C and corresponding to 6% 
of maximal coverage, b-ZZ was incubated for 5 min (indicated with dotted lines). Note that binding of b-HS and b-
ZZ scales with the square root of incubation time (red curves are fits with square-root dependence) provided that 
the surface density is sufficiently low. The square-root dependence is expected for mass-transport limited binding, 
and indicates that surface coverages can be tuned by varying the incubation time (with square-root dependence, 
as shown) and/or the incubation concentration (with linear dependence, not shown). See ref. [2] for details. 
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Significance:  We  present  here  the  application  of  the  biomimetic  GAG­presenting 
surfaces  (described  in  Chapter  III)  to  the  analysis  of  supramolecular  HS­protein 
interactions. We demonstrate that chemokines and growth factors cross­link HS chains, 
and  that  this  cross­linking  ability  is  a  common  feature  among  these  proteins  and 
depends on the architecture of the protein’s HS binding sites. This finding suggests that 
the  functions  of  chemokines  and  growth  factors may  not  simply  be  confined  to  the 
activation of cognate cellular receptors.  
 
My  contribution:  I  co­designed  research  (together with Elisa Migliorini,  Liliane Coche­
Guerente and Ralf P. Richter) and participated in data analysis. I performed the QCM­D 
measurements  with  CXCL12α  and  CXCL12γ.  I  performed  the  synthesis  and  QCM­D 






Le  glycosaminoglycane,  héparane  sulfate  (HS),  présent  à  la  surface  de  la  plupart  des 
cellules et omniprésent dans la matrice extracellulaire, se lie à de nombreuses molécules 
de  signalisation  extracellulaires  solubles  tels  que  les  chimiokines  et  les  facteurs  de 
croissance, et  régule  la  fonction de  transport et  la  fonction effectrice. Cependant, on 
ignore si ces protéines liées au HS peuvent affecter la structure à long terme du HS. Pour 
approfondir  la  question,  nous  avons  mis  en  oeuvre  un  système  supramoléculaire 
modèle, dans lequel les chaînes de HS sont greffées sur une plateforme de streptavidine 
adsorbée  sur  une monocouche  d’oligoéthylène  glycol  ou  sur  une  bicouche  lipidique 
supportée. Ces surfaces fonctionnelles de HS qui miment les matrices péricellulaires ou 
extracellulaires  riches  en  HS  ont  été  caractérisées  par  des  techniques  biophysiques 
comme la microbalance  à  quartz  (QCM­D)  et la  redistribution  de  fluorescence  après 
photoblanchiment  (FRAP). Nous  sommes en mesure de contrôler et de  caractériser  la 
présentation supramoléculaire des chaînes de HS ­  leur densité  locale,  leur orientation, 
leur conformation et  leur mobilité  latérale  ­ et  leur  interaction avec des protéines. La 
chimiokine CXCL12α (ou SDF­1α) rigidifie le film de HS, cet effet est dû à  la réticulation 
des  chaînes  de HS  induite  par  les  protéines. Des mesures  complémentaires  avec  des 
mutants  de  la  chimiokine  CXCL12α  et  l'isoforme  CXCL12γ  ont  permis  de  mieux 
comprendre  le  mécanisme  moléculaire  sous­jacent  à  la  réticulation.  Le  facteur  de 
croissance des  fibroblastes 2  (FGF­2), qui possède  trois  sites de  liaison au HS,  conduit 
également à une réticulation du HS, mais ce n’est pas  le cas du FGF­9, qui possède un 




la  perméabilité  et  la  rigidification)  implique  que  les  fonctions  des  cytokines  et  des 































cells  and ubiquitous  in  extracellular matrix, binds many  soluble  extracellular  signaling 
molecules  such  as  chemokines  and  growth  factors,  and  regulates  their  transport  and 
effector functions. It is, however, unknown whether upon binding HS these proteins can 
affect the long­range structure of HS. To test this idea, we interrogated a supramolecular 
model  system,  in which HS  chains grafted  to  streptavidin­functionalized oligoethylene 
glycol  monolayers  or  supported  lipid  bilayers  mimic  the  HS­rich  pericellular  or 
extracellular matrix with the biophysical techniques quartz crystal microbalance  (QCM­
D) and fluorescence recovery after photobleaching (FRAP). We were able to control and 
characterize  the  supramolecular  presentation  of  HS  chains  ­  their  local  density, 
orientation, conformation and lateral mobility ­ and their interaction with proteins. The 
chemokine  CXCL12α  (or  SDF­1α)  rigidified  the  HS  film,  and  this  effect  was  due  to 
protein­mediated  cross­linking  of  HS  chains.  Complementary  measurements  with 
CXCL12α  mutants  and  the  CXCL12γ  isoform  provided  insight  into  the  molecular 
mechanism underlying cross­linking. Fibroblast growth factor 2 (FGF­2), which has three 
HS binding sites, was also found to cross­link HS, but FGF­9, which has just one binding 
site,  did  not.  Based  on  these  data, we  propose  that  the  ability  to  cross­link  HS  is  a 
generic  feature  of  many  cytokines  and  growth  factors,  which  depends  on  the 
architecture  of  their  HS  binding  sites.  The  ability  to  change matrix  organization  and 
physico­chemical  properties  (e.g.  permeability  and  rigidification)  implies  that  the 
functions of cytokines and growth factors may not simply be confined to the activation 
of cognate cellular receptors. 






Heparan sulfate  (HS)1  is a  linear polysaccharide made of variably sulfated  repeating 
disaccharide units. Attached  to extracellular matrix or  cell­surface proteins  (HSPGs),  it 
pervades  the  intercellular  space  of  many  tissues  and  the  periphery  of  virtually  all 
mammalian  cells.  HS  binds  many  soluble  extracellular  signaling  molecules  such  as 
growth factors and chemokines, and these  interactions are known to be  important  for 
various  physiological  and  pathological  processes  (1–4)  including  organogenesis  and 
growth  control  (5,  6),  cell  adhesion  (7)  and  signalling  (8),  inflammation  (9),  tumour 
development (10), and interactions with pathogens (11). 
Past studies have revealed how HS­protein  interactions determine protein  function. 
For  example, HS  (as well  as  the  highly  sulfated  analogue heparin)  plays  a  role  in  the 
specificity and control of the engagement of fibroblast growth factors (FGFs) with their 
cell­surface  receptors,  through  the  formation  of  stable  ternary  complexes  (12),  thus 
modulating cell signaling. The binding of chemokines to HS in the extracellular space, on 
the  other  hand,  enables  the  formation  of  chemokine  gradients  (13),  thus  providing 
directional  cues and guiding  the migration of appropriate  cells  in  the  context of  their 
inflammatory, developmental, and homeostatic functions. 
In  contrast,  very  little  is  known  about  the  effect  of  signaling  proteins  on  HS  and 
HSPGs. HS  chains are  typically a  few 10 nm  in  length  (15) and,  thus, possess multiple 
binding sites enabling simultaneous binding of several proteins. These  interactions will 
influence  the molecular  structure  of  individual  HS  chains. Moreover,  they may  also 
profoundly affect the supramolecular organization of HS in the extracellular space. Such 
long­range  effects have hitherto been difficult  to  test, due  to  the  lack of  appropriate 
structural and biochemical methods. 




crystal microbalance  (QCM­D) and  fluorescence  recovery after photobleaching  (FRAP). 
These  techniques provide  insight  into  the binding of proteins  to  the HS  film,  and  the 
concomitant changes in film morphology and HS chain mobility. Through the analysis of 
a set of proteins and their mutants ­ including chemokines, cytokines and growth factors 
­ with  this  assay, we  identify molecular  features  that  determine  the HS  cross­linking 
                                                 
1 The abbreviations used are: HS, heparan sulfate; b­HS, biotinylated HS; SDF­1/CXCL12, stromal 
cell­derived factor 1; GAG, glycosaminoglycan; OEG, oligo(ethylene glycol); SLB, supported  lipid 
bilayer;  SAv,  streptavidin;  fl­SAv,  fluorescent  streptavidin;  FGF,  fibroblast  growth  factor;  IFN, 





propensity  of  extracellular  signaling  proteins.  The  ability  to  cross­link,  and  thus  to 
change matrix organization and physico­chemical properties  implies  that  the  functions 
of  these  proteins may  not  simply  be  confined  to  the  activation  of  cognate  cellular 
receptors, and we discuss possible physiological implications. 
Materials and Methods 
Buffer.  The  working  buffer  used  for  all  measurements  contained  10  mM  HEPES 
(Fisher,  Illkirch,  France)  at  pH  7.4  and  150  mM  NaCl  (Sigma­Aldrich,  Saint­Quentin 
Fallavier, France). 
Heparan  sulfate  and  proteins.  HS  polysaccharide  derived  from  porcine  intestinal 
mucosa  (Celsus  Laboratories,  Cincinnati,  OH,  USA)  was  found  to  have  an  average 
molecular  weight  of  12  kDa  and  a  polydispersity  of  1.6  (16).  Size­uniform  HS 







Recombinant  CXCL12α  (amino  acids  1  to  68;  8.1  kDa) was  prepared  as  previously 
described  (20). A truncated CXCL12α construct (amino acids 5 to 67; 7.4 kDa  (21)) was 
produced by solid­phase peptide synthesis, as previously reported  (4, 22). A  I55C/L58C 
mutant  of  CXCL12α  with  reduced  dimerization  propensity  (‘partial  monomer’)  was 
prepared  as previously described  (23). A  L36C/A65C mutant of CXCL12α  in which  the 
introduced cysteines promote the formation of dimers (‘locked dimer’) was prepared, as 
described  in Veldkamp et al. (24). The cDNA of murine CXCL12γ was  inserted  in a pET­
17b  vector  (Novagen, Merck  Chemical  Ltd., Nottingham, UK)  between NdeI  and  SpeI 
restriction sites, checked by DNA sequencing and the protein (11.6 kDa) was produced 
by  recombinant expression  in E. coli strain BL21 Star DE3, as previously  reported  (14). 
IFNγ  (17 kDa) was produced by  recombinant expression  in E. coli strain BL21 Star DE3 
using a pET­11a vector  (Novagen), as previously reported  (25). Recombinant FGF­2  (18 
kDa) and FGF­9 (26 kDa) were obtained by expression in C41 E. coli cells using pET­14b 
and pET­M11 for vectors (Novagen), respectively, as described by Xu et al. (26). 




Surfaces  and  surface  funtionalization  with  a  biotin­displaying  and  otherwise  inert 




Scientific, Västra  Frölunda,  Sweden) were used  as  is. Glass  cover  slips  (24  ×  24 mm2; 
Menzel­Gläser, Braunschweig, Germany) for FRAP assays were cleaned by immersion in 
freshly prepared piranha solution (i.e. a 1:3 (v/v) mixture of H2O2 (Fisher Scientific) and 




glycol)  (OEG)  as  previously  described  (7).  Briefly,  the  gold­coated  surfaces  were 
immersed overnight in an ethanolic solution of OEG disulfide and biotinylated OEG thiol 
(Polypure, Oslo, Norway), at a  total concentration of 1 mM and a molar  ratio of  thiol 
equivalents of 999:1. 
Silica  (for  QCM­D)  and  glass  (for  FRAP)  surfaces  were  functionalized  with  biotin­
displaying  supported  lipid  bilayers  (SLBs)  by  the  method  of  vesicle  spreading,  as 
described in detail elsewhere (27). Briefly, the surfaces were exposed for 30 min to small 
unilamellar  vesicles, made  from  a mixture  of dioleoylphosphatidylcholine  (DOPC)  and 
dioleoylphosphatidylethanolamine­CAP­biotin  (DOPE­CAP­b)  (Avanti  Polar  Lipids, 
Alabaster, AL, USA) at the desired molar ratio (99.5:0.5 or 95:5) at a total concentration 
of  50  μg/mL  in  working  buffer  supplemented  with  2 mM  CaCl2  (VWR  International, 
Leuven, Belgium). 
Assembly  of  HS  films.  Biotin­displaying  surfaces  were  further  functionalized  for 
studies of protein  interactions with well­defined HS  films, as described  in detail earlier 
(7). Briefly, the surfaces were first exposed to SAv, to form a SAv monolayer, and then to 
b­HS,  to  form  a  molecular  film  of  HS  that  is  site­specifically  attached  through  the 
reducing  end  to  the  surface.  This  mode  of  attachment  avoids  any  perturbation  of 
protein­HS  interactions  through  chemical  modifications  along  the  HS  chain.  Sample 
concentrations and  incubation times were chosen such that binding either saturates or 
equilibrates, unless otherwise stated. 
Quartz  crystal  microbalance  with  dissipation  monitoring  (QCM­D).  QCM­D 
measurements were performed, as previously described (7). QCM­D measures changes 
in frequency, Δf, and in dissipation, ΔD, of a quartz sensor upon interaction of molecules 
with  its  surface. Measurements were  performed with  a Q­Sense  E4  system  equipped 




of  the  third overtone  (n = 3) are presented. Any other overtone would have provided 
comparable information. 
A  viscoelastic  model  (28),  implemented  in  the  software  QTM  (Diethelm 





procedure  are  described  elsewhere  (30). We  parametrized  viscoelastic  properties  in 
terms of the elastic and viscous compliances J’ and J” at a reference frequency of f = 15 
MHz  (i.e.  close  to  the  resonance  frequency  at  n  =  3).  J’  and  J”  are measures  for  the 
softness  of  the  film.  The  elastic  compliance  can  also  be  estimated  directly  from  the 
QCM­D  responses  for  the  film  through  the  approximate  relationship  ΔD/(−Δf)  = 
4πnη1ρ1/ρ × J′, where ηl = 0.89 mPa·s and ρl = 1.0 g/cm3 are the viscosity and density of 
the aqueous bulk solution, respectively, and ρ ≈ 1.0 g/cm3 is the film density (31). 
Fluorescence  recovery  after  photobleaching  (FRAP).  For  FRAP  assays,  cleaned  glass 
cover slips were attached, using a bi­component glue (Picodent, Wipperfürth, Germany), 
to  a  custom­built  teflon  holder,  thus  forming  the  bottom  of  4  identical wells with  a 
volume of 50 μL each. All surface functionalization steps were performed in still solution. 


















Briefly,  each  post­bleach  fluorescence  image  was  first  corrected  for  background 
fluorescence, spatial aberrations and  intensity  fluctuations and  then  radially averaged. 
The  radial  intensity profiles  thus obtained were compared  to numerical  solutions of a 
diffusion equation, where  the  first post­bleach  image defined  the  initial conditions  for 
the  diffusion  process.  A  lateral  diffusion  model  with  one  mobile  fraction  and  one 
immobile  fraction  was  found  to  reproduce  our  data  well.  This  model  has  two 
independent  fitting parameters, namely,  the  size and diffusion constant of  the mobile 













1B).  IFNγ  is constitutively present as a homodimer which  features a very extended HS 
binding surface on the flexible C­termini of the monomers (Fig. 1C). The FGFs are more 
compact. FGF­2 has three distinct HS binding sites (Fig. 1D) that are separated from each 
other by borders of negatively  charged  and hydrophobic  residues.  FGF­9,  in  contrast, 
features only one HS binding site (Fig. 1E). As HS matrix model, we employed films of HS 
chains  grafted with  the  reducing  end  to  a  protein­repellant  surface  (Fig.  2A). QCM­D 




Figure  1.  Structures  of  soluble  extracellular  signalling  proteins  used  in  this  study. 
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C - IFNγ
D - FGF-2 E - FGF-9 
A - CXCL12α
HS-binding amino acids (primary site)
HS-binding amino acids (secondary sites)
Amino acids deleted in mutation
Other amino acids (first monomer)



















homodimer  with  the  C­termini  (residues  120­143,  absent  in  the  structure)  built  as 
extended β­strands. FGF­2 (D; PDB code: 1FQ9 (55)) and FGF­9 (E; PDB code: 1IHK (35)) 
are  shown as a monomers with  their known HS­binding sites,  i.e.  three sites  for FGF­2 
(37) and a single, extended site for FGF­9 (26). 
Design of HS model matrix. Our HS  films present HS  in an oriented manner and at 
controlled  density  (Fig.  2A)  (7). Gold  supports were  first  coated with  a monolayer  of 
oligo(ethylene  glycol)  (OEG)  exposing  terminal  biotin  groups  at  controlled  surface 
density.  A monolayer  of  streptavidin  (SAv) was  then  formed  and  used  to  anchor  HS 
through a biotin moiety that was conjugated to the GAG’s reducing end (7). The SAv­on­
OEG  film  inhibits non­specific protein binding  to  the  surface,  i.e. measured  responses 
are exclusively due to specific interactions. 







saturation  (Fig.  2B,  curves  without  symbols;  at  6  to  21  min  and  46  to  61  min, 
respectively,  as  indicated  by  arrows  on  top  of  the  graph)  were  consistent  with  the 
formation  of  a  relatively  rigid  SAv monolayer  (i.e.  with  Δf  =  ­23    1  Hz  and  a  low 
dissipation shift, ΔD  0.3  10­6, at saturation) and a soft, hydrated HS layer (i.e. with Δf 
=  ­28.5    1.0  Hz  and  a  high  dissipation  shift,  ΔD  =  5.0    0.2    10­6,  at  saturation), 
respectively. As  reported  in our previous study  (7),  the  frequency shift  for such an HS 
film (henceforward called high­density HS film) corresponds to an areal mass density of 
35.5 ± 2.2 ng/cm2, and to a water content of 96.9 ± 0.5%.  In this earlier work, we had 
also  estimated  the  mean  distance  between  adjacent  HS  anchor  sites  to  be  5  nm, 
consistent with  the dimensions of SAv, and  the mean  length of  the  surface­bound HS 









Effect  of  CXCL12α  binding  on  HS  films.  Exposure  of  the  chemokine  CXCL12α  at  a 






the  viscous  compliance  J”  upon  CXCL12α  binding  (Fig.  2C).  J’  and  J”  are  physical 
parameters (elastic and viscous contributions, respectively) related to film softness, and 
their  decrease  thus  confirms  film  rigidification.  This  analysis  also  revealed  that  the 
protein induces a moderate decrease in film thickness (Fig. 2C). Upon subsequent rinsing 
in buffer, frequency and dissipation  increased slowly, but did not return to the  level of 
the virgin HS  film  (Fig. 2B,  curves without  symbols;  from 89 min), demonstrating  that 
some, but not all CXCL12α  is  released over experimentally accessible  time  scales, and 
that the HS film partially recovers its original morphology. 
To test  if the protein­induced morphological changes depend on HS surface density, 
we  repeated  the QCM­D  assay  at  reduced HS  surface  coverage  (Fig.  2B,  curves with 




HS  anchors of  about 10 nm,  according  to previously  reported estimates  (7). CXCL12α 
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followed by QCM­D  (frequency  shifts,  Δf, dissipation  shifts,  ΔD).  Start and duration of 
incubation steps with different samples are indicated by an arrow; during all other times, 
the surface was exposed  to buffer. SAv was  first  incubated at 1 µg/mL and  then at 20 
µg/mL, and  responses are consistent with  the  formation of a dense protein monolayer 
(7). b­HS was incubated either at 50 µg/mL to saturation (‘high density HS films’, curves 
without  symbols) or at 1 µg/mL  for 15 min  to  reach about 30% of maximal  coverage 
(‘low  density HS  films’,  curves with  square  symbols).  CXCL12α,  incubated  at  0.64  μM, 
induced  dissipation  decreases  for  both  HS  densities,  indicating  rigidification  of  the 
hydrated HS film upon chemokine binding.  (C) Elastic compliance J’, viscous compliance 
J” and  thickness of HS  films obtained  from QCM­D data  for high density HS  films, bare 
and with CXCL12α at binding equilibrium. Data correspond to mean and standard error 
of  the  mean  from  three  independent  experiments.  All  parameters  decreased  upon 
CXCL12α incubation, confirming film rigidification and compaction. 
Effect  of CXCL12α  binding  on  HS  chain  mobility.  We  hypothesized  that  the 
rigidification  and  thinning  of  HS  films  is  due  to  cross­linking  of  HS  chains  by  the 
chemokine. However, an alternative explanation could be that individual HS chains wrap 
around CXCL12α molecules, thereby stiffening the  film and reducing the  film thickness 
without  generating  any  inter­chain  cross­links.  To  distinguish  between  these  two 
scenarios, we tested how the chemokine affects the lateral mobility of HS chains. 
To  this  end, we  used  a modified model  surface  in which  the  gold­supported OEG 






HS anchors.  In this method, a  limited surface area  is rapidly bleached, and diffusion of 
fluorescent  molecules  into  (and  bleached  molecules  out  of)  the  bleached  area  is 
subsequently monitored. 
We  verified  correct  surface  functionalization  by  QCM­D  (Fig.  3B).  The  fraction  of 
biotinylated lipids used to form SLBs was adjusted to 0.5% such that incubation of fl­SAv 
at saturation (Fig. 3B, 10 to 20 min) led to a partial protein monolayer, in which the SAv 
molecules diffused  freely,  i.e. without being appreciably hindered by  two­dimensional 







D  responses upon  subsequent binding of CXCL12α  (Fig. 3B, 92  to 105 min) were also 
similar to those observed in Fig. 2B. This indicates that the FRAP measurements can be 
directly correlated with QCM­D measurements on low­density HS films. 
The  representative  fluorescence  micrographs  in  Fig.  3C  demonstrate  close­to­
complete  recovery of  virgin b­HS  films within 100  s,  confirming  that  fl­SAv with HS  is 
indeed  laterally mobile,  as  desired.  In  contrast,  the  bleached  spot  remained  clearly 
visible  after  100  s  when  CXCL12α  was  added  to  the  HS  film.  Radially  averaged 
fluorescence  intensity  profiles were  computed  from  time­lapse  series  of micrographs 
after photobleaching, and analyzed to quantify lateral mobility. To this end, the pool of 
fl­SAv was assumed  to be distributed  in  two distinct  fractions, one  immobile  and  the 
other laterally mobile with a given diffusion constant. The size of the mobile fraction and 
its diffusion  constant are  shown  in  Figs. 3D­E. These quantitative  results  confirm  that 
virtually  all  (i.e.  ≥  95%)  fl­SAv  in  a  virgin  SAv­monolayer  was  mobile,  and  that  the 
mobility was unaffected by  the presence of b­HS.  In  the presence of CXCL12α, 40% of 
the fl­SAv became effectively immobilized, and additionally, the diffusion constant of the 
retained mobile  fraction was  strongly  reduced  (by 45%). These data provide evidence 







Figure  3.  FRAP  confirms  CXCL12α mediated  cross­linking  of  HS  films.  (A)  Schematic 
representation  of  HS  films  used  for  FRAP  experiments.  b­HS,  anchored  to  fl­SAv,  can 
diffuse along the surface (2D mobile) thanks to a fluid biotin­presenting supported  lipid 
bilayer  (left).  Cross­linking, mediated  by HS­binding  proteins,  is  expected  to  lead  to  a 
reduction of HS  (and hence  fl­SAv)  lateral mobility  (right).  (B) Surface  functionalization 




and  50  µg/mL  biotin­free  HS  produced  no measurable  response,  confirming  that  the 
fluorescent label does not induce any nonspecific binding. The QCM­D responses for b­HS 
(incubated at 50 µg/mL  to  saturation), and  for CXCL12α  (incubated at 0.64  μM), were 
comparable to the low­density HS films shown in Fig. 2B. (C) Representative fluorescence 
micrographs demonstrating the FRAP assay to assess chemokine­mediated cross­linking. 

















































































After  treatment with  2 M GuHCl, which we  know  effectively  releases  all  CXCL12α 
from  HS  while  keeping  the  HS  film  intact  (7),  the  mobile  fraction  and  its  diffusion 
constant largely returned to the values observed for a virgin HS film. This confirms that 
HS mobility is largely restored upon chemokine release, i.e. the cross­linking is reversible 
and  requires  the  presence  of  the  chemokine.  The mobile  fraction  though  remained 
marginally  reduced,  indicating  that  a  small  fraction  of  fl­SAv  remains  permanently 
immobile upon GuHCl treatment. Most  likely, the  lack of complete regeneration  is due 
to a weak yet irreversible perturbation of the fl­SAv film by GuHCl: detailed inspection of 





leave  the  ternary  structure  of  CXCL12α  essentially  intact,  but  alter  the  ability  of  the 
protein  to  form  β­sheet  dimers:  L36C/A65C  mutations  result  in  inter­molecular 





mutants  bound  to  HS  films  (Fig.  4A,  blue  curves),  but  not  to  the  supporting  SAv 
monolayer  (Fig.  4A,  grey  curves  with  triangle  symbols).  Binding  to  HS  was  distinct, 
however,  with  regard  to  the  magnitude  of  the  frequency  shift  at  equilibrium  and 
reversibility  upon  elution  in  buffer.  The  locked  dimer  exhibited  enhanced  and more 
stable binding, whereas binding was reduced and less stable for the partial monomer, as 





















Complementary  FRAP  assays  revealed  that  the  partial monomer  and  locked  dimer 
can effectively reduce  the mobile  fraction  (Fig. 4C) and  its diffusion constant  (Fig. 4D), 
confirming  that  all  CXCL12α  constructs  can  indeed  cross­link  HS.  However,  an 
appreciable reduction in mobility for the partial monomer could only be observed after 
increasing  the  protein  solution  concentration  (by  6­fold). Moreover,  after  elution  of 
residual  partial  monomer  from  the  bulk  solution  with  working  buffer,  the  mobile 
fraction and its diffusion constant returned close to the level of a virgin HS film, whereas 
both parameters remained unaffected for the  locked dimer. This demonstrates that an 
efficient  cross­linking  of  the HS  film  requires  a minimal  protein  concentration.  Taken 








HS  binding  (17),  may  be  important  for  cross­linking.  To  test  this,  we  studied  an 
additional construct with a truncated amino acid sequence, i.e. a mutant that lacked the 
four N­terminal  amino  acids  (CXCL12α(5­67); Fig.  1A).  The magnitudes  of  the QCM­D 
responses for this construct were comparable to native CXCL12α (Fig. 4A). In particular, 
the mutant also showed a negative dissipation  shift, and  the  ΔD/­Δf vs.  ­Δf curves  for 
CXCL12α(5­67)  and  native  CXCL12α  (Fig.  4B) were  indistinguishable. Moreover,  FRAP 
results  (Figs.  4C­D)  confirmed  that  the mutation  does  not  affect  HS mobility.  Taken 







Figure 4. Dimerization and N­terminal  lysine are dispensable  for HS cross­linking.  (A) 
QCM­D data for the binding of selected CXCL12α constructs to  low­density (curves with 





curves  with  triangle  symbols;  only  shown  for  Δf)  to  confirm  absence  of  non­specific 
binding.  Frequency  shifts  at  equilibrium  and  unbinding  curves  after  rinsing  differed 
between  CXCL12α  constructs,  indicating  that  their  binding  affinities  are  distinct. 
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SAv  on  SLBs)  before  incubation  with  CXCL12α  constructs,  after  incubation  with  the 
proteins  at  equilibrium  (native CXCL12α, CXCL12α(5­67)  and  locked  dimer  at  0.64  μM 
monomer  equivalents,  partial  monomer  at  3.8  μM),  and  after  elution  of  respective 
protein  from  the  solution  phase,  as  indicated.  The  fluorescent  label  of  fl­SAv  was 




we  next  tested  if  there  is  a minimal  length  of  HS  chains  required  for  cross­linking. 
CXCL12α  binding  to HS  oligosaccharides  of  different  size was  analyzed  by QCM­D,  to 
determine  the minimum  number  of  saccharides  necessary  for  CXCL12α  binding  and 
cross­linking (Fig. 5A). No response was observed on hexasaccharides (dp6), while clear 
binding was present on dp8, dp10 and dp12, confirming that an octasaccharide but not a 
hexasaccharde  is  sufficient  for efficient binding,  in agreement with  the  literature  (22). 
The dissipation decreased only slightly yet significantly (­0.1  10­6) for dp8, while films 
of  dp10  and  dp12  showed  pronounced  dissipation  decreases  upon  CXCL12α  binding. 






indicates  that  the oligosaccharides  assemble  into  relatively  small  clusters with  largely 








binding  to monolayers of b­HS oligosaccharides of different  lengths  (as  indicated; dp = 





and  larger,  indicating  that a hexasaccharide  it not sufficiently  long  for protein binding. 
Pronounced  dissipation  decreases  for  HS  as  small  as  dp8  indicate  that  even  films  of 
oligomeric HS are rigidified. (B­C) Mobile fractions and their diffusion constants of b­HS 
oligosaccharides  (bound  to  fl­SAv  on  SLBs)  either  bare  or  in  the  presence  of  0.64  μM 






































































CXCL12α,  as  indicated.  The  moderate  reduction  in  dp12  mobility  suggests  that 
oligosacharides can by cross­linked into relatively small clusters by CXCL12α. 
Effect of other HS­binding proteins on HS  films.  To  test whether HS­cross­linking  is 
unique to CXCL12α, we extended our study and systematically investigated the effect of 









for  the  α  and  γ  isoforms,  respectively  (14).  Indeed,  CXCL12γ  bound more  stably  and 
more rapidly than CXCL12α (Figs. 6A and 4A, respectively, blue curves). The decrease in 
dissipation  for  CXCL12γ  was  pronounced  at  low  and  high  HS  coverage  (Fig.  6A,  red 
curves).  The  ΔD/­Δf  vs.  ­Δf  plot  (Fig.  6B)  confirms  that  this  protein  also  has  a  strong 
propensity to rigidify the HS film. In this plot, differences between CXCL12γ and CXCL12α 











density  HS  films,  IFNγ  induced  a  negative  shift  in  dissipation  (Fig.  6A)  albeit  with  a 
reduced magnitude  compared  to CXCL12α  (Fig. 4A). However,  IFNγ generated a  slight 
increase in dissipation in low­density HS films. FRAP (Figs. 6E­F, left plots) revealed that 
IFNγ induces only moderate reductions in the mobile fraction of HS (by 15%) and in the 
diffusion  coefficient of  this mobile  fraction  (by 25%). The  lack of dissipation decrease 










right  plots).  To  this  end,  the  fraction  of biotinylated  lipids  used  to  form  the  SLB was 
increased  (from 0.5%  to 5%)  to enable  formation of a dense  fl­SAv monolayer. Under 
these conditions, the  lateral mobility of the bare HS films was  largely retained (i.e. the 
mobile fraction was only slightly reduced, to 90%) although crowding of fl­SAv entailed a 
marked  reduction of  the diffusion constant  (from 2 μm2/s  to 0.5 μm2/s).  Interestingly, 
the  mobile  fraction  as  well  as  its  diffusion  constant  decreased  only  weakly  in  the 
presence  of  IFNγ  (by  12%  and  20%,  respectively).  This  indicates  that  the  IFNγ 





the  third  on  the  opposite  face  of  the  protein  (36,  37,  40,  41).  In  contrast,  only  one 




those  observed  for  the  previously  investigated  chemokines  (Figs.  4  and  6),  indicating 
extensive binding. FGF­2 generated pronounced decreases in dissipation for high­density 
and  low­density HS films. In stark contrast, the dissipation remained  largely unchanged 
and  increased drastically,  respectively,  for FGF­9. This  contrast  is also apparent  in  the 
ΔD/­Δf vs.  ­Δf plot  (Fig. 6B), where  the curve  for FGF­9  is  located above  the  curve  for 
FGF­2, thus indicating that FGF­2 is more potent in rigidifying HS films. FRAP revealed a 







in  its multiple HS binding  sites, whereas only one HS  chain at a  time  can bind  to  the 
extended binding site on FGF­9. The results with FGFs highlight that not all HS­binding 










HS  film  density;  for  IFNγ,  the  dissipation  decreased  only  on  high­density  HS  films, 
indicating distinct, protein­specific degrees of HS film rigidification. (B) Parametric plot of 
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HS  (bound  to  fl­SAv on  SLBs at  low  surface  density)  either bare  or  in  the  presence  of 
CXCL12γ,  FGF­2  or  FGF­9,  as  indicated.  (E­F)  Mobile  fractions  and  their  diffusion 
constants of b­HS (bound to fl­SAv on SLBs at low surface density (left graphs) and high 
surface density  (right graphs)) either bare or  in  the presence of  IFNγ, as  indicated. The 
fluorescent  label of fl­SAv was confirmed by QCM­D not to  induce any measurable non­
specific binding of any of  the HS­binding proteins  (not  shown). Protein  concentrations 






protein with  an HS­binding  surface  large enough  to  accommodate more  than one HS 
chain  should be  able  to  cross­link HS.  Yet, we  found  the  extension of  the HS­binding 
surface  alone  to  be  a  poor  predictor  of  a  protein’s  cross­linking  propensity.  This  is 
illustrated by  the  limited  cross­linking propensity of  the  IFNγ homodimer  (Fig. 6), but 
also  by  the  negligible  effects  of  the  elongated  C­terminal  of  CXCL12γ,  compared  to 









Mutation  of  the  primary  binding  site  reduces  binding  of  FGF­2  to HS  substantially 
(43),  i.e. the affinities of the secondary HS binding sites on FGF­2 are rather weak. Yet, 
FGF­2 apparently is a potent HS cross­linker. This effect is not surprising if one takes into 
consideration  that, once  FGF  is  sequestered  into  the matrix  through  its primary high­
affinity  binding  site,  the  local  concentration  in  HS  is  high  such  that  even  weak 
interactions  can  occur  frequently.  Thus,  the  example  of  FGF­2  illustrates  how  rather 
weak secondary binding sites can fulfil functions. 
CXCL12  is also a potent HS cross­linker  (Figs. 4­6), yet  the molecular mechanism of 
cross­linking  must  be  different  since  this  protein  does  not  feature  several  clearly 





β­sheets  (22),  but  our  tests  with  partial  monomer  and  locked  dimer  (Fig.  4) 
demonstrated  that  this  ‘β­sheet’  dimer  is  not  directly  involved  in  HS  cross­linking. 
Crystallographic  studies  (44)  though  revealed  that  CXCL12α  can  form  another 
homodimer  through the association of two N­termini, analogous  to what  is commonly 





for  HS  whereas  dimerization  through  N­termini  induces  HS  cross­linking.  Our 







in the current binding model, dp8  is  just  long enough to fit the HS­binding  interface  in 
the  β­sheet dimer  (20);  it would  be  conceivable  that  a  single  dp8  binds  two  β­sheet 




The methodological  approach  presented  in  this  study  is  novel.  HS  films  as model 
matrices  present  HS  at  controlled  orientation  and  lateral  mobility  and  at  tuneable 
surface  density  thus  enabling  supramolecular  interaction  studies  under  well­defined 
conditions.  The  two  characterization  techniques,  QCM­D  and  FRAP,  provide 
complementary  information and together enable  identification of the protein’s binding 
and  cross­linking  activity.  Specifically,  QCM­D  provides  information  about  binding 
kinetics, and about HS/protein  film morphology  (thickness) and  rigidity, whereas FRAP 
enables quantification of  the  lateral mobility of HS chains. The assay does not  require 
any  labelling of  the protein and  is  thus broadly applicable  to assess  the propensity of 
proteins to cross­link HS and other GAGs. 
GAG­on­chip  devices  are  increasingly  used  to  probe  the  interaction  of  GAGs with 
proteins. On such devices, the extent of protein­mediated GAG cross­linking will depend 
sensitively  on  the  presentation  and  surface  density  of  GAGs.  As  a  consequence,  the 







What  is  the  functional  relevance  of  HS  cross­linking  by  extracellular  signalling 
proteins? Cross­linking of HS  requires  the  spatial proximity of HS chains. This criterion 
was met  in our well­defined model matrices. Based on  the  typical  length of HS chains 
and the typical density of HS­bearing proteoglycans, Yanagishita and Hascall estimated 
that the ensemble of HS chains on cells can readily explore the entire cell surface  (15). 
HS  cross­linking  thus may  also  be  a  frequent  phenomenon  at  the  cell  surface  and  in 
extracellular  matrix,  spatio­temporally  controlled  through  the  sequestration  of 
chemokines  or  growth  factors  in  the  course  of  specific  biological  processes  (e.g. 
angiogenesis  (46),  inflammation  (47),  cell  proliferation  (6,  42,  48)).  This  may  have 
consequences at different levels. 
On the level of the matrix, the proteins can promote changes in structure that parallel 
their  signalling  activity.  The  ensuing  changes  in  physical  properties  of  peri­  and 
extracellular matrices,  such as permeability,  rigidity or  thickness, may elicit a  range of 
additional  cellular  responses. For example, a  reduction  in  the  thickness of pericellular 
coats  may  facilitate  inter­cellular  contacts  through  membrane­bound  cell  adhesion 




On  the  local  scale,  cross­linking  of  HS  could  promote  clustering  of  cell­surface 
proteoglycans  (PGs) to which the HS chains are attached, thereby activating signalling. 
Clustering  of  the HSPG  syndecan­4,  for  example,  is  important  for  the  binding  to  and 
activation of protein kinases which ultimately determine the assembly of focal adhesions 
and  the  organization  of  the  actin  cytoskeleton  (50).  In  this  regard,  it  has  been 
demonstrated  that  a  syndecan­4  dimer  requires  a minimum  of  four HS  chains  to  be 
functional,  whereas  a  mutated  form  of  syndecan­4  with  a  single  HS  chain  was  not 
functional unless a cluster of multiple syndecan­4 dimers was formed. This suggests that 
multiple HS chains must associate  in the presence of a  ligand, to form a signalling unit 
(51).  In  this  scenario, HS­cross­linking proteins would elicit  signalling activity  in a way 
that has thus far not been appreciated. 
It has also been proposed  that  the HS chains of  syndecan control  the  formation of 
exosomes, with  an  impact  on  the  trafficking  and  confinement  of  FGF  signals  (52).  In 
particular,  the  interaction  between  FGFs  and  syndecans  has  been  demonstrated  to 
promote  receptor clustering,  translocation  to cholesterol­rich membrane domains and 
eventually internalization (53). Here, future studies comparing the effect of proteins that 
cross­link HS (such as FGF­2, CXCL12α or CXCL12γ) with those that do not (such as IFNγ 











link GAGs and propose  that  several binding  sites, well  separated either  through GAG­
repellent borders on the protein’s surface  (e.g. FGF­2) or through spatial separation  in 
quaternary  protein  structures  (e.g. N­terminal  CXCL12  dimers),  are  required  for GAG 
cross­linking. This prediction can now readily be tested with other GAG­binding proteins 
using  the here­presented GAG cross­linking assay. The ability of extracellular  signaling 
proteins  to  influence matrix organization and physico­chemical properties  implies  that 
the functions of these proteins may not simply be confined to the activation of cognate 
cellular  receptors.  This may have  far­reaching  implications  for  cell­cell  and  cell­matrix 
communication, and our predictions can be tested in future cell and in vivo assays. 
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myoblast behavior  is demonstrated.  In  addition, we  apply  the biomimetic  surfaces  to 
study the inter­play of two cellular receptors in determining cell adhesion and motility.  
 
My contribution:  I co­designed  research  (together with Liliane Coche­Guerente, Didier 
Boturyn,  Catherine  Picart  and  Ralf  P.  Richter).  I  performed  and  analyzed  all  the 










étudier  ceci,  nous  avons  conçu  des  surfaces  biomimétiques  multifonctionnelles  qui 
présentent  les chimiokines (CXCL12α),  les glycosaminoglycanes (l’héparane sulfate, HS) 




Sur  ces  surfaces modèles,  les myoblastes  répondent  à  la  chimiokine  CXCL12α  liée  de 
façon  réversible  à  son  ligand  naturel  le HS  par  l'adhésion  et  une motilité  accrue.  En 
revanche,  la chimiokine CXCL12α  liée  irréversiblement à  la surface améliore  l'adhésion, 
mais altère la motilité cellulaire. Ceci démontre que la présentation des chimiokines, en 
particulier  la  présence  des  HS,  est  importante  pour  la  régulation  du  comportement 
cellulaire.  En  augmentant  la  complexité,  nous  avons  conçu  des  surfaces 
multifonctionnelles,  qui  présentent  le  ligand  d'adhésion  cellulaire  RGD  (Arg­Gly­Asp) 
avec  la  chimiokine  CXCL12α  liée  au  HS,  comme  mimes  de  l'interface  entre  les 
myoblastes et  la matrice extracellulaire au cours de  la régénération et de  la réparation 
musculaire. La co­présentation du RGD avec la chimiokine CXCL12α liée au HS conduit à 
améliorer  l’adhésion,  l’étalement et  la motilité d'une manière distincte de  la réponse à 
chaque  signal  individuel.  Cela  indique  que  le  récepteur  cellulaire  de  la  chimiokine 
CXCL12α, CXCR4  et le récepteur cellulaire du RGD, l’intégrine peuvent agir en synergie. 
Ces  surfaces  biomimétiques  sont  prometteuses  pour  accroître  les  connaissances 



























Chemokines  are  signaling  molecules  that  guide  the  migration  of  cells. 
Glycosaminoglycans  (GAGs)  help  maintaining  gradients  of  chemokines  in  the 
extracellular matrix,  along which  cells  can migrate.  Chemokines  are  important  in  the 
migration  of muscle  precursors  during myogenesis  and muscle  regeneration.  Little  is 
known  to  date,  as  to  how  the  molecular  presentation  of  chemokines  affects  cell 
behavior. To study  this, we designed multifunctional biomimetic  surfaces  that present 
the CXCL12α  chemokine,  the heparan  sulfate  (HS)  glycosaminoglycan  and RGD as  cell 
adhesion  ligand with  controlled  orientation  and  at  tunable  densities. We  used  these 
surfaces  to  study  the  response  of myoblasts  to  extracellular  cues  in  a  highly  defined 
environment. Myoblasts responded to CXCL12α reversibly bound to its natural ligand HS 
through  enhanced  adhesion  and  motility.  In  contrast,  CXCL12α  that  was  quasi­
irreversibly  surface­bound  in  the  absence  of  HS  enhanced  adhesion  but  impaired 
motility.  This  demonstrates  that  the  presentation  of  chemokines,  in  particular  the 
presence of HS,  is essential  for  regulating cellular behavior,  in particular adhesion and 
motility.  Co­presentation  of  RGD  along  with  HS­bound  CXCL12α  led  to  enhanced 
adhesion,  spreading  and motility,  in  a way  that  is distinct  from  the  response  to each 
individual cue alone. This  indicates  that cell­surface CXCR4  (i.e.  the CXCL12α  receptor) 
and  integrins  (the RGD receptors) can act  in synergy. These novel biomimetic surfaces 
hold promise  in generating novel  insights  in the  field of glycobiology, e.g.  in dissecting 











Muscle development  and  repair  are  crucial  for body  function.  It  is  a highly organized 
process, orchestrated by muscle progenitor cells called satellite cells [1]. These cells are 
normally  quiescent  but  undergo  a  number  of  modifications  including  activation, 
differentiation  and  proliferation,  in  response  to muscle  injury.  In  vitro  studies  have 
shown  that  the  migration  of  myoblasts,  i.e.  satellite  cell  progenitors,  is  crucial  for 
myogenesis and muscle regeneration [2­4]. Migration along with cell adhesion is crucial 
to  achieve  cell–cell  contacts, which  is  essential  for  the  alignment  of myotubes,  their 
subsequent fusion and formation of myotubes [2, 4­6]. 
Migration  is  a  complex  process.  It  is  initiated  by  signalling  molecules  secreted  in 
response  to  injury. These  signalling molecules, small proteins called chemokines, have 
chemoattractant properties [7]. They are required for the migration of muscle precursor 
cells during embryonic myogenesis  [6].  In particular, the stromal cell­derived  factor­1α 
(SDF­1α:  also  called  CXCL12α)  chemokine  and  its major  receptor,  CXCR4  have  been 
shown to be  important during myogenesis and muscle regeneration, both  in vivo [6, 8­
10] and in vitro [11­13]. 
Chemokines  once  secreted,  are  trapped  and  presented  to  the  cells  via 
glycosaminoglycans (GAGs) [14]. GAGs are linear polysaccharides which are ubiquitously 
present  at  the  cell  surface  and  in  the  extracellular  matrix.  They  are  usually  found 
attached  covalently  through  their  reducing  end  to  core  proteins,  forming  the 
proteoglycan  family  [15, 16]. GAGs  interact with a plethora of proteins and  via  these 
interactions  they  regulate matrix assembly and  remodelling, as well as cell­matrix and 
cell­cell  interactions  [17]. GAGs and heparan  sulfate  (HS)  in particular, help organizing 
and maintaining the haptotactic gradients of chemokines on the cell surface and in the 
extracellular matrix, thus providing directional cues for migrating cells [18­20]. 
An  important  factor  for a cell  to migrate  is controlled adhesion and  release, cell binds 
and detaches from the substrate in a coordinated manner with extension and retraction 
of  pseudopods  executing  the  directional  migration  [21,  22].  To  control  this,  the 
extracellular matrix and the surface of cells possess cell­adhesion ligands. These ligands 
bind to specific transmembrane receptors called integrins.  
Many works have  focused on  the  role of CXCL12α  in vitro  in muscle development and 
regeneration,  mostly  by  presenting  CXCL12α  in  solution  [6,  11­13].  It  is  only  very 
recently  that  it has been presented  in  a matrix­bound manner  to  cells,  i.e. physically 
trapped  in  a  biopolymeric  film  [23].  However,  no  study  has  aimed  to  investigate  if 
CXCL12α presented via a biomimetic matrix made of GAGs, its native matrix ligand, can 
be perceived differently by the cells.  
For mechanistic studies,  it  is desirable  to arrange biomolecules  in such a way  that  the 
orientation, density and lateral mobility of the exposed biomolecules can be controlled 
and  tuned.  To  this  end,  the  biofunctionalization  of  solid  surfaces  i.e.  designing 




formation of multifunctional biomimetic  surfaces  that present  chemokines  (CXCL12α), 
GAGs (HS in particular) and ligands promoting cell adhesion with controlled orientation 
and at tunable densities, in a background of low non­specific binding [24]. In the present 
study, we have adapted  this approach  to study  the  response of myoblasts, by using a 
distinct  cell­adhesion  ligand  i.e.  RGD  peptide.  RGD  peptide  has  been  used  to  study 
myogenic  differentiation  of  C2C12  myoblasts  [25].  Our  surfaces  were  designed  to 
reproduce  selected  features  of  muscle  extracellular  matrix,  i.e.  the  supramolecular 
arrangement of ECM and cell­surface GAGs, which was attached to the surface through 
the reducing end, thus mimicking the native attachment of HS to its proteoglycan core, 
chemokines  (bound  to  GAGs)  and  cell  adhesion  ligands.    We  designed  biomimetic 
surfaces  presenting  chemokines  in  two  different  ways:  either  HS­bound  CXCL12α  or 
immobilized  CXCL12α,  the  immobilized  protein  being  available  for  binding  to  the 
receptors  but  not  for  uptake  by  the  cells. We  evaluated  the  response  of myoblasts 
towards  these  different  presentations,  to  test  if  and  how  the  presentation  of 
chemokines affects cellular adhesion, spreading and motility. In addition, we studied the 
differential response of myoblasts towards the co­presentation of chemokines and cell 
adhesion  ligands. We  demonstrate  how  surfaces  that mimic  selected  aspects  of  the 
muscle  extracellular  and  cellular  surface  enable  cellular mechanistic  studies  on  early 






France)  at  pH  7.4  in  ultrapure  water.  Heparan  sulphate  (HS)  derived  from  porcine 
intestinal mucosa with an average molecular weight of 12 kDa and a polydispersity of 
1.6  (Celsus  Laboratories,  Cincinnati,  OH,  USA)  was  conjugated  with  biotin,  site­
specifically attached to the reducing end by oxime  ligation [26]. Recombinant CXCL12α 
(amino  acids  1  to  68;  8.1  kDa) was  prepared  as  previously  reported  [27].  The  same 
protein with a biotin conjugated to the C­terminal lysine through a tetraethylene glycol 
linker (b­CXCL12α; 8.6 kDa) was produced by solid­phase peptide synthesis as previously 
reported  [28].  Lyophilized  streptavidin  (SAv, 60 kDa) and bovine  serum albumin  (BSA) 
were  purchased  from  Sigma  Aldrich.  All  proteins  were  diluted  to  0.2  mg/mL  in 
autoclaved working  buffer  and  stored  at  ­20°C.  Thawed  protein  solutions were  used 
within  5  days  and  further  diluted  as  desired.  AMD3100  was  purchased  from  Sigma 
(France). Polyethylene glycol (PEG, 3.2 kDa) with a biotin at one end and an OH group at 
the  other  (b­PEG)  was  purchased  from  Iris  Biotech  (France).  b­cRGD  (3.9  kDa)  was 








Frölunda,  Sweden). Appropriately  sized wafers with  an  optically  opaque  gold  coating 
(100 nm,  sputter­coated) were used  for  SE measurements. Glass  cover  slips  (24  × 24 
mm2; Menzel Gläser, Braunschweig, Germany) with a semi­transparent gold film (~5 nm) 
were prepared, as described previously [24]. To create a biotin­displaying and otherwise 







assembled.  To  prepare  chemokine­presenting  surfaces  (Fig.  1B),  the  following 
concentrations and exposure  times were used: b­HS  ­ 50 µg/mL, 30 min; CXCL12α – 5 
µg/mL,  30  min;  b­CXCL12α  –  5  µg/mL,  30  min.  Under  these  conditions,  binding  is 
expected  to  saturate  or  equilibrate,  irrespective  of whether  the  solution  is  flown  (in 
QCM­D measurements),  or  still  (in  SE measurements  and  for  cell  assays).  To  prepare 
multifunctional surfaces (Fig. 3), the following concentrations and incubation times were 
used: b­HS ­ 1 µg/mL, 30 min; b­cRGD ­ 1 µg/mL, 5 min (Fig. 3A­C) or 90 s (Fig. 3D); b­PEG 
­  50  µg/mL,  20 min;  CXCL12α  –  5  µg/mL,  30 min. Here,  the  reduced  concentrations 
and/or  incubation  times  of  HS  and  cRGD  were  chosen  to  obtain  the  desired  sub­




QCM­D measures  the  changes  in  resonance  frequency,  Δf,  and  dissipation,  ΔD,  of  a 
sensor  crystal  upon  molecular  adsorption  on  its  surface.  The  QCM­D  response  is 
sensitive  to  the mass  (including hydrodynamically  coupled water) and  the mechanical 
properties of the surface­bound  layer. Measurements were performed with a Q­Sense 
E4  system  equipped  with  4  independent  Flow  Modules  (Biolin  Scientific,  Vastra 
Frolunda, Sweden) and gold­coated QCM­D sensors functionalized with biotinylated OEG 
monolayers.  The  system was  operated  in  flow mode with  a  flow  rate  of  typically  10 
μL/min, at a working temperature of 24 °C. Δf and ΔD were measured at six overtones (i 












the cuvette content  (typically  for 5 s after pipetting a  sample  into  the  solution) and a 
flow­through  system  for  rapid  solution exchange during  rinsing  steps. Before use,  the 
cuvette walls were passivated against biomolecular binding by exposure to a 10 mg/mL 
BSA  solution  in working buffer  (20 min),  followed by  rinsing with ultrapure water and 
blow­drying  with  N2.  Biomolecular  binding  processes  were  monitored  at  room 
temperature.  Surface  densities were  quantified  through  fitting  of  the  data  to  optical 
models, as described in detail elsewhere [30]. Briefly, the opaque gold film and the OEG 
monolayer were  treated  as  a  single  isotropic  layer  and  fitted  as  a B­spline  substrate. 
Areal mass  densities were  determined  through  de  Fejter’s  equation,  using  refractive 
index increments, dn/dc, of 0.15 cm3/g for b­HS, b­PEG and b­cRGD; and 0.18 cm3/g for 
all  proteins.  All measurements were  repeated  twice  and  the  data  represent mean  ± 
standard errors. 
2.6. Cell culture and cell assays 
The  mouse  myoblast  cell  line  C2C12  (<20  passages  post­delivery  from  ATCC)  was 
cultured, as previously described [31]. Prior to the cell assays, serum was removed from 
the cell suspension, by centrifugation at 600 rpm at 25 °C  for 10 min; the supernatant 
was  then  removed and  the cells were exposed  to serum­free 1:1 DMEM/F12 medium 
(Life Technology,  France). Cell  adhesion assays were performed with  custom­made 4­
well plates with ~100 µl  solution per well and a  functionalized glass cover  slip on  the 
bottom,  prepared  as  described  previously  [24].  Surfaces with  the  desired  biomimetic 
coating were  sterilized  for  15 min  under UV  light,  and  C2C12  cells were  seeded  at  a 
density  of  1.5    104  cells/cm2.  CXCL12α  binds  reversibly  to  HS  and  thus  partitions 
between the HS­coated surface and the solution; based on the conditions employed for 
liquid  exchange  and  cell  seeding, we  estimate  the  residual  CXCL12α  concentration  in 
solution  to  be  500  nM.  After  incubation  for  1  h  and  4  h,  non­adhesive  (and weakly 
adhesive)  cells were  removed by gentle  rinsing with  sterile phosphate­buffered  saline 
(PBS, pH 7.4;  Sigma Aldrich) using  a pipette. To  test  for  the  specificity of  the  cellular 
recognition  of  CXCL12α  through  the  receptor  CXCR4,  the  cell  suspension  was 
supplemented with AMD3100 at a concentration of 50 µM, which inhibits interaction of 
CXCR4 with CXCL12α [6, 11]. All cell assays were repeated 3 times. 
Quantitative analysis of  cell adhesion. 10 bright­field  images of  cells per  sample were 
recorded shortly before and after gentle rinsing using an inverted microscope (Axiovert 
200 M;  Carl  Zeiss  SAS,  Le  Pecq,  France)  equipped  with  a  10  objective,  covering  a 





the  number  of  cells  after  rinsing  and  before  rinsing.  Data  represent  the mean  and 
standard  deviation  over  the  percentage  of  adherent  cells  across  three  independent 
experiments. 
Quantitative analysis of cell  spreading and morphology. Adhered cells were  fixed with 
3.7%  formaldehyde  for  20  min  and  permeabilized  in  0.2%  Triton  X­100  for  4  min, 
incubated with rhodamine­phalloidin (1:800, Sigma, France) for labelling actin and with 











LSM  700  confocal microscope  (Carl  Zeiss  SAS)  equipped with  a  5  objective  and  an 
environmental  chamber  (providing  37  °C  and  5%  CO2).  Time­lapse  image  series were 
assembled and analyzed using  ImageJ software.  Individual cell tracking was performed 
using  the  “Manual  tracking”  plugin,  which  allows  selecting  a  cell  and  recording  its 
movement by following the cell position across the image frames. 80 cells were tracked 








To directly study  the  response of myoblasts  towards chemokines presented via GAGs, 
our  approach  consisted  in  designing  biomimetic  surfaces  encompassing  the 
glycosaminoglycan heparan sulfate (HS), the chemokine CXCL12α and aadhesion  ligand 
(cyclo[­RGDfK­])  [32] with  controlled  orientation  and  at  tunable  densities  into  tailor­
made  and  multifunctional  model  surfaces.  A  monolayer  of  streptavidin  on  a  gold­
supported biotinylated OEG monolayer served as a  ‘molecular breadboard’ onto which 
the desired molecules were sequentially assembled in a background of low non­specific 
binding  [24]  (Fig. 1A). Before  construction of multifunctional  surfaces, we  ascertained 
that  the  desired  functionalities  can  be  realized  with  controlled  orientation.  For  this 
purpose,  QCM­D was  used,  providing  time­resolved  information  about  the  assembly 
process,  including overall film morphology and mechanics. Figure S1 shows that all the 
constituents of  the biomimetic  surfaces can be anchored  to surfaces  in a  specific way 
through site­specifically conjugated biotins for b­HS, b­CXCL12α and b­RGD, and through 











of  low nonspecific binding.  (B) Schematic presentation of model  surfaces  (left) used  to 
study  the  effect  of  chemokine  presentation  on  myoblast  adhesion  and  motility; 
































































native matrix  ligand  for  CXCL12α,  and was  immobilized  (iHS)  through  a  biotin  at  the 
reducing  end.  The  chemokine  CXCL12α  was  presented  either  adsorbed  (aCXCL12α) 
through heparan sulfate (HS) or immobilized (iCXCL12α) through a C­terminal biotin. All 
molecules  are  drawn  approximately  to  scale.  Arrows  indicate  the  lateral  root­mean­
square  (rms)  distance between  two molecules  (colors  of molecules  and  corresponding 
arrows are matched). Start and duration of  incubation steps with different samples are 
indicated  by  arrows  on  top  of  the  SE  graphs;  during  all  other  times,  the  surface was 
exposed to working buffer. 
In a first step, we studied how the presentation of the chemokine affects cell adhesion, 
by  comparing CXCL12α presented either  via  reversible adsorption  to  its native matrix 
ligand  heparan  sulfate  (iHS  +  aCXCl12α)  or  directly  immobilized  on  the  surface 
(iCXCL12α) (Fig. 1B, left). In these conditions, the molecule of interest is either reversibly 
adsorbed  (“a”) or quasi­irreversibly (“i”) immobilized. To quantify the surface densities
of biomolecules during  the  step­by­step  assembly process,  spectroscopic  ellipsometry 
(SE)  was  used  (Fig.  1B,  right).  Sample  incubations  in  the  SE  measurements  were 
performed  in  still  solution,  i.e. under mass­transport conditions  that were  identical  to 
those  subsequently used  for  the preparation of  surfaces  for  cellular assays. The areal 
mass  density  for  a  SAv  monolayer  was  235  ±  5  ng/cm2  (not  shown),  reproducing 




weight  of  HS  in  the  incubation  solution.  In  reality,  small­sized  HS  is  likely  to  bind 
preferentially, and the average size of the surface­bound HS  is thus  likely to be smaller 
(see  ref.  [26]  for  details).  Assuming  that  two  HS  chains  bind  per  SAv  at  maximal 
coverage, we obtain an rms anchor distance of 5 nm and a mean molecular weight of 4.6 














The well­defined biomimetic  surfaces presenting GAGs and  chemokines were used  to 
trigger  specific  cellular  responses.  In  particular,  we  first  investigated  the  effects  of 
matrix­bound CXCL12α presentation on the adhesion and spreading of C2C12 cells (Figs 
1B),  which  was  assessed  by  bright  field  imaging  (Figs.  2A,  C,  F,  H  and  S2A)  and 
fluorescence staining (Figs. 2B, D, G, I and S2B). The fraction of cells that resisted gentle 
rinsing was  quantified  (Figs.  2C  and H),  as well  as  the  spreading  (Figs.  2D  and  I)  and 
morphology  (Figs. 2E and  J) of  the adhered cells after 1 h and 4 h of contact with  the 






did after 4 h  (Fig. 2C). The cell area  increased  (Fig. 2D) while  the circularity decreased 
(Fig. 2E) significantly, demonstrating that C2C12 myoblasts do recognize and respond to 
HS­bound  CXCL12α  at  sufficiently  long  exposure  times.  In  contrast,  the  presence  of 







spreading  and  circularity.  A  to  E:  adsorbed  CXCL12α;  F  to  J:  immobilized  CXCL12α. 
Bright­field images of live cells (A and F) and representative fluorescence staining of fixed 
cells (cell nuclei labeled in blue and actin in red; B and G) for C2C12 myoblasts exposed to 
surfaces presenting different  surface  functionalizations  for 4 h.  (C and H) Quantitative 
analysis of the percentage of adherent cells that remain after gentle rinsing following 1 h 
(black) and 4 h  (blue, hatched) of exposure  to different  surface  functionalizations. The 
area (D and I) and circularity (E and J) of the adhered cells are displayed as box plots; the 
small square and  the horizontal  line  inside  the box  indicate  the mean and  the median, 
respectively,  the  box  delimits  the  25%  to  75%  percentile  of  data,  and  the  error  bar 
represents the lower 10% limit and the upper 90% limit. An ANNOVA test was performed 














































































































































(Figs.  2B  and  S2B).  The  stark  difference  in  the  temporal  response  and  in  the  cell 
morphology demonstrates  that  the mode of CXCL12α presentation plays an  important 
role  in  myoblast  adhesion.  Apparently,  distinct  mechanisms  are  involved  in  cellular 
recognition and  internal signaling. A significant decrease  in adhesion and spreading of 




Next, we aimed at  investigating  the  response of C2C12 cells  to  the co­presentation of 
chemokines and cell adhesion  ligands. For this purpose we aimed at designing surfaces 
that display an addiitonal  feature of muscle extracellular matrix,  i.e. adhesion  ligands. 
Specifically,  the biomimetic  surfaces presented HS­bound CXCL12α  together with RGD 
that was  immobilized through a biotin to the breadboard  (iHS + aCXCL12α +  iRGD, Fig. 
3A).  With  its  modular  design,  our  surface  functionalization  platform  (i.e.  the  SAv 
monolayer)  can  readily  accommodate  multiple  biotinylated  compounds,  generating 
multifunctional  surfaces.  The  densities  of  different  compounds  can  be  tuned  by 
adjusting  the  incubation  time  of  each  component  on  the  surface.  To  form  these  co­
funtionalized  surfaces, b­HS was  first  incubated with  reduced  concentration and  for a 
controlled time to reach a surface coverage of 13 ± 1 ng/cm2 (Fig. 3A), corresponding to 
an rms anchor distance of 8 nm to 13 nm (following the rationale outlined above). This 









density  of  all  remaining  biofunctional  components  unchanged  (Fig.  3B­D)  and  vacant 
biotin­binding sites back­filled by b­PEG. SE analysis (Fig. 3B­D, right) demonstrates that 
comparable  surface  densities  of  iHS  and  iRGD  could  indeed  be  obtained, 
straightforwardly  for  iHS  (Fig.  3B)  and  iHS  +  iRGD  (Fig.  3C),  and  through  a  further 
modification of  incubation  conditions  (i.e.  a  reduction  in  incubation  time  to 90  s)  for 
iRGD (Fig. 3D; dotted lines). The surface density of aCXCL12α on a sub­monolayer of iHS 
without  iRGD was around 30 ng/cm2 at equilibrium (Fig. 3B), comparable to the values 






Figure  3. Design  and  preparation  of multifunctional  biomimetic  surfaces  presenting 
GAG­bound  chemokine  and  cell  adhesion  ligands.  Schematic  presentation  of model 
surfaces (left) used to study the joint effect of HS­bound CXCL12α (iHS + aCXCL12α) and 
the  immobilized  cell  adhesion  ligand  RGD  (iRGD)  on myoblast  adhesion  and motility; 
Multi-functional surfaces
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  b­HS   CXCL12α   b­CXCL12α b­RGD 
   rrms    rrms    rrms  rrms 
  (ng/cm2) (nm)   (ng/cm2) (nm)   (ng/cm2) (nm) (ng/cm2) (nm) 
Chemokine­presenting surfaces 
iHS + aCXCL12α   35 ± 2 5 ­ 8 a)   78 ± 7 4        
iCXCL12α               60 ± 1 5 
Multi­functional surfaces 
iHS + aCXCL12α + iRGDb) 13 ± 1 8 ­ 13a) 37 ± 3 6 9 ± 2 7 ­ 9a) 
a)  Upper  bounds  are  determined  by  assuming  that  the  average  molecular  mass  of 
surface­bound  molecules  is  identical  to  the  average  solution­phase  molecular  mass; 
lower bounds are determined assuming a  stoichiometry  of  two biotinylated molecules 
per SAv at maximal coverage. 




3.4. Effect  of  co­presentation  of  HS­bound  CXCL12α  with  RGD,  on  myoblast 
adhesion 








4B),  as  expected  for  integrin­mediated  adhesion.  Interestingly  when  the  cells  were 
exposed  to  surfaces  co­presenting  HS­bound  CXCL12α  and  RGD  (iHS  +  aCXCL12α  + 




demonstrates  that HS­bound CXCL12α and RGD promote  cell  adhesion and  spreading 
synergistically. It is particularly interesting that the combined presentation of HS­bound 
CXCL12α  and  RGD  enhances  cell  spreading  already  after  1h  of  exposure,  i.e.  under 
conditions at which HS­bound CXCL12α alone did not have any appreciable effect. This 
suggests  that  the  enhanced  spreading  is more  than  the  simple  superposition  of  two 
independent  adhesion­promoting  cellular  processes.  Co­presentation  of HS with  RGD 
(iHS  +  iRGD)  did  not  affect  cell  spreading  compared  to  RGD  alone  (iRGD).  This 
demonstrates  that  the synergistic effect observed on surfaces co­presenting HS­bound 
CXCL12α and RGD requires CXCL12α. When CXCL12α binding to its cell­surface receptor 











Figure  4.  Effect  of  RGD,  and  co­presentation  of  HS­bound  CXCL12α  with  RGD,  on 
myoblast  adhesion,  spreading  and  circularity.  Adhesion  and  spreading  of  C2C12 



















































































As  CXCL12α  plays  a  key  role  in  trafficking,  by  regulating  the  migration  of  both 
proliferative and terminally differentiated muscle cells, [6, 9, 35] we next addressed the 
question  whether  matrix­bound  CXCL12α,  in  particular  HS­bound,  initiates  cell 
migration. At first, we investigated whether the CXCL12α presentation mode (“a” or ”i”) 
affected  cell  migration.  The  motility  of  C2C12  myoblasts  on  surfaces  with  different 
CXCL12α  presentations  was  assessed  by  recording  time­lapse  images  over  4  h  and 
tracking  individual  cells  (Fig.  5).  Fig.  5A­B  demonstrates  that  the  cells  are  essentially 
immotile on  iHS alone as  the cell  tracks remain confined  to a narrow area around  the 
starting point and the mean velocity  is  low. A significant  increase  in the mean velocity 
(Fig  5B) was  observed when  CXCL12α was  additionally  presented  through  HS  (iHS  + 
aCXCL12α),  demonstrating  that  aCXCL12α  promotes  myoblast  motility.  In  striking 
contrast,  the  cells were  immotile  on  iCXCL12α,  indicating  that  the mode  of  CXCL12α 







Figure  5.  Effect  of  CXLC12α,  RGD  and  their  combination  on  cell  migration.  (A,  D) 
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one  representative measurement).  (B, E) Corresponding box plots of  the mean velocity 
(µm/h)  throughout  4  h  of  exposure,  computed  for  a  total  of  240  cells  from  three 
independent measurements.  (C,  F) Corresponding  variations  in  the mean  velocity as a 
function of time; here, the mean velocity was computed over intervals of 0.5 h and data 
represent  the  average  and  standard  errors  of  the mean  (S.E.M.)  over  240  cells  taken 
from three independent measurements. 
Next, we  investigated  if the co­presentation of the cell­adhesion  ligand with HS­bound 
CXCL12α  affected  cell migration.  For  this  purpose, we  performed motility  assays  on 
multi­functional  surfaces presenting HS­bound CXCL12α  jointly with  iRGD. Figure 5D­F 
demonstrates that the motility of cells  is retained  (although reduced  in magnitude) on 
surfaces that present a roughly 2­fold reduced density of HS­bound CXCL12α compared 
to  HS­saturated  surfaces  (Fig.  5A­C).  In  contrast,  cells  were  immotile  on  surfaces
presenting  iRGD  irrespective  of  the  presence  of  iHS.  Strikingly, HS­bound  CXCL12α  in 
combination with RGD  (iHS + aCXCL12α +  iRGD) promoted a  level of motility  that was 
even  higher  than  that  observed  for  HS­bound  CXCL12α  alone.  Clearly,  HS­bound 
CXCL12α and RGD also have a synergistic effect on motility. Notably, the mean velocity 
of the cells on HS­bound CXCL12α in the presence of RGD rose to a maximum within the 
first  1.5  hours,  and  then  decreased  again  (Fig.  5F).  This  is  in  contrast  to  HS­bound 




CXCL12α  and  its  receptor  CXCR4  have  been  shown  to  play  a  key  role  in  tissue 
development  and  regeneration  [36]  as  mice  deficient  in  CXCR4  exhibited  impaired 
myogenesis  [10].  CXCR4  activation  upon  CXCL12α  binding  induces  various  signalling 





surfaces  that  display  HS  with  chemokines  and  other  ECM  components,  e.g.  integrin 
ligands  promoting  cell  adhesion.  These  model  surfaces  are  well­defined  with  a 












cell  adhesion  ligand  was  involved,  suggesting  that  CXCL12α  alone  also  promotes 
adhesion.  In  addition,  the  adhesion  on  HS­bound  aCXCL12  suggests  that  CXCL12α 
interacts simultaneously and  in  trans with HS and CXCR4, which  is consistent with  the 
observation  that  in  CXCL12α,  the  binding  domains  for  GAG  and  CXCR4  are  spatially 
distant and do not interfere functionally [14]. 
It has been previously  shown  that cell  lines derived  from  satellite cells  such as C2C12 
cells possess the CXRC4 receptor [12]. Moreover, blocking CXCL12α binding to the cell­
surface  receptor  CXCR4  with  the  CXCR4  antagonist  sAMD3100  impaired  cellular 
adhesion (Figs. 2C­E), demonstrating that the adhesion of C2C12 myoblasts to surfaces 
presenting CXCL12α  is mediated by  the specific binding of CXCL12α  to CXCR4. Besides 
CXCR4,  CXCR7  was  also  recently  reported  as  another  CXCL12α  receptor  involved  in 
C2C12 myoblast  response  to  CXCL12α  [13,  37]. However, Dalonneau  et  al.  [23]  have 








This demonstrates that the way  in which the chemokine  is presented, and  in particular 
the presence of HS, is important for regulating cellular behaviour. At the molecular level, 
HS  has  been  shown  to  dimerize  CXCL12α  upon  binding  [33,  38,  39].  In  addition, 
aCXCL12α  was  reversibly  bound  to  HS,  as  CXCL12α  can  be  eluted  in  high  salt 
concentrations [28]. In contrast, iCXCL12α which is monomeric in this presentation was 
bound via strong and stable SAv­biotin bonds and hence quasi­irreversibly bound  (Fig. 
S1B).  The  presentations  of  CXCL12α  presented  though HS  (i.e.  aCXCL12α)  and  in  the 
form of  iCXCL12α are distinct: aCXCL12α  is dimeric  [33] and reversibly bound whereas 
iCXCL12α  is  monomeric  and  quasi­irreversibly  immobilized.  These  differences  might 
account for the differences in cellular responses observed on the two presentations. We 
hypothesize  that  the  cells  prefer  the  reversibly  bound  aCXCL12α  facilitating  its 
internalization, which  could  initiate  internal  signalization  inducing motility which was 
lacking in the quasi­irreversibly bound iCXCL12α. Indeed, internalization of CXCL12α has 
been shown  to  induce downstream signalling  [40]. Future studies should  investigate  if 







ligand  RGD  along  with  chemokines  (bound  to  GAGs).  We  observed a  significant 
enhancement  in adhesion,  spreading and motility on  surfaces co­presenting RGD with 
HS­bound  aCXCL12α  compared  to  each  individual  cue  alone.  Apparently,  CXCR4  (the 
chemokine  receptor)  and  integrins  (the  RGD  receptors)  on  the  cell  surface  can  act 
synergistically  to  control  cellular  adhesion  and  migration.  This  remarkable  effect 
suggests a potential cross­talk between the two receptors.  In fact,  integrins have been 
shown  to mediate phosphorylation of growth  factor  receptors even  in  the absence of 
growth factor  ligands  [41]. Based on this,  it  is possible that  integrins may also activate 
CXCR4  receptors,  which  could  explain  the  fact  that  even  in  the  absence  of  cellular 
response to CXCL12α alone after 1h we still observed a synergistic effect between the 
two receptors  (both  the  integrins and  the activated CXCR4) on co­presentation of  two 
ligands. This  is however a hypothesis, future studies should focus on elucidation of this 
cross­talk between the two receptors. To this end, studies could focus on the different 
signalization events that are  involved  in the  inter­play between the two receptors. For 
example, Moro et al. have reported that  integrins  induce a phosphorylation of specific 






The  strategy  to  design biomimetic  surfaces  developed  here  represents  a  versatile 
experimental  platform  for  mechanistic  studies  of  chemokine­(GAG­bound)­mediated 
cell­cell  and  cell­matrix  communication.  The mode  of  CXCL12α  presentation  plays  an 
important role in myoblast adhesion and adhesion. Chemokine presentation via GAGs is 
a requisite for myoblast motility but not adhesion. These surfaces mimicking the muscle 
extracellular matrix  provide  insights  into  the  role  of  GAG­bound  CXCL12α  presented 
under  physiological  (i.e.  natural)  conditions,  in  muscle  development  and  repair.  A 
synergistic effect,  suggesting  cross­talk between CXCR4 and  integrin was observed on 
co­presentation of GAG­bound chemokines and cell adhesion ligands. Elucidation of this 
cross­talk would  lead  to  further expansion of  the already broad  functions of  integrins. 
This may  have  far­reaching  implications  for  cell­cell  and  cell­matrix  communications 
during  controlled  adhesion  and migration  of myoblasts  in muscle  development  and 
repair. Our  future studies will aim  to  study  the  directed migration  of  C2C12  cells  on
gradients  of  HS­bound  CXCL12α.  The  strategy  to  create  multifunctional  biomimetic 
surfaces  should  find  applications  as mimics  of  the  extracellular matrix  by  presenting 
different matrix or cell surface components in a well­defined way. 
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Figure  S1.  Controls  for  specific  and  oriented  immobilization  of  functional molecules. 
Binding  of  functional molecules  to  the molecular  breadboard,  i.e.  SAv monolayers  on 






detail  by  Migliorini  et  al.  [1]  Briefly,  the  data  indicate  that:  b­HS  is  immobilized 
specifically  through  its  reducing­end  biotin  and  forms  a  soft  and  hydrated HS  film  of 
approximately 12 nm  thickness; CXCL12α binds  specifically  to HS and  rigidifies  the HS 
film, this binding is partially reversible, i.e. some CXCL12α is released over experimentally 
accessible  time  scales  whereas  a  sizeable  fraction  remains  rather  stably  bound  and 
displayed by HS; b­CXCL12α is  immobilized specifically and stably through  its C­terminal 
biotin thus displaying its binding sites for HS and the cell surface receptor CXCR4 towards 
the  solution.  Immobilization  of  b­RGD  (C;  incubated  at  10  µg/mL)  and  b­PEG  (D; 






nm  in  thickness,  expected  for  monolayers  based  on  the  molecules’  dimensions  and 
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1A)  (A­C)  or  on  iRGD  (c.f.  Fig.  3D)  (D­F)  with  or  without  solution­phase  CXCL12α 
(sCXCL12α, 5µg/mL).  (A, D) Representative  fluorescence micrographs of  fixed cells with 
the  nuclei  labeled  in  blue  and  actin  in  red  reveal  no  clear  effect  of  sCXCL12α  on 
































































The  objective  of  this  PhD  thesis was  to  develop  biomimetic  surfaces  that  are  highly 
defined  and  tunable,  for  mechanistic  studies  of  GAG­protein  interactions  on  the 
molecular  and  supramolecular  levels,  and  to  probe  cellular  responses  to  defined 
biochemical and biophysical cues to better understand GAG­mediated cell­cell and cell­
matrix  communications.  In  the  following,  main  achievements  and  their  potential 
extension for further studies are summarized. 
VI.1.	Terminal	functionalization	of	glycosaminoglycans	




be  an  instrumental  technique  for  the  characterization  of  conjugates  made  from 
chemically  complex  molecules  such  as  GAGs,  providing  information  about  reaction 
yields,  sample  degradation  and  sample  composition  that  is  difficult  to  assess  using 
conventional analytical techniques,  in particular when the amount of sample  is  limited 
to a few micrograms. 
This method could be extended for creating GAG conjugates with more complex, multi­
functional  ligands,  for  example  GAG  conjugates  carrying  a  fluorescent  label  (ATTO) 
together with biotin, which would find applicability in a wide range of applications such 
as  imaging,  immobilization  or  enzymatic  detection  (e.g. with  streptavidin­horseradish 
peroxidase). 
Another possible application  is  the design of GAG mimics where different  saccharides 
are  artificially  attached  with  a  particular  conformation.  For  example,  two  different 
oligosaccharides  presenting  sulfate  groups  at  particular  distances  can  be  joined, 
providing a control over the distance between sulfate groups. These conjugates can be 
exploited  to  study  the  effect  of  distance  between  sulfate  groups  on  their  interaction 
with proteins. For  this purpose, a bifunctional  linker presenting  two oxyamine groups 
can be exploited to attach two different oligo or polysaccharides. 
In conclusion,  the method should  find broad use, as a  tool  in  the glycosciences and  in 
biotechnological  applications.  In  particular,  the  control  over  and  stability  of  GAG 
conjugates are  crucial  for  the  reliable preparation of GAG­functionalized  surfaces and 












i.e.  a  SAv  monolayer,  grafted  either  on  OEG  monolayers  or  on  SLBs.  We  have 
demonstrated that the orientation of the  immobilized molecules can be controlled and 
their  surface  density  tuned,  thanks  to  the  surface  design  and  quantitative 
characterization by surface sensitive techniques. In addition, we have demonstrated the 
potential of  this platform  for  functional  studies on  the molecular, supramolecular and 
cellular levels. 
These biomimetic surfaces mimicking  the muscle extracellular matrix provided  insights 
into  the  role  of  CXCL12α  presented  under  physiological  conditions,  in  muscle 
development  and  repair. However,  these  biomimetic  surfaces  are  not  limited  to only 
studying muscle development and repair; they also hold potential for applications well 









demonstrate that  chemokines  and other  growth  factors  cross­link HS  chains, and  this 
cross­linking  ability  is  a  generic  feature  of  these  proteins,  which  depends  on  the 
architecture  of  their  HS  binding  sites.  We  propose  that  several  binding  sites  well 
separated  either  through  GAG­repellent  borders  on  the  protein’s  surface  or  through 
spatial separation in quaternary protein structures, are required for GAG cross­linking. In 
the  case of  the  chemokine CXCL12, we propose a mechanism behind HS  cross­linking 




The  ability  of  extracellular  signaling  proteins  to  influence  matrix  organization  and 
physico­chemical properties implies that the functions of these proteins may not simply 
be confined to the activation of cognate cellular receptors. HS cross­linking on the cell 









the  inner  walls  of  blood  vessels.  Moreover,  changes  in  the  rigidity  of  the  cellular 
glycocalyx through HS­crosslinking may provide a physical cue that guides the behaviour 
of cells.  
The effect demonstrated here may have  far­reaching  implications  for cell­cell and cell­
matrix communication, and our predictions can be tested  in  future  in vitro and  in vivo 
assays. 
VI.4.	Response	of	myoblasts	to	biomimetic	surfaces	
The  strategy  to  create  biomimetic  surfaces  developed  here  represents  a  versatile 
experimental platform for mechanistic studies of chemokine­mediated cell­cell and cell­
matrix  communication, and of  the  role of GAGs  in  chemokine presentation. We have 
demonstrated that the way  in which the chemokine  is presented, and  in particular the 
presence of HS,  is  important  for  regulating myoblast  behavior. Myoblasts  respond  to 
CXCL12α  reversibly  bound  to  its  natural  ligand  HS  with pronounced  adhesion  and 
motility.  In  contrast,  irreversibly  surface­bound  CXCL12α  (in  the  absence  of  HS) 
promoted adhesion but impaired motility. Perhaps, the cells prefer the reversibly bound 
CXCL12α  facilitating  its  internalization,  which  could  initiate  internal  signalization 
inducing specific behavior. Indeed, internalization of CXCL12α has been shown to induce 




bound CXCL12α  can be used where  chemokine  instead of directly  immobilized  to  the 
surface,  is  covalently  attached  to  HS,  thus  similar  to  HS­bound  chemokine,  but with 
impaired CXCL12α release and consequently impaired internalization. This could provide 
further insights into the molecular origin of the distinct cellular behaviours observed. 
This  thesis  has  provided  novel  insights  in  the  role  of  GAGs  in  chemokine­mediated 
myoblast  behaviour.  In  addition,  the work  has  raised many  other  questions  that will 
require further work for which the biomimetic surfaces are very useful. Several possible 
directions  of  future  study  are  described  below.  To  understand  the  origin  of  different 
cellular  responses  on  HS­bound  and  immobilized  CXCL12α,  cellular  responses  on 
surfaces  that  present HS  and  immobilized  CXCL12α, where  CXCL12α  instead  of  being 
adsorbed to HS is directly immobilized on the surface, can be studied, and compared to 








get  polarised  during  movement?  Future  studies  can  be  focused  on  studying  the 
mechanism  involved  in  cellular  motility.  Next,  we  observed  a  strikingly  distinct 
morphology of the cells on iCXCL12α (i.e. CXCL12α quasi­irreversibly immobilized to the 
surface in the absence of HS), i.e. the formation of actin­rich protrusions. Future studies 
can  be  focused  on  understanding whether  these  protrusions  are  integrin  rich  and  if 
integrins are also  involved  in the profound cellular adhesion observed on  iCXCL12α. To 
this end,  integrin  labelling can be done, to  identify  if and which  integrins are  involved. 
Other  important questions  that arise are: are these protrusions static or dynamic, and 
do  these protrusions belongs  to  filopodia or  lamellipodia  type? Future  studies  can be 
focused in finding answers to these questions. 
We  next  designed  multifunctional  surfaces  that  mimic  certain  aspects  of  in  vivo 
conditions. We report a significant enhancement in adhesion, spreading and motility on 
surfaces  co­presenting RGD with HS­bound CXCL12α  compared  to each  individual  cue 
alone. This demonstrates that the cell receptors CXCR4 (CXCL12α receptor) and integrins 
(RGD receptor) can act synergistically in controlling cellular adhesion and migration. This 
suggests  a  cross­talk  between  CXCR4  and  integrin.  Future  studies  can  be  focused  on 
elucidation  of  this  phenomenon.  For  this  purpose,  biochemical  signaling  assays 





During  this  PhD  thesis,  model  biomimetic  surfaces  were  designed,  which  are  well­
defined  (i.e.  the  orientation  of  ligands  can  be  controlled,  thus  guaranteeing  their 
functionality,  in a background of  low non­specific binding), and  the  surface density of 
each ligand can be quantitatively tuned, thus fulfilling the goal of the thesis. In addition, 
the  PhD  thesis  has  also  demonstrated  the  potential  of  these  biomimetic  surfaces  in 
interrogating the role of HS in chemokine­mediated myoblast behavior in the context of 
muscle development and repair. An important process involved in muscle development 
and  repair  is  the  migration  of  myoblasts  in  response  to  gradients  of  HS­bound 
chemokines.  These  biomimetic  surfaces  open  the  door  to  mechanistic  studies  of 
myoblast migration.  To  this  end,  these  surfaces  present  excellent  platforms  for  the 
preparation of  gradients of HS­bound  chemokines.  In particular, micro­fluidic  systems 




















Lobjectif  de  cette  thèse  concerne  le  développement  de  surfaces  biomimétiques 
parfaitement  définies  et  modulables,  pour  l’étude  mécanistique  des  interactions 
protéine­GAG aux niveaux moléculaires et supramoléculaires, et pour sonder la réponse 
cellulaire  aux  signaux  biochimiques  et  biophysiques  afin  de  mieux  comprendre  les 
communications  cellule­cellule  et  cellule­matrice  induites  par  les  GAGs.  Dans  les 
paragraphes suivants, les principales réalisations et les perspectives pour de plus amples 
études sont résumées. 
VI.1.	 Fonctionnalisation	 des	 glycosaminoglycanes	 à	 leur	 extréminité	
réductrice	
Nous  avons  établi  que  le  lien  oxime  constitue  une méthode  simple  qui  permet  de 
réaliser la conjugaison sélective des GAG à leur extrémité réductrice en une seule étape. 
La  méthode  conduit  à  des  rendements  supérieurs  et  à  une  meilleure  stabilité  par 
rapport  au  lien  hydrazone  qui  est  couramment  utilisé.  La  méthode  est  polyvalente 
puisqu’elle peut être appliquée à une grande variété de GAGs (probablement à tous les 
GAGs  quels  qu’ils  soient).  De  plus,  nous  avons  démontré  que  la  QCM­D  est  une 
technique  instrumentale utile  à  la  caractérisation des  conjugués  fabriqués  à partir de 
molécules chimiquement complexes  tels que  les GAGs. La QCM­D  fournit en effet des 




des  ligands multifonctionnels,  par  exemple  des  GAGs  portant  à  la  fois  un marqueur 
fluorescent (ATTO) et un groupe biotine. Ce mode de conjugaison pourra être appliqué 
dans  de  nombreux  domaines  tels  que  l'imagerie,  l'immobilisation  ou  la  détection 
enzymatique  (par  exemple  avec  l’utilisation  de  la  streptavidine  fonctionnalisée  par  la 
peroxydase de raifort). 
Une  autre  application  possible  est  la  conception  de  mime  de  GAGs  où  différents 
saccharides sont fixés artificiellement avec une conformation particulière. Par exemple, 
deux  oligosaccharides  présentant  des  groupes  sulfate  à  des  distances  particulières 
pourraient être couplés avec un contrôle de  la distance entre  les groupes sulfate. Ces 
conjugués  pourraient  être  exploitées  pour  étudier  l'effet  de  la  distance  entre  des 
groupes  sulfate  sur  leur  interaction  avec  des  protéines.  A  cet  effet,  un  espaceur 






En  conclusion,  la  technique  de  couplage  devrait  être  largement  utilisée  comme  outil 
dans  le domaine des glycosciences et pour des applications biotechnologiques. Dans  le 
cadre  d’applications  telles  que  l'ingénierie  tissulaire  ou  pour  des  études  biologiques 
fondamentales, le contrôle et la stabilité de conjugués de GAG sont fondamentaux pour 






portant  des  GAGs  et  d'autres  composantes  de  la  surface  cellulaire  ou  des matrices 
extracellulaires, sur un substrat résistant aux  interactions non­spécifiques. Ces surfaces 
biomimétiques sont basées sur une plateforme constituée d’une monocouche de SAv, 
fixée  sur  une  monocouche  d‘OEG  ou  sur  une  SLB.  Nous  avons  démontré  que 
l'orientation des molécules  immobilisées peut être contrôlée et  leur densité de surface 




Ces  surfaces  biomimétiques  reproduisant    la matrice  extracellulaire  des muscles  ont 
permis de comprendre  le rôle de  la chimiokine CXCL12α présentés dans des conditions 
physiologiques,  dans  le  développement  et  la  réparation musculaire.  Cependant,  ces 
surfaces biomimétiques ne sont pas limitées uniquement à l'étude du développement et 
de  la  réparation musculaire; elles  recèlent également un potentiel d’applications bien 
au­delà  ce qui est exploitée dans  cette  thèse. En  fait,  toutes  les biomolécule peuvent 
être greffées sur ces surfaces, à condition d’être préalablement biotinylées. Des études 
mécanistiques  cellulaires  peuvent  alors  être  effectuées  pour  interroger  leur  fonction 
biologique.  Ces  surfaces  devraient  également  trouver  une  large  applicabilité  dans  les 
études  mécanistiques  où  les  réponses  cellulaires  à  différentes  présentations  de 
biomolécules  sont  à  étudier.  La  stratégie  visant  à  créer  des  surfaces  biomimétiques 
multifonctionnelles  qui  présentent  différentes  biomolécules  devraient  être  largement 
applicables pour interroger le crosstalk entre deux récepteurs cellulaires. 
VI.3.	Interactions	supramoléculaire	HS­chimiokines	
Les  surfaces  biomimétiques  ont  été  utilisés  pour  étudier  les  interactions 
supramoléculaires  protéine­HS.  Nous  démontrons  que  les  chimiokines  et  d'autres 
facteurs de croissance réticulent  les chaines de HS. Cette capacité à réticuler  les HS est 


















des HS sur  la surface cellulaire ou de  l'ECM conduit à une réduction de  l'épaisseur des 
couches  péricellulaires.  Cette  diminution  d’épaisseur    rendrait  accessibles  les  ligands 
d'adhésion cellulaire   alors qu’ils  sont habituellement enfouies dans  la matrice, ce qui 
faciliterait  les  contacts  cellule­cellule  et  cellule­matrice.  Cette  adhésion  est 
particulièrement  importante car elle provoque  la  traction nécessaire aux cellules dans 
leur  mouvement    (sur  la  surface),  en  l'absence  de  laquelle  les  cellules  seraient  e  
emportées  par  le  flux  sanguin  par  exemple,  dans  le  contexte  de  la  migration  des 
leucocytes  au  niveau  des  parois  internes  des  vaisseaux  sanguins.  De  plus,  des 
changements  de  rigidité  du  glycocalyx  cellulaire  par  la  réticulation  des  HS  peuvent 
fournir un signal physique qui guide le comportement des cellules.  




La  stratégie  développée  ici  pour  créer  des  surfaces  biomimétiques  conduit  à  la 
conception  d’une  plate­forme  expérimentale  polyvalente  pour  la  réalisation  d‘études 
mécanistiques  de  communication  cellule­cellule  et  cellule­matrice  induites  par  les 
chimiokines,  et  pour  analyser  le  rôle des GAGs dans  la présentation des  chimiokines. 
Nous avons démontré que la manière dont la chimiokine est présentée, et en particulier 
la présence du HS, est importante dans la régulation du comportement des myoblastes. 
Les myoblastes  répondent  à  la  chimiokine  CXCL12α  liée  réversiblement  à  son  ligand 
naturel  le HS par une adhésion et une motilité accrues. En revanche,  la CXCL12α  fixée 
irréversiblement à  la  surface  (en  l'absence de HS)  favorise  l'adhésion mais diminue  la 
motilité.  Les  cellules  préfèrent  peut­être  les  CXCL12α  liées  réversiblement,  ce  qui 
faciliteraite  son  internalisation et   déclencherait  la  signalisation  interne  induisant ainsi 







HS  sur  la  signalisation  qui  n’est  pas  détectée  dans  les  tests  utilisés  ici  d'adhésion 
cellulaire et de motilité. A cet effet, la chimiokine marquée par fluorescence pourra être 
utilisée.  Une  autre  configuration  de  la  CXCL12α  liée  irréversiblement  pourra  être 
impliquée,  il s’agit de  la chimiokine  fixée de manière covalente aux chaînes de HS. Ce 
mode de fonctionnalisation sera plus proche de celui correspondant à la chimiokine liée 
réversiblement au HS mais sans la possibilité de libérer la  CXCL12α ni son internalisation 
par  la  cellule. Cela pourrait permettre de mieux  comprendre  l'origine moléculaire des 
comportements cellulaires distincts observés. 
Cette  thèse  a  permis  d’approfondir  les  connaisssances  sur  le  rôle  des  GAGs  dans  le 
comportement  des  myoblastes  induits  par  les  chimiokines.  De  plus,  cette  étude  a 
soulevé  de  nombreuses  autres questions qui  nécessiteraient  la  poursuite des  travaux 
pour  lesquels  les  surfaces  biomimétiques  seront  très  utiles.  Plusieurs  directions 
possibles    pourraient  être  explorées,  elles  sont  décrites  ci­dessous.  Pour  comprendre 
l’influence de  la présentation de  la  chimiokine  sur  les différentes  réponses  cellulaires 
une étude pourra être  réalisée  sur des  surfaces qui présentent d’une part  le HS et  la 
CXCL12α fixée irréversiblement sur la surface et d’autre part des surfaces où la CXCL12α 
est  liée  au HS  avec  des  densités  surfaciques  similaires.  La  comparaison  des  réponses 
fournirait de nouvelles informations sur l'importance de la présentation des chimiokines 
et le rôle du HS dans les réponses cellulaires. 
La mobilité  cellulaire  observée  sur  les  surfaces  fonctionnalisées  par  la  CXCL12α  liée 
réversiblement  au  HS  soulève  une  autre  question:  les  cellules  sont­elles  polarisées 
pendant  le  mouvement?  Les  futures  études  pourraient  être  axées  sur  l'étude  du 
mécanisme  impliqué dans  la motilité  cellulaire. Nous avons observé une morphologie 
cellulaire bien distincte sur iCXCL12α (CXCL12α quasi­irréversiblement immobilisée sur la 




les  intégrines  sont  impliquées  et  le  type  d’intégrine  impliqué.  D'autres  questions 
importantes se posent : ces protrusions sont­elles statiques ou dynamiques, et de quelle 












suggère un cross­talk entre  le CXCR4 et  l'intégrine. Les  futures études pourraient être 
axées  sur  l'élucidation  de  ce  phénomène.  A  cet  effet,  des  tests  biochimiques  de 
signalisation  exploitant  les  surfaces  biomimétiques  développées  ici  pourront  être 




Au  cours  de  cette  thèse,  des  surfaces  biomimétiques modèles  bien  définies  ont  été 
conçues  (par exemple  l'orientation des  ligands peut être contrôlée ce qui garantit  leur 
fonctionnalité  sur  des  surfaces  passivées  qui  limitent  l’adsorption  non­spécifique  des 
cellules), et la densité de surface de chaque ligand peut être quantitativement modulée, 
remplissant ainsi l'objectif de  la thèse. De plus, ces travaux ont également démontré  le 
potentiel  de  ces  surfaces  biomimétiques  à  interroger  le  rôle  des  HS  dans  le 




des  études  mécanistiques  concernant  la  migration  des  myoblastes.  A  cet  effet,  ces 
surfaces  constituent  d’excellentes  plates­formes  pour  la  préparation  de  gradients  de 





sur  les  processus  physiologiques  et  pathologiques  tels  que  le  développement,la 
réparation musculaire, et  l'inflammation. 
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Well­defined  biomimetic  surfaces  to  characterize  glycosaminoglycan­mediated  interactions  on 
the molecular, supramolecular and cellular levels 
The  oriented  migration  and  controlled  adhesion  of  cells  is  fundamental  to  many  physiological  and  pathological 
processes. A  family of  linear polysaccharides,  known  as  glycosaminoglycans  (GAGs), help organizing  and  presenting 
signaling  proteins,  so­called  chemokines, on  the  cell  surface  and  in  the  extracellular matrix  thus  regulating  cellular 
behavior. The objective of this PhD thesis was to develop biomimetic surfaces that are highly defined and tunable, for 
mechanistic  studies  of GAG­protein  interactions  on  the molecular  and  supramolecular  levels,  and  to  probe  cellular 
responses  to defined biochemical  and biophysical  cues  to better understand GAG­mediated  cell­cell  and  cell­matrix 
communications. 
Applying oxime ligation, GAGs could be stably functionalized with biotin at the reducing end, and these features proved 
crucial  for  the  reliable preparation of GAG­functionalized  surfaces. A  streptavidin monolayer  served as a  ‘molecular 
breadboard’ to sequentially assemble biotinylated molecules with controlled orientation and surface densities. GAGs 
(heparan  sulfate  (HS)  in  particular),  chemokines  and  other  ECM  components  (e.g.  integrin  ligands  promoting  cell 
adhesion, RGD) were assembled into multifunctional surfaces that recapitulate selected aspects of the in vivo situation. 











Surfaces biomimétiques pour  caractériser  les  interactions  induites par  les glycosaminoglycanes 
aux niveaux moléculaire, supramoléculaire et cellulaire 
L'adhésion contrôlée et la migration orientée des cellules est fondamentale pour plusieurs processus physiologiques et 
pathologiques.  Une  famille  de  polysaccharides  linéaires,  connus  sous  le  nom  de  glycosaminoglycanes  (GAG)  est 
impliquée dans l'organisation et la présentation des protéines de signalisation, les chimiokines, à la surface des cellules 




En utilisant  la  ligation oxime,  les GAGs peuvent être fonctionnalisés de manière stable par  la biotine à  leur extrémité 
réductrice, ce mode de couplage s’est avéré déterminant pour préparer des surfaces fonctionnalisées par les GAGs de 
manière  stable.  Une  monocouche  de  streptavidine  est  utilisée  comme  plateforme  modulable  pour  assembler 
séquentiellement les molécules biotinylées, avec une orientation et des densités de surface contrôlées. Des GAGs (les 




supramoléculaires  entre  le  HS  et  la  chimiokine  SDF­1α/CXCL12α  facteur  d’origine  stromale  et  pour  analyser  les 
réponses cellulaires aux signaux extracellulaires. Nos données apportent la preuve que la chimiokine, CXCL12α rigidifie 
les assemblages de HS, et que cet effet est dû à la réticulation des chaînes de HS induite par la protéine. La cinétique 
des  interactions HS­chimiokine a été quantifiée en utilisant  la  résonance plasmonique de  surface  (SPR). Nous avons 
également démontré que  le mode de présentation de  la chimiokine sur  la surface, en particulier  la présence des HS, 
influence le comportement des myoblastes. Nos données montrent que les récepteurs cellulaires CXCR4 (récepteur de 
la  CXCL12α)  et  l’intégrine  (récepteur  du  RGD)  peuvent  agir  en  synergie  pour  contrôler  l'adhésion  et  la migration 
cellulaire. Ces surfaces modèles fournissent des indications précieuses qui pourront être appliquées au domaine de la 
glycobiologie, par exemple, pour étudier le rôle des GAGs dans la migration cellulaire induite par les chimiokines. 
Mot clés: Heparane sulfate, chimiokine, surface biomimétique, interactions HS­protéine, interactions cellule­matrice   
